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Many drugs have poor aqueous solubility which causes problems for their formulation 
as effective medicines. One way of solving this problem involves solubilizing drugs 
using aqueous dispersions of self-assembled surfactant micelles. It is well-established 
that surfactant micelles can solubilize drug, but where the drug will locate within the 
micelles and the factors that affect this are not fully understood. It is the locus of drug 
solubilization, however, that is thought to be important in determining the loading-
capacity of the micelles, and it is this too that affects the drug’s stability and its rate of 
release inside the body and so it also impacts the drug’s therapeutic activity.  
In order to gain a better understanding of the location of drug in surfactant micelles, a 
series of systematic studies have been performed to determine the extent and locus of 
solubilization of two poorly water-soluble steroids, 4-cholesten-3-one (4-CHOL) and 
adrenosterone (ADRENO) compounds in a range of C12-chain surfactant of varying 
head group. 
The solubilisation capacities of steroids in the various surfactant micelle, as well as 
the interfacial and solvation behaviour of the various surfactant systems were 
explored. In order to estimate the preferred site(s) of solubilization of the steroids 
within the micelles, neutron techniques (both small-angle neutron scattering (SANS) 
and specular neutron reflectivity (SNR)) in combination with isotopic (H/D) contrast 
variation were used. The NR study revealed that regardless of the nature of the head 
groups, steroids were solubilised within the hydrophobic chain of surfactant at the air-
water interface. The SANS studies were in good agreement with the NR study, and 
also suggested in some cases the presence of steroids could change the shape of the 
micelle.   
The information gained in these studies has provided for a more complete 
understanding of the relationship between the structure of a surfactant and the structure 
of the micelles likely to be formed when loaded with steroid drugs, allowing 
predictions to be made to guide the design of new surfactants to optimize steroid drug 
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Chapter 1  
 
Introduction 
1.1 Background  
The oral route of drug administration is generally regarded as the preferred route of 
administration, partly because it offers greater convenience and is more cost effective 
than other routes but also because it is the route that is preferred by most patients (in 
the UK, at least) and so leads to a higher level of patient compliance [1, 2]. The 
formulation of drugs for oral administration, however, regularly presents problems, 
the greatest challenge generally being to ensure a high bioavailability of the drug – 
ensuring that sufficient drug enters the patient to give the required clinical effect.  
Bioavailability is the proportion of active drug that enters the systemic circulation. For 
drugs given intravenously by injection, bioavailability is (by definition) 100% but 
drugs given orally generally have a much reduced bioavailability, this decrease arising 
because of their poor absorption and/or extensive first-pass metabolism [3, 4]. The 
dose of a drug given orally, therefore, is usually much higher than that given 
parenterally. For example, for the steroidal drug testosterone, the initial dosing for 
injection is 50 – 400 mg every 2 – 4 weeks, but when the drug is given by oral 
administration, one tablet (30 mg) is required every 12 hours [5].  
In order for an orally administrated drug to reach its required site of action, it must 
first dissolve in the gastrointestinal (GI) fluids of the digestive system and it must then 
permeate the intestinal wall and enter the bloodstream [6]. Drugs that have low 
aqueous solubility will dissolve only poorly in the GI tract, and they will thus have 
poor bioavailability, and will need to be administered at higher doses to achieve the 
required therapeutic plasma concentrations. For any drug with a water-solubility less 
than 100 µg/mL, the bioavailability achieved following oral administration is likely to 




Recent years have seen an increasing number of drug candidates developed by the 
pharmaceutical industries that fall into class 2 (low solubility, high permeability) and 
class 4 (low solubility, low permeability) on the Biopharmaceutics Classification 
System  [8]. Such compounds are considered poorly water-soluble because they have 
an aqueous solubility lower than 100 µg/mL (0.01 wt%).  It is reported that over 70% 
of the new drug candidates have poor aqueous solubility and approximately 40% of 
the new chemical entities are practically insoluble (Table 1.1) [9-11]. There has thus 
been much interest in the development of formulation strategies to improve 
bioavailability [12-14]. 
Table 1. 1 Definition of solubility of solute at 20 oC [15] 
 Solubility (wt%) 
Very soluble > 100 
Freely soluble 10 – 100 
Soluble 3.3 – 10 
Sparingly soluble 1 – 3.3 
Slightly soluble 0.1 – 1 
Very slightly soluble 0.01 – 0.1 
Practically insoluble < 0.01 
 
The various formulation strategies employed to overcome poor drug solubility have 
been summarized by Williams et al. [16]. These strategies include the use of buffers, 
the use of co-solvents, salt formation, and size reduction of the solid drug particles. 
However, these approaches each have their own limitations. Some drug solids are not 
readily amenable to effective particle size reduction, for example, and the use of 
buffers and salt formation are strategies that are only useful for ionized drugs [17, 18].  
The use of self-assembled surfactant micelles for solubilising poorly water-soluble 





Surfactants are often called surface-active agents (SAAs) and they play important 
roles as wetting agents, detergents, emulsifiers, foaming agents and dispersants in drug 
formulation [21]. Surfactants are amphipathic, possessing both hydrophilic (water-
loving) and hydrophobic (water-hating) components, and the self-assembled 
aggregates they form are referred to as micelles. Generally, the hydrophobic part of a 
surfactant consists of a long hydrocarbon chain (often referred to as the surfactant tail 
group) and the hydrophilic head group can be either ionic, non-ionic or zwitterionic. 
The most common surfactant examples are shown in Figure 1.1.  
The hydrophilic regions of conventional non-ionic surfactants consist of a 
polyoxyethylene chain (see Figure 1.1 (IV)). The polar/hydrophilic head groups of the 
ionic surfactants can carry negative or positive charges and these are referred to as 
anionic and cationic surfactants, respectively. The negatively charged head groups of 
anionic surfactants associate with positively charge counterions such as sodium, 
lithium, potassium, or ammonium ions. In these surfactants, the sulfonate head group 
is one of the most common [21], and a typical example is shown in Figure 1.1 (I). In 
cationic surfactants, a trimethylammonium moeity in the polar head group is common, 
and this is most often associated with a counterion of bromide or chloride (see Figure 
1.1 (II)). Surfactants that possess both positive and negative charges are referred to as 
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Figure 1. 1 Examples of common I-anionic surfactant (SDS), II – cationic surfactant 





In aqueous solution, due to their amphiphilicity, surfactant molecules tend to adsorb 
at the water surface – at the air-water interface – with their hydrophilic head groups 
immersed in the water and their hydrophobic groups directed outwards into the air. 
The intrusion of the surfactant molecules at the water surface leads to a reduction in 
the surface free energy because the intermolecular forces between the surfactant and 
the water molecules are much lower than those between water molecules [22]. The 
presence of surfactant at the interface thus lowers the surface tension of the solution. 
1.3 Micellisation 
1.3.1 The critical micelle concentration 
When surfactant molecules accumulate at the air-water interface they tend to form a 
monolayer across the surface. As the surfactant concentration is increased, the 
surfactant monomers become more closely packed at the surface and eventually, when 
no further molecules can be accommodated at the surface, the excess surfactant forms 
aggregates in the bulk. These aggregates are the surfactant micelles, and the 
concentration at which they begin to appear is termed the critical micelle concentration 
(CMC).  
The experimental determination of the CMC of a surfactant can be made by 
monitoring the changes seen in the physical properties of the surfactant solution as a 
function of surfactant concentration (for a review, see Mukerjee et al. [23, 24] ). One 
of the techniques most commonly used involves measurement of surface tension. With 
this technique, the concentration of a surfactant solution is increased progressively and 
the resulting change in surface tension is measured. At and above the CMC of a 
surfactant the surface tension of the solution ceases to decrease. Other forms of 
measurement that are used in determination of surfactant CMC are detailed by 
Mukerjee and Mysels [23]. 
1.3.2 Micelle structure 
Above the CMC, the nanoscale micelle is formed as a ‘core-shell’ structure with the 
apolar/hydrophobic chains of the surfactant molecules forming the micelle core. The 




groups of the surfactant molecules. The head groups of the surfactant molecules 
interact with the surrounding water molecules via hydrogen bond and/or ion-dipole 
interactions.  
The main driving force for the formation of micelles is the minimisation of the free 
energy of the surfactant-water system, which is otherwise increased by the disruption 
of the water structure caused by the presence of surfactant. The geometrical diversity 
seen in the size, shape and internal structure of surfactant micelles arises from the 
various competing forces that operate during self-assembly. These forces include the 
hydrophobic effect that leads to the removal of the surfactant hydrophobes from 
contact with water and their interaction with one another via van der Waals forces, the 
hydrogen bonding and electrostatic interactions that favour immersion of the 
surfactant head groups in the water, and the repulsive (electrostatic) interactions 
between the surfactant polar head groups which tend to keep the molecules apart [20].  
 For the structure of micelles formed by ionic surfactants (Figure 1.2, (a)), there is a 
Stern layer immediately surrounding the micelle core which contains both the ionic 
head group and (1-α)N counterions, where α is the degree of ionization (generally from 
0.2 to 0.5) and N is the micelle aggregation number [22]. Surrounding the Stern layer 
there is a diffuse layer – termed the Gouy-Chapman layer – that contains the remaining 
αN counterions and neutralises the charge on the micelle.  
In the micelles formed by non-ionic surfactants with a polyoxyethylated head group 
(Figure 1.2, (b)) the hydrophobic core of the micelle is surrounded by the so-called 










hydrated. The micelles formed by non-ionic surfactants are usually larger and more 
elongated than those formed by ionic surfactants. 
Zwitterionic surfactants are of particular interest for drug solubilisation because of 
their high aqueous solubility and their insensitivity to the presence of salt and changes 
in temperature [25]. The micelles formed by zwitterionic surfactants are generally 
small and close to spherical  [26], and since their surfaces carry both negatively 
charged and positively charged groups their behaviour is not like ionic or nonionic 
surfactant micelles but more like the micelles that are formed by ionic surfactants in 
salt-containing media [27]. For surfactants having a common hydrophobe, the micelles 
of non-ionic surfactants are formed more readily than those formed by zwitterionic 
and ionic surfactants [28].  
Most surfactant micelles are assumed to be approximately spherical when the 
surfactant concentration is near the CMC [29] but their shape will invariably change 
with an increase in the surfactant concentration, with the addition of  electrolyte, or a 
change in temperature. It is common for a micelle to change to a more asymmetric 
form when one of these conditions changes.  
It should be noted here too that a surfactant micelle is not a permanent ‘frozen’ 
structure but a dynamic structure in which there is a constant exchange of surfactant 
molecules between the aggregate and the continuous phase. This exchange of unimers 
is very rapid, the lifetime of a surfactant molecule within a micelle estimated to be 
between 10-5 and 10-3 s [21]. 
1.3.3 Factors affecting the critical micelle concentration and micellar 
aggregation 
The properties of the micellar solution of a surfactant change remarkably when the 
surfactant concentration is above the CMC. Efforts are thus invested in determining 
the CMC of a surfactant and in elucidating the factors that affect the CMC. From a 
pharmacological point of view, the micelles that are formed by surfactants with low 
CMCs are more stable in use, because they are less perturbed by their dilution within 
the large volume of the gastrointestinal fluids before they enter the systemic 




Nature of the hydrophobic group 
For surfactants with an alkyl chain hydrophobe, an increase in the alkyl chain length 
(up to 16 carbon atoms) is shown to lead to a decrease in the CMC [31]. For most ionic 
surfactants, an increase of one methylene group in the hydrocarbon chain results in the 
CMC being reduced by half [22]. For non-ionic surfactants, this effect is even more 
pronounced, with the addition of one methylene group to the alkyl chain decreasing 
the CMC to one-third of its original value [32].  
As might be expected, an increased length of a surfactant hydrophobe leads to a larger 
micelle size, and in many cases there is a linear relationship between the log micelle 
weight and the hydrocarbon chain length [22, 33]. The linear relationship between 
micelle aggregation number and the number of carbon atoms in the alkyl chains of 
non-ionic surfactants was first demonstrated by Arnarson and Elworthy [34] and later 
confirmed by Oliver et al. [35]. Tanford [36] also pointed out that the increase in 
micelle aggregation number caused by increased surfactant alkyl chain length varies 
according to the geometry of the micelle: for a prolate ellipsoid micelle, the 
aggregation number is predicted to increase by 12 – 15 monomers with each additional 
carbon in the alkyl chain, and for oblate micelles, there is an increase of 20 – 25 
monomers in the aggregation number per additional carbon atom.  
Mukerjee [37] proposed that when the number of carbon atoms in a surfactant’s alkyl 
chain exceeds 16 there is no further change in CMC because of the coiling of the 
hydrophobe.  
For surfactants with branched hydrocarbon chain hydrophobes, the change in CMC 
due to increasing carbon chain length is not as high as in the equivalent straight chain 
surfactant [38]. It has also been shown that the introduction of a phenyl group into a 
surfactant hydrophobe leads to a change in the CMC equal to that caused by the 
addition of three and a half methylene groups, while substitution of the terminal 
methyl in an alkyl chain by the CF3 group leads to a doubling of the CMC [22].  
Nature of the hydrophilic group 
For surfactants with alkyl chain hydrophobes longer than C10H21, the CMCs increase 
in the order non-ionic surfactants < zwitterionic surfactants < ionic surfactants [39]. 




of ionic surfactants as a consequence of the lower electrical work required in formation 
of the micelles [40].  
An increase in the length of the polyoxyethylene head group in a non-ionic surfactant 
makes the surfactant more hydrophilic, leading to an increase in CMC and to a 
decrease in micelle size. It is reported by Chen et al., for example, that the CMCs of 
nonionic surfactants C10E4 and C10E8 are 0.67 and 1.1 mM at 25 
oC, respectively [41]. 
For ionic surfactants, the presence of charged groups within their polar head groups 
requires more electrical work to be done to form a micelle. This additional work causes 
an increase in the surfactant CMC, and the CMC is increased further when the charged 
groups are closer to the α-carbon atom in the hydrocarbon chain [42]. Stigter [42] 
explained that when ionic surfactants form micelles, the head groups must move from 
the bulk water to the vicinity of the non-polar core of the micelle, and this leads to an 
increase in the electrostatic self-potential of the surfactant ion, and so more work must 
then be done to move the (charged) head group closer to the lower dielectric medium. 
The CMCs of ionic surfactants are also affected by their binding of counterions, with 
increased binding strength leading to an increase in the polarizability of the 
surfactant’s ionized head group and causing a decrease in its hydrated ionic radius. In 
general, the order of CMCs of ionic surfactants with alkyl chain hydrophobes decrease 
in the order: aminium salts > carboxylates > sulfonates > sulfates [43].  
Anacker et al. [44] have also found that size of an ionic surfactant micelle is influenced 
by the distance separating its centre of charge and the counterion. These workers 
demonstrated, for example, that the size of micelle formed by decylammonium 
bromide is much larger than that formed by decyltrimethylammounium bromide due 
to the fact that the Br- counterions are much closer to the N+ of the decylammonium 
moiety. With a shorter distance, the repulsive electrical forces are effectively shielded 
and a larger micelle is allowed to form.   
Electrolytes 
The presence of electrolytes in a surfactant solution causes a decrease in the surfactant 
CMC and an increase in the micelle aggregation number, and these effects are more 
pronounced for ionic surfactants than for zwitterionic or nonionic surfactants [45]. The 




increased screening of the head group charges which allows more surfactant molecules 
to insert into the micelle without increasing the free energy of the system. For 
zwitterionic and nonionic surfactants there is very little effect of added electrolyte on 
micelle size [37].  
Temperature 
In contrast, the effect of temperature on the aggregation number of ionic surfactant 
micelles is much smaller than for nonionic surfactant micelles. Increased temperature 
leads to a slight decrease in the aggregation number of ionic surfactant micelles but 
leads to a significant increase in the aggregation number of nonionic surfactant 
micelles. 
The effect of temperature on the CMC of a surfactant, however, is more complex. An 
increase in temperature initially leads to a decrease in CMC but then further increases 
in temperature cause the CMC to increase again [45]. Rosen [45] explains that the 
increased temperature causes a dehydration of the surfactant head group but also 
disrupts the structure of the water surrounding the head groups. These two opposing 
effects thus cause a minimum CMC of the surfactant over a particular temperature 
range. For ionic surfactants, the minimum CMC is generally around 25 oC, while for 
nonionic surfactants it is around 50 oC [46]. There are only limited data available of 
the effect of temperature on the CMCs of zwitterionic surfactants, but Tori reports that 
temperature increases over the range 6 – 60 oC cause the CMC to decrease steadily 
[47].  
1.4 Solubilisation 
An important property of surfactant micelles as regards their use in pharmacy is their 
ability to increase the apparent solubility of drug substances that are otherwise poorly 
soluble in aqueous media. Rosen defines micellar solubilisation as “the spontaneous 
dissolving of a substance by reversible interaction with the micelles of a surfactant in 
water to form a thermodynamically stable isotropic solution with the reduced 
thermodynamic activity of the solubilised material.” [45]. From a thermodynamic 
point of view, the solubilisation of drug within surfactant micelles can be considered 




The increase in apparent solubility of a drug within a surfactant solution is only 
observed when the concentration of the surfactant is above the CMC [48]. The extent 
of micellar solubilisation of a given solute can be described by the molar solubilisation 
capacity, which is defined as the number of moles of solute solubilised per mole of 
surfactant. In practice, however, the solubilisation capacity is also expressed as the 
weight of solute solubilised per unit weight of surfactant, because it is this quantity 
that is important as regards formulation of the drug.  
It is generally observed that an increase in surfactant concentration leads to an increase 
in its solubilisation capacity for a given solute [29, 49].  
1.4.1 Locus of the solubilisation  
The site of solubilisation of a given solute within a surfactant micelle is generally 
believed to be determined by the chemical structure of the solute. The locus of the 
solubilisation reflects the type(s) of interaction between surfactant and solubilisate 
molecules and is an important determinant of the extent to which the material is 
solubilised. Experimental data on the micellar solubilisation location have previously 
been obtained mainly using X-ray diffraction, absorption spectrometry, nuclear 
magnetic resonance spectroscopy, fluorescence depolarization, and electron spin 
resonance [22]. The main sites of solubilisation within micelles (Figure 1.3) are shown 
to be: 1) at the micelle-solvent interface; 2) between the polyoxyethylene hydrophilic 
head groups (in the case of nonionic surfactant micelles); 3) between the head group 
and the first few carbon atoms of the hydrophobic tail group; 4) more deeply within 
the tail region; and 5) in the micelle core.  
    







The locus of solubilisation of a solute within a surfactant micelle is independent of the 
surfactant concentration. For both concentrated and dilute aqueous surfactant 
solutions, polar solutes tend to be solubilised in the outer regions of a surfactant 
micelle, whereas nonpolar solutes are solubilised in the micelle core [45].  
1.4.2 Factors affecting solubilisation capacity 
Structure of the surfactant 
The solubilisation capacities of surfactants vary according to the surfactant type. For 
solubilisates which go into the micelle core or that penetrate deep into the palisade 
layer, it can be expected that there is a pronounced dependence of the solubilisation 
capacity on the surfactant alkyl chain length. An increase in the hydrocarbon chain 
length leads to increased solubilisation of hydrocarbon in the interior of the micelle, 
and the effect is more pronounced for surfactants with a charged head group [45, 50].  
Arnarson and Elworthy [51], however, proposed that while the size of a nonionic 
surfactant micelle increases with increasing surfactant alkyl chain length,  the increase 
in hydrophobe size does not lead to an increase in micellar solubilisation capacity. 
This effect was later explained as the result of a decreased solubilisation resulting from 
an intrusion of the polyoxyethylene head groups into the micelle core [34].  
Kolthoff and Stricks [52] investigated the effect of chain length on the micellar 
solubilisation of solutes by ionic surfactants. These researchers showed a linear 
increase in the solubilisation capacity for the solute, dimethylaminobenzene, in the 
micelles formed by the ionic surfactants in the series, potassium dodecanoate to 
potassium octadecanoate. Vinarov et al. [53] also investigated the effect of the 
surfactant alkyl chain length (C8 to C16) on the solubilisation of drugs and these studies  
again showed that solubilisation capacity increases linearly with increasing surfactant 
alkyl chain length.  
The solubilisation capacities of gliclazide in various micellar solutions were reported 
by Alkhamis et al. [54]. These authors showed that the solubility of gliclazide was 
dramatically increased in both cationic and anionic surfactants but that these two 
classes of surfactant showed opposite behaviour. When the carbon chain length was 
increased (from C10 to C16) in cationic surfactants the solubilisation capacity for 




surfactants led to a decrease in the solubilisation capacity. This difference in behaviour 
was explained as due to different sites of solubilisation of gliclazide within the cationic 
and anionic micelles: the drug being solubilised mainly in the inner core of the former 
and in the outer region of the latter.  
It has also been found that solubilisation capacity is influenced by the head group 
structure of surfactants. The effect of a polar head group on the solubilisation capacity 
has been investigated by Jacobs and Anacker [55, 56]. In their study, using solutes 
solubilised within the hydrophilic head group region of micelles, the micelle 
aggregation number was shown to increase with the substitution of an ethanol group 
for an ethyl in decyltriethyl-, decyltripropyl- and decyltributylammonium bromide. 
For ionic surfactants with identical hydrophobes, the solubilisation capacity is seen to 
be proportional to the micelle aggregation number [57]. 
The effect of adding ethylene oxide units into dodecyl sulfate surfactants was shown 
by Vinarov et al. to cause a marked reduction in solubilisation capacity [50, 53]. This 
was taken to indicate that the ethoxylation disrupts the packing in the dodecyl sulfate 
micelles and so decreases the solubility of the drug molecules within the micelles.  
In nonionic surfactants with polyoxyethylene head groups the effect of 
polyoxyethylene chain length on the solubilisation is dependent on the location of the 
solubilisate and Saito reports [58] that at a given temperature, an increase in 
polyoxyethylene chain length leads to a higher solubilisation capacity for aliphatic 
hydrocarbons, while Vinarov et al. [50] found that there is no significant effect on the 
extent of solubilisation of progesterone by increasing the ethoxy groups from 10 to 23.  
Furthermore, for a given hydrocarbon chain length in a surfactant, branched chain 
surfactants appear to have lower solubilisation capacities than surfactants with an 
equivalent unbranched carbon chain [45].   
Structure of the solubilisate 
The most common classification for solubilisates is according to their polarity. For 
aliphatic and alkylaryl hydrocarbons, the extent of solubilisation in micelles appears 
to decrease with increasing chain length and increases with the addition of 
unsaturation and cyclization [45]. Alkyl hydrocarbons that have branched chains show 




For solubilisates that contain aromatic rings, the solubilisation in micelles is dependent 
on their molecular size, with larger molecules exhibiting a lower solubility [59].  
For polar compounds, it is presumed that the main locus of solubilisation is at the 
micelle-water interface, with interaction then between the solubilisate and both the 
surfactant hydrophilic head group and the surrounding water molecules. Generally, in 
surfactant solutions of low concentration the extent of solubilisation of polar 
compounds is higher than that of non-polar compounds. It is also found that polar 
compounds that are solubilised in the palisade layer of nonionic surfactant micelles 
exhibit a lower micelle loading than those that locate closer to the micelle surface [60-
62].  
The importance of solubilisate polarity has been further demonstrated by studies using 
substituted steroids. The solubility of testosterone in lysophosphatidylcholine is shown 
to be dramatically reduced by 17-α substitution of an ethinyl group. In contrast, the 
17-α substitution of an ethinyl group in estradiol increases the solubility in 
lysophosphatidylcholine by more than 5-fold compared with that of estradiol. The 
difference here is attributed to a change in the net dipole moment of the steroids which 
results from introduction of the ethinyl group [63]. 
Effect of temperature 
The effect of temperature on micellar solubilisation is dependent on the structures of 
both the surfactants and solubilisates.  
Generally, an increase in temperature results in a higher solubilisation of both polar 
and non-polar solubilisates by ionic surfactants [52, 54]. Kolthoff and Stricks [52] also 
showed that the percentage increase seen in solubilisation capacity with change in 
temperature at high temperatures was opposite to that seen at lower temperatures, and 
similar findings were later reported by Bates et al. [64]. 
For nonionic polyoxyethylenated surfactants, the effect of temperature on 
solubilisation is dependent on the structure of solubilisate. For non-polar materials, 
which tend to be solubilised in the inner core of a nonionic surfactant micelle, an 
increase in temperature leads to a higher level of solubilisation, and the extent of this 
increase is greater when the temperature is close to the cloud point of the surfactant 




complex, with the solubility of a solubilisate going through a maximum as the 
temperature approaches the surfactant cloud point [62]. The amount of the solubilised 
compounds first increased with increasing temperature due to the increase in thermal 
agitation of the surfactant molecules in aqueous solution. With further increase in 
temperature, the surfactant polyoxyethylene chains become progressively dehydrated 
and more tightly coiled, with the result that there is then less space to accommodate 
the solubilisates and the amount solubilised decreases. This effect is more pronounced 
for small polar compounds and for compounds that are solubilised close to the micelle 
surface [65].  
1.5 Aim of the project 
Over 70% of the new drug candidates discovered over recent years exhibit low 
aqueous solubility, and this presents as a major problem in drug development [66]. 
Much effort is expended in trying to improve the water solubility of these drug 
candidates and one of the strategies commonly explored in the pharmaceutical 
industries is to try and solubilise them inside colloidal aggregates – either polymeric 
or surfactant micelles. 
Although micellar solubilisation is an extensively studied topic our understanding of 
such systems is not yet at a stage where we can predict the structure of the surfactant 
that is best to use to solubilise a given drug. The locus of solubilised drug within a 
micelle is thought to be important in determining the micelle’s loading capacity, and 
it is this too that affects the drug’s stability and its rate of release inside the body and 
so it also impacts the drug’s therapeutic activity [67, 68]. We do not yet have sufficient 
understanding of the molecular mechanism that governs the solubilisation of drug in 
a micelle, however, and so we are unable, therefore, reliably to predict either the level 
of its solubilisation or its locus of solubilisation. 
Accordingly, the aim of this project was to clarify the link between the structure of 
surfactant molecules and the micelles they form in aqueous solution, and then to 
determine how these influence the level and manner of solubilisation of poorly water 
soluble compounds. The resulting improved understanding of micellar solubilisation 
would hopefully then make it possible to optimize the design of drug delivery systems 




A series of systematic studies have been performed to determine the extent and locus 
of solubilisation of two poorly water-soluble compounds in a range of surfactant 
micelles. Specifically, two steroidal molecules, 4-cholesten-3-one and adrenosterone 
have been solubilised in a range of C12-chain surfactants with varying head group. The 
choice of these two steroids will be further discussed in Chapter 2. By altering the 
head groups of the surfactants, it was expected that the solubilisation capacities and 
micelle properties would vary. The physical chemical parameters of the surfactants 
were determined and these studies are described in Chapter 2. In order to estimate the 
preferred site(s) of solubilisation of the steroids within the surfactants/micelles, 
neutron techniques (neutron reflectivity and small-angle neutron scattering) were used 




Chapter 2  
 
Solubilisation, surface tensiometry, viscometry 




The solubilisation of drugs within surfactant micelles has long been considered as a 
means by which to facilitate the formulation and delivery of drugs that have poor 
aqueous solubility [66, 69, 70]. The factors governing the level of solubilisation which 
might be achieved for a given drug in a given surfactant system, however, are not yet 
fully understood. 
Investigations into the factors influencing the micelle solubilisation of steroids were 
first reported in 1949, by Ekwall and Sjoblom [71]. These authors showed that water-
insoluble steroid hormones could be solubilised using different types of surfactants, 
with the amount of solubilised hormone increasing with increased concentration of 
surfactant. 
Guttman et al. later [72] investigated the solubilisation of the steroid drugs 
prednisolone, methylprednisolone, and fluorometholone in Triton X-100 solution, and 
found that the level of drug solubilised varied according to the drug’s aqueous 
solubility. Thakkar and co-workers subsequently proved that was not the case for other 
steroid drugs [73], demonstrating that the level of solubilisation of testosterone in the 
micelles formed by non-ionic surfactants, polysorbate 20, 40 and 60, decreased in the 
order polysorbate 60 > 40 > 20 [74]. The same researchers also went on to determine 




dodecyltrimethylammonium bromide (DTAB), hexadecyltrimethylammonium 
bromide (HTAB) and potassium laurate (KL) [75]. They showed that the solubilisation 
capacity for testosterone in these ionic surfactant systems varied in the order KL > 
HTAB > DTAB and in all cases was higher than was achieved using the non-ionic 
surfactants. Since the solubilisation capacities of surfactants which have identical 
hydrophobic chain groups were different, the authors concluded that testosterone was 
not solubilised in the micelle interior. 
Further studies, looking at the solubilisation of steroids in the micelles formed by non-
ionic surfactants with polyoxyethylene (POE) head groups showed that the level of 
solubilisation could be increased by methylation or esterification of the terminal 
hydroxyl group of the POE head group. Ong and Manoukin [76] showed that for the 
corticosteroid timobesone acetate the solubilisation capacity of drug was increased by 
increasing the length of surfactant tail but unaffected by changes in the length of the 
POE head group. On the basis of their latter observation it was suggested that 
timobesone acetate was solubilised in the hydrophobic tail region of the micelle and 
not the palisade layer.  
The solubilisation of the 17α-ethinylestradiol in non-ionic rhamnolipid micelles was 
reported by Guo et al. [77] and the micelle aggregation number and shape were shown 
to change as the concentration of the biosurfactant increased, with the suggestion made 
that the drug was solubilised at several loci within the micelle. 
Barry and Eini also showed that the solubilisation capacity for some steroids increased 
with increasing ethylene oxide (EO) units in the head group [65]. In more recent times 
Vinarov et al. [78] studied the solubilisation of the hydrophobic steroid drug danazol 
both in ionic surfactants and non-ionic surfactants. It was shown that danazol has high 
solubility in ionic surfactants and this was attributed to ion-dipole interactions between 
the drug molecules and the charged head group of the surfactants, particularly those 
with head groups that contained sulfate or trimethyl ammonium bromide (TAB). It 
was further shown that the solubilisation capacities of all types of surfactants for 
danazol increased with the increased length of hydrocarbon chain, and that introducing 
an EO group into the dodecyl sulfate surfactants dramatically decreased the 
solubilisation of danazol (with the suggestion here that the incorporation of EO 




Vinarov et al.[50] have also recently reported an extensive and systematic study of the 
solubilisation of progesterone in 17 different types of surfactant systems using 
surfactants with different charges, lengths of hydrophobe and types of head group. 
From the results obtained in these studies the authors concluded that the best 
candidates to enhance the drug’s solubility were surfactants with charged hydrophilic 
head groups and long hydrocarbon chains. For surfactants having a common C12 chain, 
the solubilisation capacity for the drug varied with the head group type, decreasing as 
SO4
- > (C2H4O)1SO4
- > +N(CH3)3 > (C2H4O)3SO4
-. Surfactants with non-ionic head 
groups presented the lowest solubilisation capacity for progesterone. The general 
conclusion reached in these studies was that the progesterone was solubilised in the 
micelle palisade layer with its hydrophobic part inserted into the core of the micelles. 
Another systemic study of micellar drug solubilisation has been performed [79] for a 
series of steroid drugs solubilised in the non-ionic surfactant, Polysorbate 80. In this 
study the aim was to find out the relationship between molar solubilisation capacity 
and the log octanol-water partition coefficient (log P) of testosterone and its 
derivatives. Alvarez-Núñez and Yalkowsky pointed out that although the 
solubilisation capacity was correlated to the log P for testosterone and its derivatives, 
such a relationship did not appear to hold for other steroids. 
So far, many studies have proved that surfactants might have different solubilisation 
capacity depending on the types of drugs. Many reports have suggested that by 
increasing the alkyl chain length of the surfactant, the solubilisation capacity would 
also increase for most water insoluble drugs [80-82]. However, the influence of the 
surfactant head group on micellar drug solubilisation remains uncertain and there is 
no generally applicable theory to allow one to predict the amount of solubilised drug 
and its locus of solubilisation in a specific micelle system.  
In the work reported here, the aim was to probe the effect of surfactant head group on 
the solubilisation of two steroidal molecules: 4-cholesten-3-one (4-CHOL) and 
adrenosterone (ADRENO), both of which have extremely poor water solubility (23 
µg/L and 55 mg/L, respectively). 4-CHOL has a long hydrocarbon chain (2, 6 – 
dimethylheptyl chain) at C17 and a single carbonyl group at C3; ADRENO contains 
three carbonyl groups, at C17, C3 and C11 and thus is more polar than 4-CHOL and 




Systematic studies have been performed to determine the micellar solubilisation 
capacity of 4-CHOL and ADRENO in a range of surfactant systems, with surfactants 






Table 2. 1 Structures of the steroids 4-cholesten-3-one and adrenosterone 



























    
  Sodium dodecyl sulfate (SDS)             Ammonium dodecyl sulfate (ADS) 
      
         Lithium dodecyl sulfate (LDS)        Dodecyl trimethylammonium bromide (DTAB) 
 
N-dodecyl-N, N-dimethyl-3-ammonio-1- propanesulfonate (DDAPS) 
                   
N, N-dimethyldecylamine N-oxide (DDAO)        Dodecyl phosphocholine (DPC)  
 
          
Polyoxyethylene (23) lauryl ether (Brij 35)      Polyoxyethylene sorbitan monolaurate (Tween 20) 





4-cholesten-3-one (98+ %) was purchased from Alfa Aesar (Heysham, UK) and 
adrenosterone (97+ %) from Santa Cruz Biotechnology (Heidelberg, Germany). 
Sodium dodecyl sulfate (SDS), ammonium dodecyl sulfate (ADS), lithium dodecyl 
sulfate (LDS), dodecyl trimethylammonium bromide (DTAB) and N, N-
dimethyldecylamine N-oxide (DDAO) were purchased from Sigma-Aldrich (Dorset, 
UK). N-dodecyl-N, N-dimethyl-3-ammonio-1-propanesulfonate (DDAPS) and 
polyoxyethylene (23) lauryl ether (Brij 35) were obtained from MP Biomedicals LLC 
(Ohio, USA). Dodecyl phosphocholine (DPC) was obtained from Avanti Polar Lipids 
(Alabama, USA) and ultra-pure polyoxyethylene sorbitan monolaurate (Tween 20) 
was supplied by National Diagnostics (Hull, UK). 
Propan-2-ol was purchased from Fisher scientific (Loughborough, UK). 






The equilibrium solubilities of 4-cholesten-3-one and adrenosterone in the micellar 
solutions were measured by taking excess of the steroid into freshly prepared 
surfactant solution (1 mL), with the surfactant concentration varied between 2.5 wt% 
and 20 wt%. The steroid/surfactant systems were then subjected to continuous rotary 
mixing, with the sample vials placed on a rotary wheel (Stuart Tube Rotator SB2, 
Cole-Parmer Ltd, Staffordshire, UK) for 3-4 days at room temperature to achieve 
saturation. The rotary wheel was covered with aluminium foil to prevent possible 
photochemical degradation. After mixing, the samples were centrifuged at 13,000 rpm 
for 30 minutes (Biofuge pico, Kendro, U.S). The resulting supernatant was transferred 
to a new sample vial and the concentration of dissolved steroid measured by UV-Vis 
spectroscopy (LAMBDA 35 spectrophotometer, Perkin-Elmer). Surfactant solutions 
with no added steroid were also prepared using the same method. 
UV calibration curves for the 4-cholesten-3-one and adrenosterone were obtained with 
steroid solutions prepared in propan-2-ol at concentrations from 4 μg/mL to 24 μg/mL. 
Absorbances were recorded at λmax = 240nm. All measurements were recorded in 
triplicate. 
The solubilisation capacity for steroid of a given surfactant micelle system was taken 
as the slope of the linear region from the solubilisation profile (wt% dissolved steroid 
vs. wt% surfactant). Solubilisation capacities were presented in g/g and also as molar 
solubilisation ratios (MSR), which define the number of moles of steroid solubilised 






Figures 2.2 to 2.6 show the amounts of 4-cholesten-3-one (4-CHOL) and 
adrenosterone (ADRENO) solubilised in 2.5 wt % to 15 wt % aqueous dispersions of 
C12-chain surfactants with varying hydrophilic head groups (and these data are 
presented in tabular form in Appendix A, Tables A.1 and A.2). Beyond 15 wt% of 
surfactant (at 17.5 wt% and 20 wt%) the steroid/surfactant solutions were generally 
too viscous to allow accurate determination of solubility.  For both steroids, 
irrespective of surfactant type, the amount of material solubilised increased linearly 
with increased surfactant concentration, demonstrating an association between the 
steroids and the micelles. The solubilisation capacities of each surfactant for 4-CHOL 
and ADRENO were calculated as the slope of the solubilisation profiles shown in 
Figures 2.2 to 2.6.  
Solubilisation of 4-cholesten-3-one 
From Figures 2.2 to 2.4, it is clear that 4-cholesten-3-one (4-CHOL) is solubilised 
much more efficiently by the anionic surfactants, the solubilisation capacity in sodium 
dodecyl sulfate (SDS) being more than five times that in any of the other surfactant 
systems (Table 2.2). It is interesting to note too, however, that if the counterion for the 
dodecyl sulfate is changed to NH4
+ or Li+, the level of 4-CHOL solubilisation capacity 
decreases, with the solubilisation capacities decreasing in the order SDS > ADS > LDS 
(0.432 ± 0.010 g/g vs 0.360 ± 0.014 g/g vs 0.328 ± 0.012 g/g, respectively).  
When the C12 surfactant head group is replaced with the trimethyl ammonium bromide 
(TAB) group, the amount of 4-CHOL solubilised does not increase linearly with 
increasing concentration of surfactant solution. As shown in Figure 2.3, the amount of 
steroid solubilised rises rapidly for concentrations of DTAB above 10 wt%, the 
solubilisation profile then following a second order polynomial. The solubilisation 
capacity for 4-CHOL in DTAB was very much lower compared to that found for the 
anionic surfactants (as discussed above) and even at the highest concentration (15 
wt%), the total amount of 4-CHOL solubilised into DTAB micelles (1.463 ± 0.070 
wt%) was less than the amount solubilised into SDS micelles (1.616 ± 0.248 wt%) at 








































Figure 2. 2 Level of solubilisation of 4-cholesten-3-one in C12-chain surfactant micelles 
●: in SDS, ■: in ADS, ▼: in LDS (error bars shown indicate standard deviations, n=3). 
*Note that since the CMC’s of these surfactants (which range from 10-3 to 10-1 wt%) 
are an order of magnitude smaller than the measured surfactant concentrations, the 
surfactant concentrations are not corrected for the surfactant CMC values. 
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Figure 2. 3.  Level of solubilisation of 4-cholesten-3-one in DTAB micelles (details as 




The solubilisation capacity for 4-CHOL in zwitterionic surfactants decreased in the 
order DDAO > DDAPC > DPC (Figure 2.4). It is not surprising that DDAO shows the 
best solubilisation capacity among these surfactants as the superior solubilisation 
properties of surfactants with an N-oxide head group have been reported previously 
[84, 85]. The hydrophilic part of DDAPS has a strong interaction with water molecules 
[86] and might be detrimental to its solubilisation of 4-CHOL. 
Among the investigated non-ionic surfactants Brij 35 and Tween 20, the latter showed 
a much higher solubilisation capacity for 4-CHOL. Given that the molecular weights 
for these surfactants are significantly higher than those of the other surfactants studied 
here (1200-1300 g/mol vs 250-350 g/mol), it is more instructive to compare their 
molar solubilisation ratios (MSR) and not their solubilisation capacities. When 
comparing the MSR of these surfactants for 4-CHOL, we see that 0.194 ± 0.007 mole 
of 4-CHOL molecules can be solubilised into 1 mole of Tween 20, which is slightly 
lower than achieved with LDS (0.232 ± 0.012) while only 0.020 ± 0.001 mole of 4-
CHOL are solubilised into Brij 35 micelles. Tween 20 therefore presents a much better 
solubilisation for 4-CHOL than Brij 35 and this suggests that there are different 
solubilisation loci of 4-CHOL in the micelles of these two surfactants, or perhaps that  
Surfactant concentration (wt%)


































Figure 2. 4 Level of solubilisation of 4-cholesten-3-one in C12-chain surfactant micelles. 
●: in DPC, ♦: in DDAPS, ▼: in DDAO, ▲: in Tween 20, ■: in Brij 35 (details as given 




the level of solubilisation is influenced by the number of polyoxyethylene (POE) 
groups in the surfactant head group (Brij 35 having more POE units than Tween 20). 
Table 2. 2 Solubilisation capacity (g/g) and molar solubilisation ratio (MSR) of C12 
surfactant for 4-cholesten-3-one (n = 3) 
SAA Solubilisation capacity 
(g/g) 
MSR 
SDS 0.432 ± 0.010 0.324 ± 0.007 
ADS 0.360 ± 0.014 0.265 ± 0.010 
LDS 0.328 ± 0.012 0.232 ± 0.012 
DTAB 0.086 ± 0.004 0.069 ± 0.003 
DPC 0.023 ± 0.001 0.021 ± 0.001 
DDAPS 0.051 ± 0.001 0.044 ± 0.001 
DDAO 0.077 ± 0.004 0.046 ± 0.003 
Tween 20 0.061 ± 0.002 0.194 ± 0.007 
Brij 35 0.006 ± 0.000 0.020 ± 0.001 
 
Solubilisation of adrenosterone 
The solubilisation capacity for adrenosterone (ADRENO) is lower than found for 4-
CHOL for all types of surfactant. The required time for ADRENO to achieve an 
equilibrium solubility, however, was in all cases much shorter than for 4-CHOL, with 
equilibrium achieved in a matter of hours, whereas 4-CHOL required several days. 
As found for 4-CHOL, the anionic surfactants presented as the best solubilisers. For 
ADRENO, the rank order of the dodecyl sulfate solubilisation capacities decreased as 
Na+ > Li+ > NH4
+. The amount of ADRENO solubilised in ADS micelles was only 
half that solubilised in SDS (0.048 ± 0.002 g/g for ADS and 0.090 ± 0.002 g/g for 
SDS). 
Unlike 4-CHOL, the level of solubilisation of ADRENO in the cationic surfactant 




solubilisation was only a third that achieved with SDS (0.031 ± 0.001 g/g) and a 
similar level of solubilisation was seen with the zwitterionic surfactant DDAPS, and 
lower levels of solubility in DDAO and DPC. The non-ionic surfactants exhibited the 
lowest solubilisation capacity for ADRENO with no benefit resulting from the 
increases in POE units provided by Tween 20 and Brij 35. When considering the MSR, 
the non-ionic surfactant Tween 20 gave a similar solubilisation capacity to the 
zwitterionic surfactants while Brij 35 only solubilised around half that amount of 
ADRENO. 
Table 2. 3 Solubilisation capacity (g/g) and molar solubilisation ratio (MSR) of C12 
surfactant for adrenosterone (n = 3) 
SAA Solubilisation capacity (g/g) MSR 
SDS 0.090 ± 0.002 0.087 ± 0.002 
ADS 0.048 ± 0.002 0.045 ± 0.002 
LDS 0.062 ± 0.006 0.056 ± 0.005 
DTAB 0.031 ± 0.001 0.032 ± 0.001 
DPC 0.020 ± 0.000 0.024 ± 0.000 
DDAPS 0.033 ± 0.002 0.037 ± 0.002 
DDAO 0.018 ± 0.001 0.015 ± 0.001 
Tween 20 0.005 ± 0.000 0.020 ± 0.001 








































Figure 2. 5 Level of solubilisation of adrenosterone in C12-chain surfactant (ionic) 
micelles. ●: in SDS, ■: in ADS, ▼: in LDS ▲: in DTAB (details as given in Figure 2.2). 
Surfactant concentration (wt%)





























Figure 2. 6 Level of solubilisation of adrenosterone in C12-chain surfactant (zwitterionic 
and nonionic) micelles. ●: in DPC, ♦: in DDAPS, ▼: in DDAO, ▲: in Tween 20, ■: in 






The effect of C12 chain surfactants with varying head group on solubilisation of two 
steroids 4-cholesten-3-one and adrenosterone was investigated. According to the 
results obtained, the solubilisation capacity was calculated (Table 2.4) and analysed, 
and the main conclusions drawn are as follows:  
• The solubilisation capacity of C12 surfactants for 4-cholesten-3-one decreases 
in the order SDS > ADS > LDS > DTAB > DDAO > Tween 20 > DDAPS > 
DPC > Brij 35 
• The solubilisation capacity of C12 surfactants for adrenosterone decreases in 
the order SDS > LDS > ADS > DTAB ≈ DDAPS > DPC ≥ DDAO > Tween 
20 > Brij 35 
• The ionic surfactants have the greatest capacity for solubilisation of both of the 
steroids studied but 4-cholesten-3-one is solubilised much better than 
adrenosterone. The non-ionic surfactant Brij 35 has the worst solubilisation 
capacity for both steroids while the zwitterionic surfactants afford an 
intermediate solubilisation capacity. 
• Surfactants having a sulfate head group provide the best solubilisation for 
steroids, however, the level of solubilisation varies according to the type of 
counterion. This result is consistent with the observations reported by Vinarov 
et al. [78]. Saaka [87] also suggested that the head group of C12 surfactants 
might play an important role in solubilising the testosterone derivatives and 
the locus to solubilise the steroids might not be in the core of micelles. 
• The high solubility of 4-cholesten-3-one in micelles formed by Tween 20 may 
be due to a different locus of solubilisation. Because of the large head group 
of this non-ionic surfactant, the penetration of drug molecules into the chain 
region of the surfactant micelle might be made more difficult. 
• On the basis of the solubilisation measurements detailed above, the preferred 
site of solubilisation of the steroid molecules in the surfactant micelles still 




molecules might suggest that 4-cholesten-3-one and adrenosterone would be 
solubilised in different regions within the micelles.  
Table 2.4 Solubilisation capacity (g/g) of C12 surfactant for 4-cholesten-3-one and 
adrenosterone (n = 3) 
SAA 4-cholesten-3-one (g/g) Adrenosterone (g/g) 
SDS 0.432 ± 0.010 0.090 ± 0.002 
ADS 0.360 ± 0.014 0.048 ± 0.002 
LDS 0.328 ± 0.012 0.062 ± 0.006 
DTAB 0.086 ± 0.004 0.031 ± 0.001 
DPC 0.023 ± 0.001 0.020 ± 0.000 
DDAPS 0.051 ± 0.001 0.033 ± 0.002 
DDAO 0.077 ± 0.004 0.018 ± 0.001 
Tween 20 0.061 ± 0.002 0.005 ± 0.000 
Brij 35 0.006 ± 0.000 0.003 ± 0.001 
 
2.2 Surface tensiometry 
2.2.1 Introduction 
When surfactants are added into an aqueous medium, their molecules – by virtue of 
their amphiphilic nature – tend to arrange at the air-water interface, as a layer with the 
hydrophilic/polar head groups immersed in the water and their hydrophobic/apolar 
parts directed away from the water toward the air. The surfactant molecules at the 
water surface disrupt the water structure, reducing the free energy of the system and 
thereby lowering the surface tension. As the concentration of the surfactant is 
increased, so the number of surfactant molecules at the water surface increases, and 
the surface tension progressively decreases. When the water surface is saturated, the 
surface tension remains constant and the additional molecules aggregate within the 




begin to form is defined as the critical micelle concentration (CMC) of the surfactant, 
and this can be determined from surface tension measurements performed as a 
function of surfactant concentration.  
The equilibrium surface tension of surfactant solution can be measured in several 
ways. The two most common methods used are the Du Noüy ring method and the 
Wilhelmy plate method, and the pendant drop and the bubble pressure methods [88] 
are usually used only in dynamic surface tension measurement.  
The Wilhelmy plate method can be prone to errors arising through the adsorption of 
organic compounds from the environment, but compared to the Du Noüy ring method, 
this method is generally considered more accurate [89]. In the ring method, since the 
ring needs to be pulled through the liquid and results in a non-equilibrium state of the 
surface, the measured surface tension may vary with the pulling speed [88, 90]. With 
the Wilhelmy plate method, the surface tension is measured with the surface at 
equilibrium. 
Given that the solubilisation of poorly water soluble solutes by surfactants is 
influenced by the structure and properties of the surfactant micelles, and because this 
in turn is influenced by their interfacial adsorption behaviour, an understanding of the 
latter can directly inform their use for solubilisation. Surfactants with lower CMCs 
potentially have higher solubilisation capacities due to their greater tendency for 
micelle formation.  
The CMC of a given surfactant in aqueous solution is influenced by the structure of 
its hydrophobic and hydrophilic groups, by the presence of electrolyte or other organic 
compounds present in the solution, and by the solution temperature [45].  
Table 2.5 shows the CMCs previously reported for some C12-chained surfactants with 
varying head groups. It may be noted here that the zwitterionic surfactants have much 
lower CMCs than the anionic and cationic ones (~1 mM vs ~10 mM) and that the 
CMCs of the anionic surfactants vary according to the nature of the bound counterion. 
The CMC is higher when the centre of charge is close to the α-carbon of the C12 
hydrocarbon chain. In some n-alkyl surfactants, the order of the effect of the head 
group on the CMC is aminium salts > carboxylates > sulfonates > sulfates [43]. Stigter 




it requires more work to aggregate and form micelles due to an increase in electrostatic 
self-potential of the surfactant ion [42].  
The binding of counterions to surfactant micelles is positively correlated with the 
polarizability and valence of the counterions and inversely correlated with their 
hydrated radius [45]. The increased binding of counterions to a given anionic 
surfactant causes a lowering of the surfactant’s CMC and increases the micelle 
aggregation number [37]. 
In the studies reported here, surface tensiometric measurements were used to 
determine the CMCs for a range of C12-chain surfactants in aqueous solution at 25 ± 
0.1 oC. For the two surfactants studied which showed the highest levels of 4-CHOL 
solubilisation, viz., SDS and DTAB, the surface tension measurements were also made 
in the presence of this steroid, and for the sake of completeness, the surface tension 
measurements for SDS and DTAB were also repeated in the presence of ADRENO. 
For DPC, DDAPS, DDAO, Tween 20 and Brij 35, however, the measurements of 
surface tension were not repeated in the presence of 4-CHOL or ADRENO because it 
was not considered likely that the steroids would cause significant changes in the 
surface tension curves for these surfactants given that their levels of solubilisation of 











Table 2. 5 The CMCs of C12-chain surfactants 
Surfactant Name Abbreviation CMC (mM) Reference 
Anionic Sodium dodecyl sulfate SDS 8.0 – 8.4 [45, 91-94] 
Lithium dodecyl sulfate LDS 8.5 – 10 [45, 95, 96] 
Ammonium dodecyl sulfate ADS 6.2 – 7.1 [97-99] 
Cationic Dodecyl trimethylammonium bromide DTAB 14.6 – 16 [45, 93, 100, 101] 
Zwitterionic N-dodecyl- N, N-dimethyl-3-ammonio-1-
propanesulfonate 
DDAPS 2 – 4 [90, 93, 102] 
 
Dodecyl phosphocholine DPC 1 – 1.52 [103, 104] 






4-cholesten-3-one (98+ %) was purchased from Alfa Aesar (Heysham, UK) and 
adrenosterone (97+ %) from Santa Cruz Biotechnology (Heidelberg, Germany). 
Sodium dodecyl sulfate (SDS), ammonium dodecyl sulfate (ADS), lithium dodecyl 
sulfate (LDS), dodecyl trimethylammonium bromide (DTAB) and N, N-
dimethyldecylamine N-oxide (DDAO) were purchased from Sigma-Aldrich (Dorset, 
UK). N-dodecyl-N, N-dimethyl-3-ammonio-1-propanesulfonate (DDAPS) was 
obtained from MP Biomedicals LLC (Ohio, USA). Dodecyl phosphocholine (DPC) 
was obtained from Avanti Polar Lipids (Alabama, USA). 
All chemicals were used as received. 
2.2.3 Methods 
Surface tension measurements were performed using a Tensionmeter K11 (Krüss, 
Germany). All glassware used was soaked in Decon® and then scrupulously rinsed 
with ultrapure water (resistivity of 18.2 MΩ.cm at 25 ± 0.1 oC). The external accuracy 
of measurements was checked by frequent measurement of the surface tension of 
ultrapure water, and comparing against the reference value, 71.99 mN/m at 25 ± 0.1 
oC [107]. 
Figure 2. 7 A schematic of Wilhelmy plate method 
Prior to measurement, the platinum plate of the tensiometer was soaked in Decon® 
and rinsed with ultrapure water, flamed until red-hot, and then allowed to cool to room 
temperature before use. The surface tension was measured by dipping a thin platinum 
plate 
Θ=0o 







plate into the liquid and then raising the plate so that it was just within the surface of 
the liquid and the surface then allowed to relax and achieve equilibrium (Figure 2.7). 
From the measured force required to hold the plate in the surface, the surface tension 
of the liquid was calculated.  
Dilutions were made in the vessel directly using the ultrapure water to minimize the 
effect of adsorption of surfactant onto the container thus ensuring the accuracy of the 
concentration. The measurement was made after 15 minutes after each dilution and 
the surface tension was checked at 5 minutes interval until no significant changes were 
observed. The platinum plate was cleaned and flamed after each reading to remove all 
adsorbed surface active material. Each measurement was made in triplicate to ensure 
the reproducibility of the results. 
For a given surfactant solution, at a given concentration, the surface tension (γ, nM/m) 




                    [2.1] 
where L (m) is the length of the Wilhemy plate and θ is the contact angle formed 
between the plate and the solution which here (because of the use a platinum plate) 
was taken as 0° [108]. With γ measured as a function of surfactant concentration, c, a 
plot of γ vs. log[c] is obtained and the slope, dγ/dlog[c] is used to derive the surface 







                   [2.2] 
where R is the gas constant (8.31 J K-1 mol-1) , T is the absolute temperature (K), and 
n = 1 for non-ionic or ionic surfactants (DDAPS, DDAO and DPC) in the presence of 
excess electrolyte, or n = 2 in the case of  1:1 ionic surfactants (SDS, LDS, ADS and 
DTAB) [109].  
The interfacial area per surfactant molecule, 𝒶1
𝑠, can be calculated as: 
𝒶1  
𝑠 =  
1016
𝑁Γ
                     [2.3] 





Surface tensions for the seven C12-chain surfactants measured as a function of 
concentration are shown in Figure 2.8. 
In each case, as expected, the surface tension decreases with increasing surfactant 
concentration and then at a given concentration it ceases to change (significantly) as 
the water surface becomes saturated. For some systems (LDS, ADS and DTAB) there 
is a minimum seen in the surface tension plot and this can be attributed to impurities 
present in the commercially-obtained surfactant solutions [110]. According to ISO 
guidelines, the minima in the γ vs log[c] curve can still be used to determine the CMC 
of the surfactant [111]. 
 
Figure 2. 8 Variation of surface tension (𝛄, nM/m) with the concentration (c, g/mL) for 
C12 surfactants dispersed in H2O at 25 ± 0.1oC. Standard errors on the data are shown 
(n=3). 
The CMCs calculated for each of the C12-chain surfactants are given in Table 2.6, 





















































































tension at the CMC(γCMC), the surfactant surface excess (Γ) and its interfacial area per 
molecule (𝒶1
s). 
It has been reported that the CMC of a surfactant is related to its degree of binding of 
counterions to its micelles [37]. The increased binding of counterions causes a 
decrease in the surfactant CMC, and the extent of binding of counterions increases 
with a decrease in the hydrated radius of the counterion [45]. The hydrated counterion 
radii for the anionic surfactants studied here decrease in the order Li+ > Na+ > NH4
+, 
and the CMC of these dodecyl sulfate surfactants increase in the order ADS < SDS < 
LDS, as shown in Table 2.6. 
Surface tension is related to the number of surfactant monomers per unit area adsorbed 
at the interface. Therefore, surface excess (Γ) and area per molecule (𝒶1  
s )  are 
calculated and used to give an indication of the packing of surfactant molecules at the 
air-water interface. In the case of LDS, due to its largest hydrated radius, the distance 
between its positive centre and negative centre is the largest, and this results in a higher 
Coulombic repulsion between the adjacent sulfate groups. Thus, the LDS molecules 
are more loosely packed at the interface. This is evidenced by the area per molecule 
(𝒶1
s) values shown in Table 2.6. The order of 𝒶1
s  for these anionic surfactants thus 
correlates with the variation in the hydrated counterion radii (Li+, 0.382 nm, Na+, 0.358 
nm, and NH4
+, 0.331 nm) and indicates that the packing of these surfactants in 
governed by their electrostatic interactions [112]. 
The cationic surfactant DTAB has the highest CMC of all the C12-chain surfactants 
tested and its 𝒶1  
s is lower than those of the anionic surfactants which could suggest 
that the aggregation number for DTAB micelles is higher than that for the dodecyl 
sulfate surfactant micelles.  
For the zwitterionic surfactants, the measured CMCs are around one order of 
magnitude lower than those of the ionic surfactants, and follow the order: DDAPS > 
DPC > DDAO. DDAO has the highest Γ and lowest 𝒶1
s , so the DDAO monomers may 
be packed more closely at the interface than other surfactant monomers. The 𝒶1  
s of the 
zwitterionic surfactants are likewise lower than those of the ionic surfactants, 
indicating that the zwitterionic surfactant monomers are more closely packed at the 




The differences seen in  𝒶1  
s between the surfactants probably result in the variation in 
the solubilisation capacity. If the locus of solubilisation is in the micelle core, the 
micelles having the more closely packed molecules may hinder the access of the 
steroids to the micelle core region and thus lead to a smaller number of solubilised 
steroids. However, if the hydrophilic head group of the surfactant is considered as the 
major locus of solubilisation, the higher 𝒶1  
s will result in a higher aggregation number 
for the micelles and will thus lead to a greater number of solubilised steroids per 
micelle. Such conclusions assume the same number of water molecules per surfactant 
head group but this, of course, may not be the case. The hydrodynamic properties of 
the surfactant dispersions will be further discussed in the next section. 
The interfacial properties mentioned above were calculated from the Gibbs equation, 
whose application has been debated over the years. Menger et al. [113, 114] proposed 
that at the CMC, the adsorption of surfactant at the air-water interface is not yet at the 
saturation. Xu et al. [115] and Li et al. [116, 117] also found a disparity in the results 
of ionic surfactants from neutron reflectometry and surface tension while zwitterionic 
and non-ionic surfactants showed a good agreement from the results obtained using 
these two techniques. Neutron reflectivity is suggested as the better technique for 
determining Γ and 𝒶1  
s than surface tension measurement. However, the results 
obtained from these techniques are often reported to be comparable. It may be noted 
here, for example, that Lyttle et al. [118] have used neutron reflectivity measurements 
to study DTAB, and report an 𝒶1  
s  of 48 Å2 which is close to the value of 55 ± 3 Å2 
obtained via the surface tension measurements reported here.  
The principle parameters of interest determined from the surface tension 
measurements reported here are the CMCs of the C12-chain surfactants. The surface 
excess and area per molecule of the surfactants in the presence or absence of steroids 
were further measured using neutron reflectivity and these studies are described in 
Chapter 3. 
The CMCs of surfactants in the presence of 4-cholesten-3-one and adrenosterone 
Surface tension measurements were also performed to determine the CMCs of SDS 
and DTAB in the presence of saturated 4-cholesten-3-one and adrenosterone. As noted 
earlier (section 2.1), SDS and DTAB have the highest solubilisation capacities for 4-




these steroids solubilised in the surfactant monolayers could potentially lower the 
surface tension and lead to changes in the CMC. Meanwhile, as was found in 
solubilisation experiment, it took much longer for 4-CHOL (ca. 2 hours) than 
ADRENO (ca. 5 minutes) to reach the equilibrium in the SDS monolayer. 
Figure 2.9 shows the surface tension curves for SDS and DTAB in the presence of 4-
CHOL and ADRENO. It is clear that at the high SDS concentrations, the presence of 
4-CHOL in the monolayer lowers the surface tension by ca. 10 mN/m while the 
presence of ADRENO causes no significant change in the surface tension. As with the 
pure surfactant systems, when the concentration of the surfactant is below the CMC, 
the surface tension increases with decreased surfactant concentration. For the 
DTAB/ADRENO and DTAB/4-CHOL system, the surface tension approaches the 
expected low concentration limit of 72 mN/m which is the surface tension of pure 
water. In the case of the SDS/ADRENO and SDS/4-CHOL systems, however, the low 
concentration limit is << 72mM/m and this would seem to suggest that there is 
significant steroid at the interface even when the SDS concentration is low.  
Table 2.7 shows the interfacial properties of SDS and DTAB monolayers in the 
presence of 4-CHOL/ADRENO. The CMCs of the surfactants in the presence of these 
steroids were slightly lower than those determined for the pure surfactant systems. The 
increased area per molecule of the surfactants in the presence of ADRENO and 4-
CHOL indicates simply that the surfactants monomers are less tightly packed at the 
interface, as the result of steroid molecules inserted in the interfacial layer. These 







Figure 2. 9 Variation of surface tension (𝛄, nM/m) with the concentration (c, g/mL) for 
C12-chain surfactants in the presence of 4-cholesten-3-one (4-CHOL) and 



































































aTable 2. 6 Values of C12-chain surfactants effectiveness (ϒCMC), critical micelle concentration (CMC), surfactant surface excess (Γ) and area per 
molecule (𝓪𝟏  















Surfactant ϒCMC (± 0.2 mN m
-1) CMC (± 0.02 wt%) CMC (± 0.5 mM) Γ (± 0.1 x 10-6 mol m-2) 𝒶1  
𝑠  (± 3 Å2) 
SDS 36.4 0.23 8.0 2.4 70 
LDS 38.4 0.26 9.7 2.2 75 
ADS 31.2 0.18 6.2 2.7 60 
DTAB 37.4 0.43 14.0 2.5 55 
DDAPS 39.4 0.078 2.3 3.4 49 
DDAO 33.9 0.032 1.4 4.1 40 













Table 2. 7 Values of effectiveness (ϒCMC), critical micelle concentration (CMC), surfactant surface excess (Γ) and area per molecule (𝓪𝟏  
𝒔 ) of SDS and 
DTAB in the presence of steroids (n = 3). 
Surfactant ϒCMC (± 0.2 mN m
-1) CMC (± 0.02 wt%) CMC (± 0.5 mM) Γ (± 0.1 x 10-6 mol m-2) 𝒶1  
𝑠 (± 3 Å2) 
SDS 36.4 0.23 8.0 2.4 70 
SDS + 4-cholesten-3-one 24.1 0.21 7.5 1.9 86 
SDS + adrenosterone 35.8 0.22 7.8 1.9 86 
DTAB 37.4 0.43 14.0 2.5 55 
DTAB+ 4-cholesten-3-one 33.7 0.39 12.8 2.2 74 





From the surface tensiometry results reported above, it can be concluded that: 
• The measured CMCs of the C12 chain surfactants decreased in the order of 
DTAB > LDS > SDS > ADS > DDAPS > DPC > DDAO, and the CMCs are 
very close to or fall within the range of the CMC values determined by others 
(Table 2.8).  
Table 2. 8 the comparison of CMC values of surfactants 
Surfactant CMC  
in this study (± 0.5 mM) 
CMC  
from literature 
SDS 8.0 8.0 – 8.4 
LDS 9.7 8.5 – 10 
ADS 6.2 6.2 – 7.1 
DTAB 14.0 14.6 – 16 
DDAPS 2.3 2 – 4 
DDAO 1.4 1.6 – 2 
DPC 1.6 1 – 1.52 
 
• The CMCs of the ionic surfactants are seen to be influenced both by the nature 
of the surfactant head group and by the nature of the counterions. 
• DDAO has the highest Γ and lowest 𝒶1
s , thus the DDAO monomers are packed 
more closely at the interface than other surfactant monomers. In addition, ADS 
is more effective at lowering the surface tension.  
• The CMCs of the C12-chain surfactants in the presence of steroids were also 
determined, and although these were found to be a little lower than those for 
the corresponding pure surfactant systems, the differences are within the 




• Observationally, the presence of steroid in the surfactant monolayers decreases 
the surface tension, and the effect is more pronounced for 4-CHOL than 
ADRENO. 
• The difference in the 𝒶1
s  of the surfactant monomers in the presence of 4-




2.3 Viscometry and densitometry 
2.3.1 Theoretical background 
Given that the solubilisation of solutes by surfactant micelles is likely to cause changes 
in the micelle size, shape and hydration, and because these micelle properties impact 
the viscosity of the systems, it is of interest to determine their viscosities 
experimentally.  
The viscosity 𝜂  is the resistance of a fluid to flow and the effect of surfactant 
molecules on a solution is given by the relative viscosity 𝜂𝑟𝑒𝑙, which can be calculated 




                 [2.4] 
where t and t0 are the flow times for a given volume of surfactant solution and solvent, 
respectively. The specific viscosity of a surfactant solution 𝜂𝑠𝑝 is obtained as: 
𝜂𝑠𝑝 = 𝜂𝑟𝑒𝑙 − 1                 [2.5] 




                  [2.6] 
where c is the surfactant concentration (g/mL). A related term, inherent viscosity 




                 [2.7] 
As can be seen from equations 2.6 and 2.7, both 𝜂𝑟𝑒𝑑  and  𝜂𝑖𝑛ℎ  are concentration 
dependent. In the limit as the surfactant concentration approaches zero (c → 0), the 
limiting value of viscosity is defined and is referred to as the intrinsic viscosity [𝜂]: 
[𝜂] = lim
𝑐 →0
𝜂𝑟𝑒𝑑                 [2.8] 
[𝜂] = lim
𝑐 →0
𝜂𝑖𝑛ℎ                [2.9] 
[𝜂] reflects the capability of a surfactant to enhance the viscosity of the solution. To 




measured and the dependence of the reduced viscosity on concentration is modelled 




= [𝜂] + K𝐻[𝜂]
2𝑐              [2.10] 
where KH is the Huggins constant and [𝜂] is taken as the intercept (see Figure 2.10). 
Alternatively, [𝜂]  can be determined through a linear extrapolation of the 
concentration dependent variation in the inherent viscosity 𝜂𝑖𝑛ℎ, as modelled in the 




= [𝜂] − K𝐾[𝜂]
2𝑐              [2.11] 
where KK is the Kraemer constant, and  [𝜂] is again taken as the intercept (see Figure 
2.10). 
 
Figure 2. 10 Huggins and Kraemer extraction methods for intrinsic viscosity. 
In practice, it is common to use [121-125] both Huggins and Kraemer formalisms in 
a dual Huggins-Kraemer plot, taking [𝜂] as the mean of the two intercepts on the 
ordinate (see Figure 2.10). 
Measurement of the viscosities of surfactant solutions can be used to determine the 
hydration and asymmetry of the surfactant micelles. In the original treatment by 











= 1 + 𝐹∅               [2.12] 
where 𝜂  and 𝜂0  are the viscosities of the solution and pure solvent. For a 
solution/dispersion of non-deformable, completely wetting non-interacting spherical 
particles (micelles), that are large in comparison with the molecule of the solvent, F 
takes the value 2.5 [126, 127].  
As shown by Oncley [128], the volume fraction ∅ can be expressed in terms of the 
surfactant concentration c, the partial specific volume of the anhydrous surfactant ?̅?1, 
the hydration of the micelle (w gram of solvent bound by one gram of surfactant) and 
the density of solvent 𝜌0: 
𝜂
𝜂0
= 1 + 2.5?̅?1𝑐(1 +
𝑤
?̅?1𝜌0
)                        [2.13] 
Polson later showed [129] that the specific viscosity (
𝜂
𝜂0
− 1) varied linearly with 
concentration only at very low surfactant concentration (<1% w/w) and so proposed 
that w could be more reliably determined by extrapolating a plot of (
𝜂
𝜂0
− 1)/𝑐 vs. 
concentration to infinite dilution. Simha [130, 131] also suggested that the parameter 
𝐹 could be expressed as a function of the axial ratio (𝑣) when applied to ellipsoidal 
micelles. To conclude: 
lim
𝑐→0
= [𝜂] = 𝑣 (?̅?1 +
𝑤
𝜌0
) = 𝜐 ∙ 𝑣𝑠                  [2.14] 
where 𝑣𝑠 is the partial specific volume of the hydrated/swollen surfactant. The value 
of 𝑣 can be used to predict the axial ratio via a polynomial function given by Simha 
[130, 131] if the shape of the micelle is known to be a prolate or oblate ellipsoid but 
generally, the Simha shape factor 𝑣 is taken as 2.5 for most ellipsoidal micelles [132-
134]. 
The partial specific volume of anhydrous surfactant ?̅?1  is usually determined by 
measuring the change in solution density as a function of concentration: 
𝜌 = 𝜌0 + 𝑐(1 − ?̅?1𝜌0)                                    [2.15] 




                      [2.16] 
In cases where ?̅?1 is difficult to determine, Durchschlag and Zipper proposed an ab – 









               [2.17] 
where ?̅?𝑖  is its partial molar volume and 𝑀𝑖  is its molar mass. The partial molar 
volume is calculated from the volume increments with corrections applied for ionic 
and/or cyclic compounds as: 
?̅? = ∑ 𝑉𝑖 + 𝑉𝐶𝑉 − ∑ 𝑉𝑅𝐹 − ∑ 𝑉𝐸𝑆             [2.18] 
where ∑ 𝑉𝑖 is the volume increment for a given atom or groups of atoms, 𝑉𝐶𝑉 is the 
covolume correction, and ∑ 𝑉𝑅𝐹 and  ∑ 𝑉𝐸𝑆 are the volume decrements accounting for 
ring formation and ionization. 
For ionic surfactant systems, where the solution viscosities measured in water are 
influenced by electro-viscous effects due to the charged head groups, the viscosity 
measurements can instead be performed in 0.2 M NaCl solution [136]. For nonionic 
surfactants, the intrinsic viscosities are much the same regardless of whether the 
measurements are made in water or in electrolyte solution [137]. 
2.3.2 Materials 
4-cholesten-3-one (98+ %) was purchased from Alfa Aesar (Heysham, UK) and 
adrenosterone (97+ %) from Santa Cruz Biotechnology (Heidelberg, Germany). 
Sodium dodecyl sulfate (SDS), dodecyl trimethylammonium bromide (DTAB) and N, 
N-dimethyldecylamine N-oxide (DDAO) were purchased from Sigma-Aldrich 
(Dorset, UK). N-dodecyl-N, N-dimethyl-3-ammonio-1-propanesulfonate (DDAPS) 
was obtained from MP Biomedicals LLC (Ohio, USA). Polyoxyethylene (23) lauryl 
ether (Brij 35) were obtained from MP Biomedicals LLC (Ohio, USA). 
Ethanol was purchased from Sigma-Aldrich (Dorset, UK). 







The viscosities of the surfactant solutions were measured using a suspended-level 
(Ubbelohde, Schott-Geräte, Hofheim, Germany) viscometer immersed vertically in a 
thermostat controlled water bath (CT 1650, Schott-Geräte, Hofheim, Germany) 
maintained at 25 ± 0.1 oC. The flow times of solutions at a constant volume through a 
capillary tube were automatically recorded using an AVS 350 viscosity measurement 
unit (Schott-Geräte, Hofheim, Germany) with an accuracy of 0.01%.  
Before the experiment, the viscometer was carefully rinsed with pure water and 
ethanol and dried by a stream of nitrogen gas. Approximately 15 mL of each test 
solution was transferred to the viscometer and the solution allowed to equilibrate for 
5 minutes to the desired bath temperature. Flow times were measured at several 
concentrations (from high to low) and the dilutions of the surfactant solution within 
the Ubbelohde viscometer were performed using a programmable Visco Doser AVS 
20 piston burette (Schott-Geräte, Hofheim, Germany).  
Density 
The densities of the surfactant solutions and solvent were measured with an Ostwald 
pycnometer (10 mL) maintained at 25 ± 0.1 ℃. The pycnometer was first filled with 
water and equilibrated in the water bath (RCT basic, IKA, Germany), and the filled 
mass corrected for the mass of the empty pycnometer, recorded as 𝑀𝐻2𝑂. 
The premade surfactant solution was then transferred into the same pycnometer 
(cleaned and dried), and after equilibrium the filled mass corrected for the mass of the 
empty pycnometer and recorded as Ms.  The density (𝜌𝑠) of the measured sample was 




𝜌𝐻2𝑂              [2.19] 
with 𝜌𝐻2𝑂  taken as 0.997 g/mL at 25 
oC [138]. The measured sample was further 
diluted with solvent and the mass measured following the same procedures. Each 





Surfactant solutions in the absence of steroids 
In the present study, the intrinsic viscosity of the surfactant solutions [η] was taken as 
the average of the reduced viscosity (ηsp/c) and inherent viscosity (ln(ηrel/c)) values 
extrapolated to zero concentration. The variations in the reduced and inherent 
viscosities of the surfactants as a function of concentration are presented in Tables A.3 
to A.7 in Appendix A; the Huggins – Kraemer plots obtained from these data are 
shown in Figure 2.11, and the calculated intrinsic viscosities are summarized in Table 
2.9. As discussed above, to correct for the electro-viscous effects of the ionic 
surfactants, the determination of viscosity was performed in 0.2 M NaCl solution. The 
[η] so obtained for the SDS and DTAB solutions were in good agreements with the 








Figure 2. 11 Reduced and inherent viscosities of surfactant solutions as a function of 
surfactant concentration. Standard errors on the data are shown (n=3) but fall inside 
the plotted symbols. 
The ionic surfactants (SDS and DTAB) and the zwitterionic surfactants (DDAO and 
DDAPS) show relatively similar [η] while the non-ionic surfactant Brij 35 has a much 
higher [η] (6.33 mL/g vs 3 – 4 mL/g). The increased [η] for Brij 35 is attributed to its 
much larger head groups and the fact that the ethylene oxide units in the head group 
provide more space for the mechanical trapping of water and hydrogen bonding. The 
change in nature of the head groups in the ionic surfactants is not expected to cause a 
significant change in size of their micelles and as expected causes little change in [η] 
[139].  
To analyse the hydration of the surfactant micelles, the partial specific volume ?̅?1 of 





















































































































































obtained for SDS and DTAB were little different from those determined here through 
density measurements (SDS ?̅?1=0.867 vs 0.795 cm
3/g and DTAB ?̅?1 = 0.927 vs  0.933 
cm3/g respectively), and for all  of the surfactants studied, the results generally accord 





Table 2. 9 The intrinsic viscosity [η] of surfactant solution and the surfactant partial 
specific volume ?̅?𝟏, molar volume V, hydration properties. 
Surfactant [η] (mL/g) ?̅?1(cm
3/g)a V (Å3)a H2O/single SAA 
molecule 
Hydration % 
SDS 3.62 ± 0.07 0.795 380.8 9.2 ± 0.1 82.0 
DTAB 3.13 ± 0.02 0.933 477.7 5.4 ± 0.1 54.1 
DDAO 4.06 ± 0.07 1.110 422.6 6.6 ± 0.1 74.1 
DDAPS 3.11 ± 0.04 0.960 534.7 5.3 ± 0.0 47.2 
Brij 35 6.33 ± 1.77 0.892 1774.2 109.2 ± 1.8 69.7 
a: values calculated ab-initio [135] 
Many early studies of aqueous surfactant studies concluded that surfactant micelles 
are heavily hydrated, with 4 – 10 water molecules bound per surfactant molecules, and 
with the total number of the bound waters accounting for almost half the total volume 
of a micelle [142-144]. In the micelles formed by ionic surfactants, water molecules 
can readily insert between their relatively small head groups and are tightly bound 
through charge-dipole interactions. The hydration number obtained here for SDS falls 
within the range 7 – 12 reported by Tokiwa et al. [132] and also agrees with the result 
presented by Lindman et al. [145]. 
Likewise, for the cationic surfactant DTAB, the hydration number determined here 
(5.4 ± 0.1 H2O/molecule) agrees with the result presented by Griffiths et al. [146], who 
reported a hydration of 54% determined through electron paramagnetic resonance 
experiments. Griffiths et al suggested [146] that water molecules were displaced from 
the polar shell due to the larger size of the Br- / DTA+ head group by comparison with 
the sulfate headgroup of SDS and that this lead to the lower hydration of DTAB 
compared with SDS.  
The calculated hydration of 6.6 ± 0.1 H2O per DDAO molecules in much lower than 
the 10 H2O/molecules reported by Courchene [140], but does accord with the values 
later reported by Barlow et al. (4 – 8 H2O/molecules; [141]) and Lorenz et al. (~8 




The hydration of 5.3 H2O/molecule here for DDAPS is a little lower than the 6 – 7 
H2O/molecule reported by La Mesa et al. [148] on the basis of their nuclear magnetic 
resonance (NMR) measurement, and the hydration of 4.8 H2O/EO unit determined 
here for Brij 35 is rather higher than was reported by Tanford et al. [149] (2.5 – 3.3 
H2O/EO) but close to the value (of ~4 H2O/EO) reported by Shikata et al. [150]. 
Surfactant solutions in the presence of steroids 
The intrinsic viscosities of SDS, DTAB and DDAPS micelle solutions in the presence 
of 4-cholesten-3-one (4-CHOL) and adrenosterone (ADRENO) were determined and 
the Huggins-Kraemer plots are shown in Figure 2.12. (The concentration-dependent 
variations in the reduced and inherent viscosities of these systems are presented in 
Tables A.8 – A.13 in Appendix A). As can be seen, the presence of steroids in the 
surfactant micelles causes an increase in the intrinsic viscosities. The densities of the 
solutions, however, did not change significantly (see Table A.14, in Appendix A).  
The extent of the increase in [η] in the presence of steroids seems dependent on the 
level of steroid solubilisation within the micelle. The solubilisation capacity of SDS 
for 4-CHOL was much higher than was found for ADRENO (Chapter 2.1) and so 4-
CHOL causes a greater increase in [η] relative to that for SDS alone (vis, 30% vs 5%). 
Likewise, because the solubilisation capacities of DTAB micelles for 4-CHOL and 
ADRENO were far less than were found for SDS, the resulting changes in [η] caused 
by steroids were much smaller. 
Interestingly, although the solubilisation capacity of DTAB for 4-CHOL was found to 
be 3-fold higher than for ADRENO, the [η] of DTAB micelles saturated with 4-CHOL 
was slightly lower than with ADRENO (3.30 ± 0.05 mL/g and 3.44 ± 0.10 mL/g for 
ADRENO/DTAB micelles and 4-CHOL/DTAB micelles, respectively). The likely 
reason for the reverse trend can be explained by the low solubility of 4-CHOL in 





Figure 2. 12 Reduced and inherent viscosity of surfactant/steroid solutions as a 
function of surfactant concentration (○: pure surfactant system, □: surfactant system 
saturated with 4-cholesten-3-one, ∆: surfactant system saturated with adrenosterone). 
Standard errors are shown (n = 3) but fall inside the plotted symbols. 
The intrinsic viscosities of DDAPS micelles in the presence of 4-CHOL and 
ADRENO did not show noticeable differences. The solubilities of 4-CHOL and 
ADRENO in DDAPS micelles at concentrations below 5 wt% were found to be very 
similar (see section 2.1), and the intrinsic viscosities of DDAPS micelles in the 
presence of these two steroids show little difference (both ~3.6 mL/g). 
Saturation of the surfactant micelles with the steroids, however, leads to a higher level 
of hydration (Table 2.10).  This might be because the shape factor ν used in equation 
2.14 was assumed to be 2.5, with the assumption that the micelles were spherical. If 
the micelles are not spherical, however, the value of 2.5 used for ν might not be 
appropriate. With steroids solubilised in the surfactant micelles, the increased intrinsic 
viscosities would suggest larger micelles which in turn might suggest that the 
aggregates could become more rod-like, and so the shape factor ν would then be higher 
than 2.5. The value of the shape factor to be used in calculating the micelle hydration 












































































































micelle hydration are nevertheless of use in guiding the model-fitting of small angle 
neutron scattering data (as presented in Chapter 4). 
Table 2. 10 The intrinsic viscosity [η] and hydration properties for surfactant micelles 
in the presence and absence of 4-cholesten-3-one and adrenosterone. (n=3) 




SDS 3.62 ± 0.07 9.2 82.0 
SDS + 4-cholesten-3-one 4.76 ± 0.17 16.7 89.2 
SDS + adrenosterone 3.83 ± 0.05 10.6 84.0 
DTAB 3.13 ± 0.02 5.4 54.1 
DTAB + 4-cholesten-3-one 3.30 ± 0.05  6.8 59.9 
DTAB + adrenosterone 3.44 ± 0.10 7.7 62.8 
DDAPS 3.11 ± 0.04 5.3 47.2 
DDAPS+ 4-cholesten-3-one 3.57 ± 0.06 8.7 59.5 
DDAPS+ adrenosterone 3.58 ± 0.13 8.8 59.8 






The measurement of the surfactant intrinsic viscosities and densities have been used 
to determine the hydration of the C12-chain surfactant micelles. The hydration number 
of the non-ionic surfactant, Brij 35 was the largest due to its large, EO-containing, 
head group.  
The anionic surfactant SDS has a relatively higher hydration compared with the other 
surfactants studied (Table 2.11). The hydration of ionic surfactant head groups also 
has been determined by Allen et al. [151]. They investigated surfactants with a C12 
hydrocarbon chain and DS- head group but bound with different counterions and found 
that although the micelle size did not change with a change in counterion, the hydration 
of the head group did change. With counterions that more strongly bound to the head 
group, the head group became less heavily hydrated. 
The presence of steroids in the micelles did not change the density to a large extent, 
however, the intrinsic viscosity changed significantly and was shown to be dependent 
on the solubility of steroids in the micelles.  
From the solubilisation measurements performed here, the poorly water-soluble 
steroids 4-cholesten-3-one (4-CHOL) and adrenosterone (ADRENO) both have the 
lowest solubilities in dispersions of the non-ionic surfactant, Brij 35, and this may be 
because of the large number of waters bound to the surfactant head groups, which 
could perhaps hinder entry of the steroids into the micelle interior.  
Given that the Simha shape factor for ellipsoidal micelles, ν, is a function of their 
semi-axis dimensions, it can be used – if determined independently – to predict the 
axial ratios of micelles. It is generally taken to be 2.5 for surfactant micelles [140, 152, 
153], and increased values of ν indicate higher axial ratios. It is not possible, however, 
to use ν to distinguish whether a surfactant’s micelles are prolate or oblate.  
On the basis of the solubilisation and surface tension studies it can be concluded, 
therefore, that the ideal surfactant for solubilising 4-CHOL and ADRENO should 
either be an ionic surfactant and/or have a relatively small number of water molecules 
hydrating the polar head group. More detailed insights into the influence of the 




the presence and absence of steroids) are afforded through small angle neutron 
scattering studies, and these are reported in Chapter 4. 
Table 2. 11 Summary of the results obtained from solubilisation (solubilisation 
capacity, Scap), surface tensiometry (the critical micelle concentration, CMC and area 
per surfactant molecule, 𝜶𝟏
𝒔 ), number of water molecules per surfactant head group 
(H2O / SAA), hydration value (% H2O) and solubilisation capacity (Scap*) 
 CMC 
± 0.02 wt% 
𝛼1
𝑠 
± 3 Å2 








SDS 0.23 70 9.3 82 1 1 
ADS 0.18 60 6.6 a 70 a 2 3 
LDS 0.26 75 7.3 a 53 a 3 2 
DTAB 0.43 55 5.6 55 4 5 
DDAPS 0.078 49 5.3 47 7 4 
DPC 0.056 55 7.6 b 55 b 8 6 
DDAO 0.032 40 6.6 74 5 7 
Tween 20 0.0078 b 110 b 61.8 b 56 b 6 8 
Brij 35 0.0057 b 70 b 109.1 70 9 9 
Scap* Solubilisation capacity (g/g) expressed as a rank order, where 1 presents the best 
solubilizer and 9 presents the worst. 
a determined by Allen et al. [151] 









Neutron reflectometry allows the study of thin film structure on the sub-nanometre 
length scale and is a non-destructive and non-invasive technique that has been 
extensively used in the study of the structure and behaviour of surfaces and interfaces 
in soft matter systems since the mid-1980s. 
Lu et al. [154] have reviewed the used of the technique in investigations of 
surfactant/mixed surfactant adsorption at the air-water interface showing how it can 
be used to reveal the surface excess, and the organisation thickness and composition 
of the adsorbed layers.  
The applications of neutron reflectivity in studies of the adsorption of surfactant and 
mixed surfactant systems at the liquid-solid interface have been widely reported [155-
158]. A more general review of the applications of the technique and a perspective on 
recent progress has been provided by Penfold and Thomas [155, 159]. 
3.1.1 The specular neutron reflection technique 
Neutrons are reflected from the interface between media of differing refractive index 
in the same way as light, and the intensity of the specular reflected beam is measured 
as a function of wave vector transfer in the perpendicular direction (Qz). Qz varies 









The neutron reflectivity measurement can either be made keeping the wavelength of 
the neutron beam, λ, constant and then varying the angle of incidence, θ, or else by 
selecting a constant θ while varying λ.  
The neutron refractive index is the ratio of the wave vectors inside and outside at the 





                 [3. 2] 
where N is atomic number density, and b is bound scattering length of the material. 
 
For most materials, n is less than 1, and so total external reflection can be observed, 
with Snell’s law giving the critical glancing angle (θc) under which the total reflection 
would occur. At the air-water interface, given that the refractive index of air is very 




                 [3. 3] 
where ρ refers to the scattering length density of the material at the interface. 




|2               [3. 4] 
For a uniform thin film with a thickness d (Figure 3.2), the incident neutron beam will 
be partially transmitted and partially reflected, and analysis of the specular reflectivity 
can either be performed using an exact optical matrix method, or the kinematic (Born) 
approximation method. In the neutron reflectivity studies reported here, the data were 
modelled using the optical matrix methodology, as explained below. For details of the 




Figure 3. 1 Interface between two bulk media of refractive index n0 and n1 showing 
the incident (k1) and reflected waves (k2) at angel θ0 and the transmitted wave of 















Figure 3. 2 Interfacial film of thickness, d, and refractive index n1 separating bulk 
media of refractive index, n0 and n2 showing the angle of incident (θ0) and refraction 
(θ1) for neutrons incident on the film 
For a uniform layer of material of thickness d at the interface between two bulk media 
with refractive index n0 and n2, the reflectivity can be expressed using the standard 
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,                  [3. 6] 
and pi = nisinθi, and the optical path length in the film β = (2π/λ)n1dsinθ1. 
The reflectivity for a system including several interfacial layers is generally calculated 
using the optical matrix method [161]. For each layer j in such a film, this standard 
method gives a characteristic matrix by applying the condition that the wave functions 







]              [3. 7] 
The resulting reflectivity for a system comprising n layers is then obtained from the 






              [3. 8] 
In this study, the NR profiles were analysed by the optical matrix method using 
MOTOFIT software [162].  The main features of interest for surfactant monolayers 










relative position of the surfactant head and chain groups, and the level of solvent 
penetration. For the surfactant systems in the absence of steroid, the thickness of the 
monolayer (d), the surface excess concentration (ΓSAA) and the limiting area per 
molecule (𝑎1
𝑠 ) were determined. For the systems with steroid incorporated in the 
monolayer (4-cholesten-3-one or adrenosterone), the volume fraction (Vf) of steroid 






3.2 Experimental details 
3.2.1 Materials 
Sodium dodecyl sulfate (SDS), ammonium dodecyl sulfate (ADS), lithium dodecyl 
sulfate (LDS), dodecyl trimethylammonium bromide (DTAB) and N, N-
dimethyldecylamine N-oxide (DDAO), N-dodecyl-N, N-dimethyl-3-ammonio-1-
propanesulfonate (DDAPS) were purchased from Sigma (Dorset, UK) and dodecyl 
phosphocholine (DPC) was obtained from Avanti Polar Lipids (Alabama, USA) 
Alkyl chain deuterated d25SDS, d25ADS, d25LDS, d25DTAB, d25DDAO and 
d25DDAPS were kindly provided by the Oxford Deuteration Facility (Didcot, UK). 
d38DPC was obtained from CDN Isotopes (New Jersey, USA) 
4-cholesten-3-one (98+%) was purchased from Alfa aesar (Thermo fisher Scientific, 
UK) and adrenosterone (97+%) from Santa cruz (Germany). 
n-Hexane was from Fisher Scientific (Loughborough, UK) and D2O (99.9 atom % D) 
was supplied by Oxford Deuteration Facility (Didcot, UK). 
3.2.2 Sample preparation 
Each surfactant and surfactant/steroid system was studied using four isotopic 
contrasts: h25SAA (protiated surface-active agent) in D2O; h25SAA in air contrast 
matched water (8.1 % D2O/91.9 % H2O by volume; ACMW); d25SAA (alkyl chain 
deuterated surfactant) in D2O; d25SAA in ACMW.  All solutions for the study were 
prepared at the concentrations required for the reflectivity measurement. 
For surfactant/steroid systems, excess steroid was added into the surfactant micellar 
solution and left on a rotary wheel for 7 days until equilibrium was achieved. Excess 
steroid was then removed by filtration through a 0.2 µm filter. For surfactant/steroid 
samples prepared at surfactant concentrations below the surfactant CMC, the solutions 




3.2.3 Neutron reflectometry 
Neutron reflectivity measurements on the monolayers adsorbed at the surface of 
surfactant micellar solutions in the presence and absence of saturating levels of 4-
cholesten-3-one (4-CHOL) or adrenosterone (ADRENO) were made in time-of-flight 
mode using the FIGARO reflectometer at ILL (Grenoble, France) and INTER at ISIS 
(Didcot, UK). At FIGARO, neutrons of wavelength (λ) 2-25 Å were selected and data 
collected at fixed incident angles θ = 0.62 ̊ and 3.8 ̊ with a Qz resolution of 7%. At 
INTER, the θ were at 0.8 ̊ and 2.3 ̊ with a resolution Qz of 5.5% and neutrons were 
selected with wavelengths (λ) from 2 to 30 Å. The background scattering was 
subtracted from the data obtained at FIGARO but not for the data obtained at INTER. 
The procedure for each measurement was the same. The prepared sample was poured 
into a 5 cm x 22 cm Teflon trough. The height of trough with the sample was aligned 
automatically using a laser, and the trough was then covered with a lid before 
measuring. To ensure the surface was equilibrated, a kinetic run was first determined 
until the structure of the air-water interface became stable. Most of the samples 
reached equilibrium within 30 minutes. In some cases, the surface equilibrium was 
achieved after a much longer time. After each measurement, the height of each sample 
was aligned again to make sure the evaporation effect was not significant.  
Hexane containing steroid was spread onto the interface after the measurement for 
each sample and left for at least 20 minutes to make sure the hexane had fully 
evaporated before measuring again. 
3.2.4 NR data fitting 
The fitting of neutron reflectivity data is most commonly carried out using the optical 
matrix method, but there have been no systematic studies conducted to aid, for 
example in selecting an appropriate choice of surface roughness or number of layers 
to include, with most workers adopting an ad hoc strategy that they consider 
appropriate to the system studied. Recently, however, Campbell et al. [163] have 
proposed a robust model for the fitting of neutron reflectivity data, suggesting to split 
the adsorbed layer into separate layers, but with the layer roughness treated as 
conformal, and constraints applied to ensure that the volume fractions of the surfactant 




the number of free-fitted parameters is minimized. In this study, the fitting of the 
reflectivity data was performed according to this approach. 
To fit the obtained profiles, the surfactant monolayer was divided into two layers. 
Layer 1 consists of the hydrophobic chain groups and layer 2 contains the hydrophilic 
head groups. When the monolayer was saturated with 4-CHOL or ADRENO, the 
steroid molecules were assumed to insert with layer 1 (Model 1), or layer 2 (Model 2), 
or to insert beneath layer 2 in the subphase (Model 3) 
Table 3. 1. The assumptions made in models 1-3 regarding the locations of the steroids 
in relation to the surfactant monolayer formed at the air-water interface 
 Model 1 Model 2 Model 3 
Layer 1 SAAtail + steroid SAAtail SAAtail 
Layer 2 SAAhead SAAhead + steroid SAAhead 
Layer 3 / / steroid 
 




Due to the similar neutron scattering length density between the protiated surfactant 
and steroids, neutrons could not distinguish between the steroids and surfactant 
molecules. Thus the neutron reflectivity profile for contrasts with h25SAA show little 
change in the presence of steroids and yield little information. The difference in the 
neutron reflectivity profiles of the monolayers of deuterated surfactants in the presence 
and absence of steroids is more pronounced, and the d25SAA/ACMW contrast gives 
more information about the thickness of the monolayer while the d25SAA/D2O 
contrast is more sensitive to solvent penetration.  For all of the systems studied all four 




Figure 3. 3 Schematics showing the different interfacial layer structures assumed in 




used to fit the reflectivity data, but only the two contrasts involving deuterated 
surfactant are presented here.  
Likewise, instead of fitting the full Q-range of the neutron profiles, different regions 
were fitted according to their sensitivity to changes in specific fitted parameters. For 
the d25 SAA/ACMW neutron profile, the experimental data within the Q-range 0.05-
0.10 Å-1 were fitted, while for d25 SAA/D2O data, a high Q-range between 0.10-0.15 
Å-1 was refined.  
The variable parameters in the global fit of each layer included the layer thickness (d), 
roughness (σ) and neutron scattering length density (ρ).  The scattering length density 
was calculated from the scattering lengths and molecular volumes as given in Table 
3.2. As reported by Fullagar et al. [164], the interfacial roughness of both layer 1 and 
layer 2 was fixed at 4 Å.  
A quantitative assessment of the fit between the calculated and observed NR profile 










𝒊=𝟏              [3. 9] 
where N is the number of experimental points and Np is the number of free parameters, 
Rexp and Rtheo are the experimental and theoretical reflectivity values. Note that χ
2 is a 
measure of the difference between the calculated curve and the error bars, and not the 























Table 3. 2 The chemical formulae, scattering length densities (), scattering lengths (b) and molecular volume (Vm) for each surfactant and steroid. 
Chemical Molecular formula  (x 10−6 Å−2) bc (x 10
−5 Å) Vm (Å
3) 
h25 d25 h25 d25 
4-cholesten-3-one C27H44O 0.34 N/A 20.80 N/A / 
Adrenosterone C19H24O3 1.27 N/A 54.01 N/A / 
DTAB C15H34BrN -0.23 5.08 -11.24 249.05 489.9 
TAB C3H9BrN 0.18 N/A 2.46 NA 136.2 
DPC C17H38NO4P 0.16 7.53 8.64 404.28 536.7 
PC C5H13NO4P 1.22 8.62 22.34 148.32 183.0 
DDAO C14H31NO -0.18 6.04 -7.67 252.62 422.4 
DAO C2H6NO 0.88 N/A 6.03 N/A 68.7 
DDAPS C17H37O3SN 0.08 4.98 4.25 264.54 531.4 
DAPS C5H12O3SN 1.01 N/A 17.95 N/A 177.7 
 SDS NaC12H25SO4 0.39 6.66 15.94 276.22 414.4 
SS NaSO4 4.89 N/A 29.65 N/A 60.7 
ADS NH4C12H25SO4 0.13 6.42 6.72 267.01 414.8 
AS NH4SO4 3.35 N/A 20.42 N/A 61.1 
 LDS LiC12H25SO4 0.26 6.64 14.31 274.60 417.7 
LS LiSO4 4.40 N/A 28.02 N/A 64.0 




3.2.5 Modelling parameters 
If an adsorbed surfactant monolayer is treated as a single uniform layer, the surface 




 =  
𝝆𝒊×𝒅𝒊
∑ 𝒃𝒊×𝑵𝑨
                               [3. 10] 
where 𝑎𝑖, ∑ 𝑏𝑖 and 𝜌𝑖 are the area per molecule, scattering length and scattering length 
density of species, d is the layer thickness, and NA is Avogadro’s number. If the 




                 [3. 11] 
Vf,i is the volume fraction of species i in the layer and the volume fraction of solvent 
in the layer, Vs is obtained as:  
Vs = (1- Vf,i - Vf,j) x 100              [3. 12] 
And if there is no solvent in the layer: 
Vf,i +  Vf,j = 1                [3. 13] 
 
Model 1 
For Model 1 the adsorbed monolayer was taken to comprise two layers. Layer 1, the 
upper layer (on the air side of the interface) was taken to involve surfactant 
hydrocarbon chains and any added steroid, with no solvent. Layer 2, the lower layer 
(on the aqueous subphase side of the interface) was taken to involve surfactant 
hydrophilic head groups and solvent. 
For layer 1, given that vs = 0, the scattering length density ρ1 thus taken as: 
ρ1 = ρSAA_tail x Vf, SAA_tail + ρsteroid x Vf, steroid           [3. 14] 
and 
Vf, SAA_tail + Vf, steroid = 1                        [3. 15] 
Combining equations 3.14 and 3.15, the volume fraction for each species is: 
Vf, SAA-tail = 
𝛒𝟏−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅
𝛒𝑺𝑫𝑺_𝒕𝒂𝒊𝒍−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅
                    [3. 16] 
Vf, steroid = 
𝛒𝑺𝑫𝑺_𝒕𝒂𝒊𝒍−𝛒𝟏
𝛒𝑺𝑫𝑺_𝒕𝒂𝒊𝒍−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅




and the surface excess for the surfactant tail region and steroid in layer 1 are obtained 
as: 




             = 
𝛒𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝒅𝟏×(𝛒𝟏−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅)
𝛒𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝑵𝑨×(𝛒𝑺𝑫𝑺𝒕𝒂𝒊𝒍−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅)
                             [3. 18]    




           =
𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅×𝒅𝟏×(𝛒𝑺𝑫𝑺_𝒕𝒂𝒊𝒍−𝛒𝟏)
𝜮𝒃𝒔𝒕𝒆𝒓𝒐𝒊𝒅×𝑵𝑨×(𝛒𝑺𝑫𝑺_𝒕𝒂𝒊𝒍−𝛒𝒔𝒕𝒆𝒓𝒐𝒊𝒅)
                  [3. 19] 
For layer 2, d2 was fixed and ρ2=ρSAA_head. Since ΓSAA_tail = ΓSAA_head = ΓSAA, 
Vf, SAA_head = 
𝚪𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝜮𝒃𝑺𝑨𝑨_𝒉𝒆𝒂𝒅×𝑵𝑨
𝛒𝑺𝑨𝑨_𝒉𝒆𝒂𝒅×𝒅𝟐
               [3. 20]         
and Vs,2 = (1- Vf, SAA_head) x 100                    [3. 21]       
 
In model fitting the NR data assuming model 1, the only parameters fitted were thus 
d1 and ρ1, and Vs,2 was constrained to satisfy equation 3.12.  
 
Model 2 
For model 2, the added steroid molecules were assumed to reside in layer 2, the 
surfactant head group layer. Layer 1 was taken to involve surfactant, with ρ1 = ρSAA_tail, 
Vs,1=0. The surface excess of surfactant was obtained as: 
ΓSAA_tail = ΓSAA = 
𝛒𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝒅𝟏
𝜮𝒃𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝑵𝑨
                                [3. 22] 
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and the surface excess for the surfactant head groups obtained as: 
ΓSAA_head = 









Given the constraint then that ΓSAA = ΓSAA_head, the volume fraction of solvent in layer 
2, Vs,2 is obtained as: 
Vs,2 =100 -  
𝛒𝐒𝐀𝐀_𝐭𝐚𝐢𝐥×𝐝𝟏×𝜮𝒃𝐒𝐀𝐀_𝐡𝐞𝐚𝐝×(𝛒𝐒𝐀𝐀_𝐡𝐞𝐚𝐝−𝛒𝐬𝐭𝐞𝐫𝐨𝐢𝐝)
𝛒𝐒𝐀𝐀_𝐡𝐞𝐚𝐝 ×𝐝𝟐×𝜮𝒃𝐒𝐀𝐀_𝐭𝐚𝐢𝐥× (𝛒𝟐−𝛒𝐬𝐭𝐞𝐫𝐨𝐢𝐝)
× 𝟏𝟎𝟎             [3. 26]    
In model fitting assuming model 2, d1 and ρ2 were fitted, with Vs,2 constrained as 
above. The fitting process was repeated until the minimum χ2 was obtained with input 
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Model 3 
For model 3, the adsorbed layer was taken to consist of three layers. Layer 1 was taken 
to involve the surfactant hydrocarbon chains as in model 2. Layer 2 was taken to 
include the surfactant head groups and solvent. Layer 3 – a layer assumed to lie 
underneath Layer 2 – was taken to contain the added steroid and solvent. 
The surface excess of surfactant was obtained as in model 2: 
ΓSAA_tail = ΓSAA = 
𝛒𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝒅𝟏
𝜮𝒃𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝑵𝑨
                              [3. 28] 
In layer 2 there is only one specie present, the surfactant head groups, and so ρ2 = 
ρSAA_head, and Vs,2 is obtained as: 
Vs,2 = 100-100× 
𝛒𝑺𝑨𝑨_𝒕𝒂𝒊𝒍×𝒅𝟏×𝜮𝒃𝑺𝑨𝑨_𝒉𝒆𝒂𝒅
𝛒𝑺𝑨𝑨_𝒉𝒆𝒂𝒅×𝒅𝟐×𝜮𝒃𝑺𝑨𝑨_𝒕𝒂𝒊𝒍
                            [3. 29] 
For model 3 the model fitting was performed taking the fitted parameters as d1 and 
Vs,3, with Vs,2 constrained to satisfy equation 3.29. The thickness of layer 3 (d3) was 










3.3.1 Characteristics of the C12 surfactant monolayers in the absence 
of steroid 
Neutron reflectivity (NR) studies were performed for the various C12 surfactant 
monolayers adsorbed at the air-water interface. The studies were carried out using 
surfactant concentrations both below and above the CMC. The NR profiles obtained 
were analysed using a simple 2-layer model in which the adsorbed surfactant 
monolayer was partitioned with the C12-chains in one layer and the hydrated surfactant 
head groups in a second layer. 
Figure 3.4 shows the NR profiles obtained for SDS monolayers, with concentrations 
of SDS at 0.5, 1.5 and 2 times the CMC (with the CMC for SDS taken as 0.23 wt%).  
It can be seen here that while the scattering curves obtained for d25SDS adsorbed on a 
sub-phase of D2O show no significant change with changing surfactant concentration, 
this is not true for the profiles obtained for d25SDS on ACMW. For the 
d25SDS/ACMW monolayers there is a significant difference between the NR profiles 
obtained for surfactant concentrations above and below the CMC, but no significant 
change in the profiles obtained for concentrations above the CMC. 
 Modelling of these data gave the best-fitted structural parameters summarized in 
Table 3.3. As would be expected (and wholly consistent with the surface tension 
measurements presented earlier, see section 2.2), these results show that the adsorbed 
SDS monolayer is not fully saturated when the surfactant concentration is below its 
CMC. At this concentration the SDS molecules are less tightly packed, and so they 
occupy a larger interfacial area (48 ± 2 Å2 vs. 40 ± 2 Å2) and give rise to a slightly 
thinner alkyl chains layer (7.5 ± 0.3 Å vs. 9.0 ± 0.3 Å). The results are broadly 
consistent with those presented by Lu et al. [160] who reported an interfacial area for 
SDS (at a concentration of 3 x CMC) of 44 ± 4 Å2 and noted changes in monolayer 
thickness of the order of 1 Å with SDS concentrations varied between 0.13 and 1.3 x 
CMC. The results obtained here are also in agreement with those presented more 
recently by Yanez Arteta et al. [165] who reported a C12 layer thickness of 11 ± 3 Å 




Table 3. 3 Model-fitted structural parameters for SDS monolayers 
SDS 
 (x CMC) 
dtail 
 (± 0.3 Å) 
Vf H2O 
 (± 1%) 
ΓSAA  
(± 0.1 x10-10 mol. cm-2) 
α  
(± 2 Å2)  
0.5 7.5 68 3.5 48 
1.5 9.0 62 4.2 40 
2.0 9.0 62 4.2 40 
 
NR measurements performed to determine the structures of the monolayers formed at 
the air-water interface by the related anionic surfactants ADS and LDS showed the 
same concentration-dependent changes as seen with SDS (see Figure 3.5), with the 
interfacial area per molecule decreasing and the alkyl chains layer thickness increasing 
as the surfactant concentration is increased up to the CMC (see Table 3.4).    
Comparison of the three anionic surfactant monolayers shows that the interfacial 
molecular areas and C12 layer thicknesses are closely similar for the monolayers 
formed in the presence of the alkali metal counterions, lithium and sodium – a result 
that accords with the observations reported by Allen et al. [151] – but they are 
somewhat different for the monolayer formed in the presence of ammonium 
counterions. With a surfactant concentration of 2 x CMC, the ADS area per molecule 
is around 5 Å2 smaller and the alkyl chains layer thickness around 1 Å thinner. This 
difference in packing of the ADS monolayer by comparison with the LDS and SDS 




















Table 3. 4 Model-fitted structural parameters for ADS and LDS monolayers 
ADS (x CMC) dtail (± 0.3 Å) Vf H2O (± 1%) ΓSAA (± 0.1 x10
-10 mol cm-2) α (± 2 Å
2)  
0.2 6.4 72 3.0 55 
0.5 7.8 66 3.7 45 
1.5 10.6 55 4.9 34 
2.0 10.0 57 4.7 35 
LDS (x CMC) dtail (± 0.3 Å) Vf H2O (± 1%) ΓSAA (± 0.1 x10
-10 mol cm-2) α (± 2 Å
2)  
0.2 6.9 69 3.2 52 
0.5 8.1 63 3.8 44 
1.5 9.0 60 4.2 39 
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Figure 3. 4 NR profiles for d25-SDS monolayers adsorbed at the air-water interface, 
on sub-phases of ACMW and D2O, with concentrations above and below the CMC 










































0.2 x CMC 0.5 x CMC 1.5 x CMC 2.0 x CMC
 
Figure 3. 5 NR profiles for d25-ADS and d25-LDS monolayers adsorbed at the air-water 
interface, on sub-phases of ACMW and D2O, with concentrations above and below the 




Given that there were no significant changes seen in the structures of the SDS, ADS 
and LDS monolayers when the surfactant concentration was increased beyond the 
CMC, the NR measurements for the other C12 surfactants studied were only performed 
using a surfactant concentration of 2 x CMC. The structural parameters obtained in 
model-fitting these data are summarized in Table 3.5. 
The results obtained for DPC agree with those reported by Lu et al. [166], and those 
for DTAB and DDAPS are likewise consistent with the findings reported by Lyttle et 
al. [118] and Qu et al. [167].  
It is significant to note here that although these surfactants all share the same C12 alkyl 
chain, they form monolayers with quite different alkyl chain layer thicknesses (ranging 
from 7.1 Å for DPC to 11.0 Å for DDAO) and as a consequence of their differing 
polar head groups they show differences in their surface excess and area per molecule. 
While six of the seven surfactants studied here have interfacial molecular areas of 45-
50 Å2, the interfacial area of DDAO is much smaller – only ca. 50% greater than the 
cross-sectional area of the C12 chain (32 Å
2 vs. 21 Å2) – and the surface excess for 
DDAO is thus ca. 50% greater than that of the other surfactants (viz., 5.1 x 1010 
mol.cm-2 vs. ~3.5 x 1010 mol.cm-2). 
Table 3. 5 Model-fitted structural parameters for DTAB, DDAO, DDAPS and DPC 
monolayers (with surfactant concentration, 2 x CMC). 
 dtail 
 (± 0.3 Å) 
Vf H2O 
 (± 1%) 
ΓSAA  
(± 0.1 x10-10 mol cm-2) 
α  
(± 2 Å2)  
DTAB 7.8 55 3.6 46 
DDAO 11.0 62 5.1 32 
DDAPS 8.1 55 3.8 44 





3.3.2 Characteristics of the C12 surfactant monolayers in the presence 
of 4-cholesten-3-one and adrenosterone 
NR studies were performed to determine the structure of the C12 surfactant monolayers 
in the presence of 4-cholesten-3-one and adrenosterone, in all cases using a surfactant 
concentration of 2 x CMC. Model fits to the NR profiles were explored using models 
with the steroid incorporated within the C12 alkyl chains layer (model 1), within the 
polar head group layer (model 2), or otherwise present in the aqueous sub-phase 
forming a separate layer immediately beneath the polar head group layer (model 3). 
Table 3.6 shows the best-fitted structural parameters obtained in modelling the NR 
data for the surfactant monolayers saturated with 4-cholesten-3-one (4-CHOL) and 
Table 3.7 shows the corresponding parameters obtained in modelling the monolayers 
formed in the presence of adrenosterone (ADRENO).  
 For the SDS monolayers formed in the presence of 4-CHOL, model fits performed 
assuming models 2 and 3 gave significantly poorer fits than that obtained using model 
1 (with χ2 values of 91 and 40 vs. 6; see Appendix B, Figure B.1 and Table B.1). The 
use of models 2 and 3 also resulted in a counterintuitive decrease in the monolayer 
thickness (of 1.2 Å), while the use of model 1 gave a more physically reasonable 
increase in the monolayer thickness of 2.9 Å, and with the introduction of additional 
4-CHOL onto the surface of the monolayer leading to a further small increase in the 
thickness, taking it to 12 Å. It is concluded, therefore, that the 4-CHOL sits within the 
alkyl chains layer of the SDS monolayer. The surface excess is consequently seen to 
decrease from 4.2 x 1010 mol.cm-2 to 3.7 x 1010 mol.cm-2, thereby leading to an 
increase in the interfacial molecular area of the SDS, from 40 Å2 to 45 Å2.  From the 
ratio of the surface excesses calculated for the SDS and 4-CHOL, it is found that the 
monolayer contains one steroid molecule for every 3.5 molecules of SDS. 
When the SDS monolayer is saturated with ADRENO, the use of model 1 again 
provides the best fit to the NR data (giving the lowest χ2), and so this steroid too is 
concluded to lie within the alkyl chains layer of the monolayer. In this case, however, 
the thickness of the C12 layer remains unchanged at approximately 8 Å. There is a 
slight difference in the surface excess for SDS between the 4-CHOL- and ADRENO-
containing monolayers, and there is a difference too in the surface excesses of the two 




the steroid:surfactant ratio being much lower for ADRENO compared with 4-CHOL 
(viz., 1:7.3 vs. 1:3.5). This difference in stoichiometry is consistent with the results 
obtained in the solubilisation experiments reported earlier (section 2.1). 
For the cationic surfactant DTAB, the use of model 1 once again provides the best fit 
to the NR data for the monolayers containing 4-CHOL. The model fits achieved using 
model 2 give a higher χ2 and show that there are no 4-CHOL molecules in the polar 
head groups layer, which seems unreasonable given the findings from the 
solubilisation studies (section 2.1). Although there is very little difference in χ2 
between the fits achieved using models 1 and 3, the use of model 3 is not considered 
satisfactory. The use of model 3 shows that if 4-CHOL forms a separate layer 
underneath the surfactant molecules at the air-water interface, the length of the alkyl 
chains layer and the surface excess of surfactant decrease, and such changes seem 
physically unreasonable. In addition, the fit achieved using model 3 shows that the 
number of solubilised 4-CHOL molecules is much lower than is found if model 1 is 
used, and the surfactant:steroid stoichiometry is not then consistent with the results 
obtained in the solubilisation studies.  
Much the same observations are made for the DTAB/ADRENO monolayers as for the 
DTAB/4-CHOL monolayers, with models 1 and 3 giving comparable fits to the NR 
data in terms of χ2 but the use of model 1 leading to a DTAB:4-CHOL stoichiometry 
that better agrees with the findings from solubilisation studies. 
For both the DTAB/ADRENO and DTAB/4-CHOL monolayers the NR data show 
that there is no change in the thickness of the alkyl chains layer caused by the addition 
of steroid, and the surface excesses calculated in the two cases show that there are 2-
3 times more 4-CHOL molecules inserted into the surfactant layer compared with 
ADRENO.  The addition of extra steroid onto the surface of these monolayers caused 
changes in the NR profiles which indicated slight increases in the C12 layer thickness 
and small increases too in the numbers of steroid molecules inserted into the layers.   
In the case of the zwitterionic DDAPS monolayer, regardless of which of the three 
models was used to fit the NR data, the calculated stoichiometries of the 4-CHOL and 
ADRENO were always close to zero, and it had to be concluded that the NR 




different models. The locus of solubilisation of the 4-CHOL and ADRENO in the 
DDAPS monolayer could not therefore be determined. 
Modelling of the NR data for the steroid-containing monolayers of the zwitterionic 
surfactants, DDAO and DPC, showed once again that the steroid molecules insert into 
the surfactant chains layer of the monolayers, but in these systems there were some 
differences seen for the 4-CHOL and ADRENO. In the case of the DDAO monolayers, 
the insertion of 4-CHOL led to a slight decrease in the alkyl chains layer thickness 
(from 11 Å to 10 Å), and the addition of extra 4-CHOL onto the surface of the 
monolayer resulted in an increase in surface excess of the steroid (from 0.4 x 1010 
mol.cm-2 to 0.7 x 1010 mol.cm-2). With the insertion of ADRENO, however, there was 
no change in the alkyl chains layer thickness of the DDAO monolayer and no change 
in the surface excess of the steroid after the addition of extra material onto the surface 
of the monolayer. 
In the case of the DPC monolayers, the fits to the NR data showed that the addition of 
the steroids caused small increases in the alkyl chains layer thickness (to 9.4 Å and 
8.4 Å, for 4-CHOL and ADRENO, respectively), and no significant changes were seen 
in either monolayer when extra steroid was added on the surface.  
At the culmination of these studies, it was thus concluded that the locus of 
solubilisation of 4-CHOL and ADRENO in all the (anionic, cationic, and zwitterionic) 
C12 surfactant monolayers was in the alkyl chains layer – albeit that the NR data for 
the DDAPS systems did not afford the sensitivity necessary to provide conclusive 
proof of this. 






















Table 3. 6 Model-fitted structural parameters for C12 surfactant monolayers in the presence of 4-cholesten-3-one (with 
surfactant concentration, 2 x CMC). 
 dtail  
(± 0.3 Å) 
Vf H2O  
(± 2%) 
ΓSAA  
(± 0.1 x 10-10 mol cm-) 
Γ4-CHOL  
(± 0.1 x 10-10 mol cm-2) 
α  
(± 2 Å2) 
Composition 
 (SAA : 4-cholesten-3-one) 
SDS 11.9 66 3.7 1.1 45 3.5 ± 0.1 
DTAB 7.9 55 3.2 0.3 51 12.7 ± 0.4 
DDAO 10.3 66 4.2 0.4 40 11.1 ± 0.3 
DDAPS 7.4 54 3.5 0.0 48 / 






















Table 3. 7 Model-fitted structural parameters for C12 surfactant monolayers in the presence of adrenosterone (with 
surfactant concentration, 2 x CMC). 
 
 dtail  
(± 0.3 Å) 
Vf H2O  
(± 2%) 
ΓSAA  
(± 0.1 x 10-10 mol cm-) 
ΓADRENO  
(± 0.0 x 10-10 mol cm-2) 
α  
(± 2 Å2) 
Composition  
(SAA : adrenosterone) 
SDS 8.9 67 3.6 0.5 46 7.3 ± 0.2 
DTAB 7.7 52 3.5 0.1 48 31.0 ± 0.9 
DDAO 11.3 66 4.1 1.0 40 4.0 ± 0.1 
DDAPS 7.7 52 3.6 0.0 46 / 




3.3.3 Characteristics of the SDS monolayer as a function of SDS 
concentration in the presence of 4-cholesten-3-one and adrenosterone 
NR studies of the structure of the SDS monolayer in the presence of 4-CHOL and 
ADRENO were carried out using concentrations of SDS of 0.2, 0.5, 1.0, 1.5 and 2.0 
times the surfactant CMC (0.23 wt%). Given the observations which were noted 
above, all these data were modelled using model 1 – wherein the steroid molecules 
were assumed to reside within the alkyl chains layer of the SDS monolayer. Since the 
scattering length densities of the 4-CHOL and ADRENO are close to zero   (0.34 x 
10-6 Å-2 and 1.27 x 10-6 Å2) – and so would not cause a significant/detectable change 
in the NR profile obtained using the chain protiated surfactant contrasts – these 
systems were modelled using only the contrasts of d25SDS on ACMW and d25SDS on 
D2O. 
The NR profiles obtained for d25SDS on ACMW in the presence of 4-CHOL show, as 
was found for the corresponding system studied in the absence of steroid, that the NR 
signal increases as the concentration of SDS is increased (Figure 3.6). The NR profiles 
obtained for the d25SDS/4-CHOL system in D2O, however, show no noticeable change 
in the reflected signal (Figure 3.7). This lack of a change in the NR signal for the 
d25SDS/D2O contrast, however, is just as would be expected given that this contrast is 
sensitive to changes in the structure and composition of the polar head group layer of 
the monolayer but much less sensitive to changes in the alkyl chains layer – which is 
where the 4-CHOL and ADRENO appear to insert.  
The model-fitted structural parameters for the SDS/4-CHOL monolayers are 
summarized in Table 3.8. These data show that the thickness of the alkyl chains layer 
of the monolayer generally increases as the concentration of SDS is increased, and that 
there is a concomitant decrease in the surfactant area per molecule, and a decrease in 
the level of head group hydration. It is interesting to note too that when the 
concentration of SDS was 0.5 x CMC, the surfactant surface excess was much the 
same as that calculated for the SDS monolayer formed in the absence of 4-CHOL (3.9 
vs. 3.5 x 1010 mol.cm-2), whereas when the SDS concentration is at 1.5 x and 2 x CMC, 
the surface excess of the surfactant is seen to be decreased. This decrease in the 
surfactant excess at the higher SDS concentrations might be explained by the 




closely packed at the interface. Such an exchange of 4-CHOL for SDS would lead to 
a lowering of the CMC for SDS in the presence of 4-CHOL, and this is just as was 
observed in the surface tension studies (see section 2.2). 
The NR profiles obtained for SDS monolayers in the presence of ADRENO are shown 
in Figure 3.7, and the associated model fitted values of the various structural 
parameters are summarized in Table 3.9. As expected, the thickness of the alkyl chains 
layer of the monolayer increases until the CMC is achieved, but thereafter (at 1.5 x 
and 2 x CMC) the thickness of the layer is seen to decrease to ca. 9 Å, which is the 
thickness of the layer found for the SDS monolayer in the absence of steroid. Given 
that the surface excess of ADRENO is also seen to drop from 0.7 x10-10 mol cm-2 to 
0.6 x10-10 mol cm-2 when the concentration of SDS is increased from 0.5 x to 1.5 x 
CMC, it may be the case that when SDS micelles are formed in the bulk, some of the 
ADRENO partitions out of the monolayer and into the micelles. In contrast to what 
was seen with 4-CHOL, the presence of ADRENO in the SDS monolayer does not 
appear to change the thickness of the alkyl chains layer when the concentration of SDS 
is above the CMC, and the ratio of SDS to ADRENO at these higher concentrations is 
much higher than the ratios determined for SDS in the presence of 4-CHOL, which is 






















































1.5 x CMC 2.0 x CMC  
Figure 3. 6 NR profiles for monolayers of d25-SDS on a sub-phase of ACMW, in the 
presence of 4-CHOL, with the SDS concentration below the CMC (upper panel) and 





















































1.5 x CMC 2.0 x CMC
 
Figure 3. 7 NR profiles for monolayers of d25-SDS on a sub-phase of D2O, in the 
presence of ADRENO, with the SDS concentration below the CMC (upper panel) 





















Table 3. 8 Model-fitted structural parameters for SDS monolayers in the presence of 4-CHOL 
Concentration of SDS (x CMC) 0.2 0.5 1.0 1.5 2.0 
dtail (± 0.3 Å) 7.0 8.6 9.7 11.6 11.9 
VfH2O (± 1%) 73 65 62 66 66 
ΓSDS (± 0.1 x 10
-10 mol cm-2) 3.0 3.9 4.2 3.8 3.7 
Γ4-CHOL (± 0.1 x10
-10 mol cm-2) 0.2 0.1 0.2 1.0 1.1 
Stoichiometry (SDS:4-cholesten-3-one) 15.6 ± 0.5 51.7 ± 1.4 20.1 ± 0.5 3.9 ± 0.1 3.5 ± 0.1 


























Table 3. 9 Model-fitted structural parameters for SDS monolayers in the presence of ADRENO 
Concentration of SDS  
(x CMC) 
0.1 0.2 0.5 1.5 2.0 
dtail (± 0.3 Å) 9.7 12.1 13.7 9.2 9.0 
VfH2O (± 1%) 64 53 49 68 67 
ΓSDS (± 0.1 x 10
-10 mol cm-2) 4.0  5.1  5.53 3.5  3.6 
ΓADRENO (± 0.1 x 10
-10 mol cm-2) 0.5  0.5  0.7  0.6  0.5  
Stoichiometry (SDS : adrenosterone) 8.4 ± 0.2 11.3 ± 0.2 7.4 ± 0.1 5.7 ± 0.2  6.7 ± 0.2 




3.3.4 Monitoring changes in the C12 surfactant/steroid monolayers 
following addition of extra steroid 
The NR studies of the C12 surfactant monolayers formed at the air-water interface in 
the presence of 4-CHOL and ADRENO clearly show that the steroid molecules are 
incorporated into the surfactant monolayers both above and below the CMC in each 
surfactant system. The effect of steroids on the monolayer and their location were 
probed when the monolayer was fully saturated with steroids. For monolayers where 
the surfactant concentrations were below the CMC, and where the level of steroid in 
the monolayer was below saturation, additional steroid was added externally onto the 
surface of the sub-phase. The theoretical amounts of steroids required to saturate the 
surface were calculated based on the solubilisation results given in Chapter 2.1.4.  
These additional NR measurements which were performed to determine the effects of 
additional steroid added to the surfactant monolayers were in some cases carried out 
using the FIGARO reflectometer at the ILL and in other cases were carried out using 
Inter at the ISIS facility. 
The NR profiles obtained after the external addition of 4-CHOL onto the surface of 
equilibrated SDS monolayers are shown in Figure 3.8. It is clearly seen here that the 
reflected signal decreases after spreading extra 4-CHOL on the surface when the 
concentration of SDS is below the CMC, indicating that the additional (protiated) 4-
CHOL has inserted into the (chain-deuterated) SDS monolayer. From the model-fitted 
values of the structural parameters for the monolayers (summarized in Table 3.10) it 
is apparent that the level of solvent in the monolayer decreases following the external 
addition of 4-CHOL, and that there is a concomitant decrease in the surface excess of 
surfactant (from 3.0 to 2.2 x1010 mol.cm-2) and a dramatic increase in the surface 
excess of 4-CHOL. Given that the SDS molecules in the monolayer will not be close 
packed at the water surface due to the low concentration in this system (0.2 x CMC), 
it is concluded that the externally introduced 4-CHOL has inserted into the monolayer 
occupying the space between the surfactant molecules, altering the packing within the 
monolayer and causing an extension of the SDS alkyl chains (and thus increasing the 
alkyl chain layer thickness, dtail). For the SDS monolayer formed with the SDS 
concentration at 2 x CMC, there is little difference between the NR profiles obtained 




data show that there is a slight increase in the surface excess of steroid in the 
monolayer (from 1.1 to 1.7 x1010 mol.cm-2) after the additional 4-CHOL was 
introduced at the surface, but the surface excess is still lower than that found for the 
monolayer formed with the SDS concentration at 0.2 x CMC. For the monolayer 
formed with the SDS concentration at 2 x CMC, it is concluded that the surfactant 
molecules are sufficiently tightly packed at the surface that the excess 4-CHOL cannot 
intrude (deeply) into the layer, although some of the steroid molecules might perhaps 
sit within the extremities of the SDS dodecyl chains and this would then explain the 
small increase seen in dtail, and would also account for the change in 4-CHOL 
stoichiometry from 3 to 2. 
The corresponding results obtained for the SDS monolayers formed in the presence of 
ADRENO (Figure 3.9), show much the same effect of externally applied steroid. With 
the SDS concentration below the CMC, there is an increase in surface excess of the 
steroid, and this seems to cause in reduction in the alkyl chains layer thickness (Table 
3.11). When the SDS concentration is above the CMC, the externally applied 
ADRENO causes no change in the monolayer structure and no change in its 
composition (Table 3.11). 
The NR profiles obtained after the external addition of 4-CHOl and ADRENO onto 
the surfaces of the equilibrated monolayers formed with the other C12 chain surfactants 
studied show the same sorts of change as seen with the SDS monolayers. In these 
studies, the concentration of each surfactant was fixed just at 2 x CMC. Tables 3.12 
and 3.13 show the model fitted values of the various structural parameters for these 
systems. 
For the DTAB and DPC surfactant monolayers formed in the presence of 4-CHOL 
and ADRENO, the external application of additional steroid resulted in no significant 
change in the structures of the monolayers, with the small differences seen in the 
model-fitted parameter values falling within experimental error. The DDAO 
monolayer, however, showed what appeared to be an increase in the amount of 4-
CHOL within the monolayer when further steroid was applied externally, but there 
was no such increase seen for the DDAO monolayers in the presence of ADRENO. 










































































































2.0 d25SDS on D2O 2.0 d25SDS on D2O + 4-CHOL  
Figure 3. 8 NR profiles for d25SDS monolayers formed in the presence of 4-cholesten-
3-one on sub-phases of ACMW (previous page) and D2O (this page), with SDS 






























(± 0.1 x10-10 mol cm-2) 
Γ4-CHOL 
(± 0.1 x10-10 mol cm-2) 
α 
(± 2 Å2) 
Stoichiometry 
(SDS: 4-CHOL) 
0.2 x CMC 7.0 0.90 3.0 0.2 56 15.6 ± 0.5 
0.2 x CMC + 4-CHOL 13.0 0.36 2.2 2.3 77 1.0 ± 0.1 
2.0 x CMC 11.9 0.67 3.7 1.1 45 3.5 ± 0.3 





























(± 0.1 x10-10 mol cm-2) 
ΓADRENO 
(± 0.1 x10-10 mol cm-2) 
α 
(± 2 Å2) 
Stoichiometry 
(SDS:ADRENO) 
0.2 x CMC 12.1 0.53 5.1 0.5 32 11.4 ± 0.2 
0.2 x CMC + ADRENO 10.2 0.63 4.1 0.6 41 6.9 ± 0.2 
2.0 x CMC 9.0 0.67 3.6 0.5 46 6.8 ± 0.2 







































































































2.0 d25SDS on D2O 2.0 d25SDS on D2O + ADRENO  
Figure 3. 9 NR profiles for d25SDS monolayers formed in the presence of 
adrenosterone on sub-phases of ACMW (previous page) and D2O (this page), with 


























  dtail 




(± 0.1 x 10-10 mol cm-2) 
Γ4-CHOL 
(± 0.1x 10-10 mol cm-2) 
α  
(± 2 Å2) 
Stoichiometry 
(SAA:4-cholesten-3-one) 
DTAB 2.0 x CMC 7.9 0.55 3.3 0.3 51 12.7 ± 0.4 
 2.0 x CMC +  
4-CHOL 
8.5 0.53 3.4 0.3 48 10.5 ± 0.3 
DDAO 2.0 x CMC 10.3 0.66 4.2 0.4 40 11.0 ± 0.3 
 2.0 x CMC +  
4-CHOL 
10.6 0.69 3.7 0.7 45 5.0 ± 0.1 
DDAPS 2.0 x CMC 7.4 0.54 3.5 0.0 48 NA 
 2.0 x CMC + 
 4-CHOL 
7.3 0.43 3.4 0.2 49 15.6 ± 0.5 
DPC 2.0 x CMC 9.4 0.66 2.6 1.0 63 2.6 ± 0.1 
 2.0 x CMC +  
4-CHOL 




















 Table 3. 13 Model-fitted structural parameters for C12 surfactant monolayers in the presence of ADRENO and with additional ADRENO added to 
the monolayer. 
  dtail 




(± 0.10 x 10-10 mol cm-2) 
ΓADRENO 
(± 0.10 x 10-10 mol cm-2) 
α  
(± 2 Å2) 
Stoichiometry 
(SAA:ADRENO) 
DTAB 2.0 x CMC 7.7 0.52 3.5 0.1 48 31.5 ± 0.9 
 2.0 x CMC + 
ADRENO 
7.7 0.52 3.5 0.1 48 31.5 ± 0.9 
DDAO 2.0 x CMC 11.3 0.66 4.1 1.0 40 4.1 ± 0.1 
 2.0 x CMC +  
ADRENO 
11.3 0.66 4.1 1.0 41 4.1 ± 0.1 
DDAPS 2.0 x CMC 7.7 0.52 3.6 0 46 NA 
 2.0 x CMC +  
ADRENO 
7.7 0.52 3.6 0 46 NA 
DPC 2.0 x CMC 8.4 0.64 2.7 1.0 61 2.7 ± 0.1 
 2.0 x CMC + 
 ADRENO 




3.3.5 SDS/steroid monolayer structure as a function of time 
The surface tension studies described earlier (section 2.2) showed that the time taken 
for a surfactant monolayer to reach equilibrium in the presence of added steroid could 
vary significantly depending upon the particular surfactant and steroid involved. For 
SDS, for example, it was found that the monolayer took much longer to reach 
equilibrium in the presence of 4-CHOL compared with ADRENO (ca 2 hours vs. 5 
minutes). In the NR experiments reported above, therefore, it would be expected that 
when the sample solutions were poured into the Teflon trough, the surfactant (and 
steroid) molecules would take time to diffuse from the bulk to the surface, and they 
would then take time to orient and adsorb at the interface. For different samples and 
sample concentrations, the time taken for this diffusion and adsorption might vary 
from milliseconds to days [168]. It was thus considered worthwhile to determine the 
kinetics of the surfactant and steroid adsorption using neutron reflectivity, modelling 
the changes in monolayer structure as a function of time. Note that all the NR data 
obtained in this section were measured on INTER. 
NR measurements performed for SDS monolayers in the absence of steroids showed 
no noticeable change between the profile recorded over the first hour and the profile 
recorded several hours later, and this was the case regardless of whether the SDS 
concentration was below or above the CMC (see Figure 3.10). The same observation 
was made for the SDS monolayers formed in the presence of ADRENO (see Figure 
3.11). 
In order to monitor the kinetics of formation of the SDS monolayers formed in the 
presence of 4-CHOL, the NR measurements were recorded at 15 min intervals over a 
1 h period following sample preparation and instrument set-up, with the SDS 
concentration at 0.5 x CMC. As shown in Figure 3.12, the NR profiles collected over 
the initial one-hour period showed no noticeable difference, and no differences were 
apparent several hours later. It was therefore concluded that the SDS/4-CHOL 
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Figure 3. 10 NR profiles of d25SDS monolayer on ACMW at 0.5 x CMC (upper 




















































0 hour 4h 10 hours
 
Figure 3. 11 NR profiles of d25SDS monolayer on ACMW in the presence of 




With the same experiments repeated for the SDS monolayer formed in the presence of 
4-CHOL and with an SDS concentration of 1.5 x CMC, the NR profiles showed that 
the measured reflectivity was slightly lower at 1 h than was measured at 0.25 h, but 
the difference was quite small (Figure 3.13). However, after 6 hours the reflected 
signal was seen to decrease further. The NR profile recorded at 9 h overlaid perfectly 
with the profiles recorded > 9 hours (Appendix B), and it was thus concluded that this 
system attained equilibrium somewhere between 6 and 9 hours according to the NR 
profiles. 
To further study the kinetics on the SDS monolayer in the presence of 4-CHOL, 
samples with an SDS concentration at 2 x CMC were also studied and the NR profiles 
recorded are shown in Figure 3.14. Comparisons of the various profiles recorded show 
that at this higher SDS concentration the monolayer attained equilibrium only after ca. 
12 hours. Moreover, a comparison made between the initial NR profile recorded for 
the SDS/4-CHOL system and the one recorded initially for SDS at 2 x CMC showed 
no difference between the two, which would suggest that there were few if any 4-
CHOL molecules present in the SDS monolayer when the monolayer was newly-
formed. The slow progressive change in reflectivity for these systems seen over time, 
therefore, would seem to be explained by a slow diffusion and penetration of the 
steroid molecules into the SDS monolayer. 
Table 3.14 shows the model fitted values of the structural parameters for the SDS 
monolayers formed at an SDS concentration of 1.5 x CMC and in the presence of 4-
CHOL. Over the first hour it can be seen that the composition and structure of the 
monolayer remain more-or-less unchanged but then at 1-3 hours the surface excess of 
SDS begins to decrease, while dtail and the surface excess of 4-CHOL begin to 
increase. After 20 hours, Γ4-CHOL has increased almost three-fold to 1.5 x10
-10 mol.cm-
2, and the replacing of SDS by the steroid has increased the thickness of the alkyl 
chains layer by ca. 4 Å taking it to 13 Å. It is clear, therefore, that the 4-CHOL 
penetrates the SDS monolayer only quite slowly and that the time taken for it to attain 
equilibrium is much longer than found for any of the other systems studied. Much the 
same behaviour is seen when the monolayer of SDS/4-CHOL is prepared with an SDS 




When the same kinetics experiments were performed using monolayers prepared with 
the other C12 surfactants in the presence of 4-CHOL, only the anionic surfactants, ADS 
and LDS showed time effects like those seen with SDS (Figure 3.15; Tables 3.16 and 
3.17). The time taken for these systems to attain equilibrium at the air-water interface 
was much quicker than was seen in the SDS system. Equilibrium was achieved after 
3.5 hours for the ADS/4-CHOL monolayer and after 5 hours for the LDS/4-CHOL 
monolayer.  
The anomalously slow adsorption of 4-CHOL into the C12 surfactant monolayers thus 
seems to be associated with the sulfate head group, with the rate also depending on the 
nature of the cationic counter-ion. The same behaviour is not seen in the adsorption of 
ADRENO into the anionic surfactant monolayers, nor was it reported by Saaka et al. 
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Figure 3. 12 NR profiles of d25SDS in ACMW monolayer in the presence of 4-
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Figure 3. 14 NR profiles of d25SDS monolayer in ACMW in the presence of 4-





















 Table 3. 14 Model-fitted structural parameters SDS monolayers in the presence of 4-CHOL and with additional 4-CHOL added to the monolayer 







Time (hours) 0.25 0.5 0.75 1 3 6 9 16 20 
dtail (± 0.3 Å) 10.5 10.4 10.8 10.7 11.1 11.7 11.9 12.3 13.2 
Vf H2O (± 1 %) 0.63 0.63 0.61 0.63 0.64 0.65 0.67 0.69 0.68 
ΓSDS (± 0.1 x 10
-10 mol cm-2) 4.1 4.0 4.2 4.0 4.0 3.8 3.6 3.4 3.5 
Γ4-CHOL (± 0.1 x 10
-10 mol cm-2) 0.5 0.5 0.5 0.6 0.7 1.0 1.1 1.4 1.5 
Stoichiometry (SDS:4-CHOL) 8.2 ± 0.2 8.6 ± 0.2 8.5 ± 0.2 7.0 ± 0.2 5.7 ± 0.2 4.0 ± 0.1 3.2 ± 0.1 2.5 ± 0.1 2.3 ± 0.1 





















Table 3. 15 Model-fitted structural parameters for SDS monolayers in the presence of 4-CHOL and with additional 4-CHOL added to the 
monolayer at 2.0 x CMC 
Time (hours) 0 8.5 12 19 
dtail (± 0.3Å) 10.3 11.4 11.6 11.9 
Vf H2O (± 1%) 0.61 0.62 0.65 0.66 
ΓSDS (± 0.1 x 10
-10 mol cm-2) 4.2 4.1 3.8 3.7 
Γ4-CHOL (± 0.1 x 10
-10 mol cm-2) 0.3 0.7 1.2 1.1 
Stoichiometry (SDS:4-CHOL) 12.6 ± 0.3 5.8 ± 0.1 3.2 ± 0.1 3.5 ± 0.1 
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Figure 3. 15 NR profiles of ADS (upper panel) and LDS (lower panel) monolayer in 




















Table 3. 16 Fitting parameters (chain thickness, volume fraction of solvent, surface excess, area per molecule and stoichiometry) for ADS 
monolayer in the presence of 4-CHOL at 2.0 x CMC 
Time (hours) 0 3.5 8 12 18 22 
dtail (± 0.3Å) 9.7 13.0 13.1 13.5 13.7 13.4 
Vf H2O (± 1%) 0.60  0.69  0.70  0.69  0.69  0.68  
ΓSDS (± 0.1 x 10
-10 mol cm-2) 4.3 3.4 3.3 3.4 3.4 3.5  
Γ4-CHOL (± 0.1 x 10
-10 mol cm-2) 0.1 1.6 1.7 1.7 1.8 1.6 
Stoichiometry (ADS:4-CHOL) 33.5 ± 0.8 2.2 ± 0.1 2.0 ± 0.1 2.0 ± 0.1 1.9 ± 0.1 2.2 ± 0.1 






















Table 3. 17 Fitting parameters (chain thickness, volume fraction of solvent, surface excess, area per molecule and stoichiometry) for LDS 
monolayer in the presence of 4-CHOL at 2.0 x CMC 
Time (hours) 0 3 5 13 18 22 
dtail (± 0.3 Å) 10.4 12.5 13.3 13.6 14.4 14.3 
Vf H2O (± 1 %) 0.61  0.66  0.70  0.71  0.69  0.69  
ΓSDS (± 0.1 x 10
-10 mol cm-2) 4.0 3.5 3.1 3.1 3.2 3.2 
Γ4-CHOL (± 0.1x 10
-10 mol cm-2) 0.5 1.3 1.8 1.9 2.0 2.0 
Stoichiometry (LDS:4-CHOL) 8.4 ± 0.2 2.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 




3.4 Conclusions  
The neutron reflectometry revealed the structure and composition of the C12-chain 
surfactant monolayers in the presence/absence of steroids 4-cholesten-3-one (4-
CHOL) and adrenosterone (ADRENO). In this study, the interfacial properties were 
investigated and linked to the bulk properties for a better understanding of the 
surfactants’ solubilisation of the steroids 4-CHOL and ADRENO. To conclude: 
• The 4-CHOL and ADRENO appear to insert into the surfactant monolayers 
between the C12 chains.  
• No significant change was found at the air-water interface after introducing 
extra steroid into the monolayers at surfactant concentrations above the CMC. 
However, at surfactant concentrations below the CMC, externally applied 
steroid gave rise to an increase in the amount steroid in the monolayer, and this 
was more pronounced for the surfactant monolayers in the presence of 4-
CHOL. 
• For a freshly formed surfactant monolayer, the time taken for the surfactants 
adsorbed at the surface to reach equilibrium might range from milliseconds to 
days [168]. In the NR studies reported here, the steroid-free monolayers of 
surfactant and those saturated with ADRENO reached equilibrium within one 
hour.  For the air-water interface of dodecyl sulfate surfactants in the presence 
of 4-CHOL, the time taken to reach equilibrium was much longer than for any 
of the other systems studied and this is consistent with the time effects seen for 
these systems in the surface tension studies (Chapter 2.2). 
• Significant time effects were only found in the dodecyl sulfate surfactant/4-
CHOL system, and the equilibration times varied depending on the nature of 
the associated counterions. The dodecyl sulfate monolayers with Na+ 
counterions were found to have the longest equilibration time while the 





Chapter 4  
 
Small angle neutron scattering 
4.1 Introduction  
Scattering techniques are widely used to study the relationship between the physical 
properties and molecular structure in micellar systems [170-173]. For micelles of the 
order of 102 Å in size that are formed from hydrogen-rich organic or biological 
materials, there are particular advantages provided by small angle neutron scattering 
(SANS). With this technique, the use of neutrons as probe allows that samples can be 
studied in a non-invasive and non-destructive manner, yielding quantitative 
information on the size, shape and internal structures of micelles. In addition, by 
exploiting the neutron’s isotopic sensitivity, contrast variation can be used, 
exchanging hydrogen (1H) for deuterium (2D), for example, so that different molecules 
or parts of molecules within a system can be selectively highlighted. Some recent 
reports in which SANS has been used to determine the structures of surfactant micelles 
are given in [174-177]. 
4.1.1 Scattering basics 
Neutron beams are either produced continuously by nuclear fission in reactor-based 
neutron sources or in pulses by spallation in accelerator-based neutron sources. 
Immediately after production, the neutrons are slowed by passage through moderating 
materials such as liquid hydrogen so that they have the right energy to be used in the 
application of interest. The incident neutron beam will be collimated to an appropriate 
size and shape before it encounters the sample. The neutron instruments count the 
number of scattered neutrons as a function of scattering vector, Q. The scattering 
vector, Q, describes the relationship between the incident and scattered wave vectors 
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Figure 4. 1 The geometry of a SANS experiment 
Q has dimensions of reciprocal length and units are normally Å-1.  Large structures 
scatter to low Q and small structures at high Q values.  
According to Bragg’s low of diffraction: 
𝜆 = 2𝑑 sin 𝜃/2                [4.2] 




                    [4.3] 
where d is a molecular-level length scale by virtue of the Q-range accessible from 
SANS [178]. 
4.1.2 Differential scattering cross-section 
The differential scattering cross-section, (𝑑Σ/𝑑Ω)(𝑄), is generally referred to as the 
intensity of scattering, I(Q). When neutrons of a given wavelength are scattered 
through a particular angle and are incident on a small area of the detector, the neutron 
flux – the number of neutrons arriving in unit time – can be measured, and I(Q. 
(𝑑Σ/𝑑Ω)(𝑄) contains information on the size, shape and interaction between particles 








where N is the number concentration of scattering centres, V is the volume of a 
scattering centre, (Δ𝜌)2 is the neutron contrast, 𝑃(𝑄) and 𝑆(𝑄) are the form factor 
and structure factor (discussed below), and B is the sample background. 
4.1.3 Form factor 
The form factor, P(Q), can provide the intra-particle information and is dependent on 
the size and shape of the scattering centre. In general, the form factor is a 
dimensionless function that describes how (𝑑Σ/𝑑Ω)(𝑄) is modulated by interference 
effects between neutrons scattered by different parts of the same scattering centre 






            [4.5] 
4.1.4 Structure factor 
The inter-particle structure factor, S(Q), is another dimensionless function but 
describes how (𝑑Σ/𝑑Ω)(𝑄) is modulated by interference effects between neutrons 
scattered by different scattering centres. Consequently, it depends on the type of 
interactions between scattering centres (i.e., whether the interactions are repulsive or 
attractive) and is given by: 
S(Q) = 1 +
4𝜋𝑁
𝑄𝑉𝑆
∫ [𝑔(𝑟) − 1]
∞
0
𝑟 sin(𝑄𝑟)𝑑𝑟            [4.6] 
where g(r) is the pair correlation function for the scattering objects and is related to 
the radial distribution function. 
P(Q) is independent of the concentration of a scattering sample while S(Q) can be 
obtained from the measured ( 𝑑Σ/𝑑Ω)(𝑄)  at two different concentrations. 
Alternatively, the data of (𝑑Σ/𝑑Ω)(𝑄) can be model-fitted by approximating S(Q) 
using some analytical expression developed for a particular type of system. Attractive 
interactions between the scattering centre leads to an increase in [(𝑑Σ/𝑑Ω)(𝑄)]𝑄→0 




4.1.5 Neutron contrast variation 
As mentioned earlier, the significant difference in neutron scattering lengths (b) 
between hydrogen and deuterium can be exploited in small-angle neutron scattering 
to provide information on selected components within a scattering sample. In practice, 
the scattering length density, ρ, is more frequently used to quantify the difference in 
scattering efficiency. ρ can be calculated from the composition and density of the ith 
set of atoms in the system: 
ρ = 𝑁𝐴 ∑ 𝑏𝑖𝑖 =
𝛿𝑁𝐴
𝑀
∑ 𝑏𝑖𝑖                  [4.7] 
where b is the coherent neutron scattering length (Å), NA is Avogadro’s number, 𝛿 is 
the bulk density of the molecule (g/cm-3) and M is the molar mass (g/mol). It should 
be noted that ρ has dimensions of (length)-2 with units of 10-6 Å-2 or 1010 cm-2. 












Figure 4. 2 Elucidation of the structure of micellar solution by contrast variation. The 















The very different neutron scattering properties of hydrogen and deuterium can be 
applied to great advantage in the study of micellar systems, with different regions 
“highlighted” by selectively varying the ρ of the surfactant and solvent. 
There are three solvent contrasts that are commonly used in such studies, generally 
referred to as the core, shell and drop contrasts, and these are illustrated schematically 
in Figure 4.2. By using these three contrasts in the SANS study of a micellar system 
the micelle can be considered as comprising a poorly solvated core and a well-solvated 







𝑁𝑃(𝑄)𝑆(𝑄) + 𝐵                [4.8] 
where 
P(Q) = [(𝜌𝑠ℎ𝑒𝑙𝑙 − 𝜌𝑐𝑜𝑟𝑒)
2𝑅𝑜𝑢𝑡𝑒𝑟
6 𝑃(𝑄, 𝑅𝑜𝑢𝑡𝑒𝑟)]






+ [(𝜌𝑐𝑜𝑟𝑒 − 𝜌𝑠ℎ𝑒𝑙𝑙)
2𝑅𝑖𝑛𝑛𝑒𝑟
6 𝑃(𝑄, 𝑅𝑖𝑛𝑛𝑒𝑟)] 
                  [4.9] 
𝑃(𝑄, 𝑅𝑜𝑢𝑡𝑒𝑟) and 𝑃(𝑄, 𝑅𝑖𝑛𝑛𝑒𝑟) are the form factors for spheres of drop radius 𝑅𝑜𝑢𝑡𝑒𝑟 
and core radius 𝑅𝑖𝑛𝑛𝑒𝑟, respectively. Clearly, for the core contrast, only the scattering 
from the core can be observed since the shell of the micelle is contrast matched to the 
continuous phase/solvent medium, so 𝜌𝑠ℎ𝑒𝑙𝑙 = 𝜌𝑚𝑒𝑑𝑖𝑢𝑚 , and for the shell contrast 
𝜌𝑐𝑜𝑟𝑒 = 𝜌𝑚𝑒𝑑𝑖𝑢𝑚. Therefore 























By fitting these equations to the measured scattering, it is possible to obtain the 
thickness of the micelle core, and shell and their respective scattering length densities. 
In addition, the hydration of the surfactant micelles can be obtained. 
4.2 Small angle neutron scattering measurement and data 
treatment 
The SANS measurements performed in the studies reported here were performed on 
the LOQ and SANS 2D instruments at the ISIS Facility (Rutherford Appleton 
Laboratory, UK). Both instruments use time-of-flight (TOF) while SANS2D uses 
neutrons within an incident wavelength (λ) between 2.2 to 14 Å and for LOQ the 
incident wavelength range is 2.2 Å < λ < 10 Å, giving a scattering vector Q = 
(4π/λ)/sin(θ/2) ranges of 0.006 Å-1 < Q < 0.7 Å-1 and 0.008 Å-1  < Q < 0.24 Å-1 
respectively. The measured samples were placed in 1 mm or 2 mm Banjo cells 
(Hellma, UK) and the SANS measurements recorded with the samples maintained at 
25 ± 0.1 oC, using an incident beam diameter of 12 mm. The scattering patterns of 
neutrons passing through the samples were recorded on a detector with a sample-to-
detector distance of 4 m. (NB, For all the measurements reported here – other than 
those presented in section 4.4.4, the samples were at equilibrium.)  
The scattering of the empty cell and solvent background were firstly measured as 
transmission measurements. The raw SANS data were corrected by subtracting the 
data from transmission and converted to scattered intensity data as a function of wave 
vector transfer (I(Q) vs Q) and placed on an absolute scale (Å -1) using standard 
procedures [179, 180]. Background was subtracted manually.  
SANS profiles were analysed using Heenan’s FISH software [179]. The structure of 
micelles was established by fitting the SANS data using standard models for the 
structure factor S(Q). The scattering data were fitted with different models in order to 
obtain the best fit.  
Consequently, the core-shell form factor was used to describe the micelle geometry.  
The form factor can be modelled assuming either spherical or elliptical micelles. For 
a sphere with a radius of R, the micelle volume, 𝑉𝑚𝑖𝑐𝑒𝑙𝑙𝑒 =
4
3








2 (Rmajor and Rminor are the semi major axis and 
semi minor axis, respectively). The aggregation number, Nagg, was then obtained by 
dividing Vmicelle by the calculated swollen molecular volume of its corresponding 
surfactant (Vs). For surfactant micelles in the presence of steroids, the surfactant 
volume was recalculated according to the molar solubilisation ratio determined in the 
earlier studies (see section 2.1).  
                
 
Sphere            Prolate    Oblate 
Figure 4. 3 Schematic representation of micelle shape 
The surface area of a spherical micelle is obtained as 4𝜋𝑅2. For a prolate ellipsoid 
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2 ∙ 𝑎𝑟𝑐 tanh(𝑒)), where 𝑒




2        [4.12] 
4.2.1 SANS studies and model-fitting of the surfactant/steroid systems 
In the SANS studies for the surfactant micelles formed in the presence of the steroids 
4-cholesten-3-one (4-CHOL) and adrenosterone (ADRENO), the steroids were used 
at concentrations that ensured the solute saturation in each system (as determined 
earlier; see 2.1)  
Given the conclusion reached in the monolayer neutron reflectivity studies of these 
systems that the 4-CHOL and ADRENO inserted into the hydrocarbon chain layers of 




the SANS profiles for the corresponding surfactant/steroid micellar systems was that 
the steroids would be solubilised within the hydrophobic cores of the micelles.     
4.3 Materials 
Sodium dodecyl sulfate (SDS), ammonium dodecyl sulfate (ADS), lithium dodecyl 
sulfate (LDS), dodecyl trimethylammonium bromide (DTAB) and N, N-
dimethyldecylamine N-oxide (DDAO), N-dodecyl-N, N-dimethyl-3-ammonio-1-
propanesulfonate (DDAPS) were purchased from Sigma (Dorset, UK) and dodecyl 
phosphocholine (DPC) was obtained from Avanti Polar Lipids (Alabama, USA). 
Ultra-pure polyoxyethylene sorbitan monolaurate (Tween 20) was supplied by 
National Diagnostics (Hull, UK) and polyoxyethylene (23) lauryl ether (Brij 35) was 
purchased from MP Biomedicals LLC (Ohio, USA) 
Alkyl chain deuterated d25SDS, d25ADS, d25LDS, d25DTAB, d25DDAO and 
d25DDAPS were kindly provided by the Oxford Deuteration Facility (Didcot, UK). 
The ethylene oxide deuterated Tween 20 was also supplied by the Oxford Deuteration 
Facility (Didcot, UK). d25DPC was obtained from CDN Isotopes (New Jersey, USA).  
4-cholesten-3-one (98+%) was purchased from Alfa aesar (Thermo fisher Scientific, 
UK) and adrenosterone (97+%) from Santa cruz (Germany). 
D2O (99.9 atom % D) was supplied by the Oxford Deuteration Facility (Didcot, UK). 
4.4 Results 
4.4.1 SANS studies for ionic surfactants 
Fitting parameters for ionic surfactant micelles 
For ionic surfactants, the two-shell ellipsoid model incorporating the Hayter-Penfold 
structure factor was used to fit the data [181]. The parameters fitted in this model 
included the micelle’s core radius (R1), core axial ratio (x), and charge (Z) and the 
inverse Debye length (AKK). For spheres, the axial ratio x has a value of 1, and for 
ellipsoidal micelles it is < 1 if they are oblate and > 1 if they are prolate. The inner 




(lext, 16.7 Å), acceptable values taken to lie in the range 95% to 105% of lext (viz., ca. 
16 – 17 Å). The micelle shell thickness (δ) was constrained by R1 and the molecular 
volume and hydration of the surfactant head group. In some studies, model fits were 
also explored wherein part of the surfactant alkyl tail intruded into the micelle shell. 
As was previously reported by Saaka  [87], however, there was no significant effect 
on the outcome fits choosing either of these criteria.  
Other parameters which were used to fit the SANS data are shown in Table 4.1. The 
molecular volume and hydration were obtained from viscosity and density 
measurements (section 2.3) or else were calculated ab-initio. The scattering length 




















Table 4. 1 Molecular formulas, molecular volume (Vm), molecular weight (Mw) and scattering length density (ρ) of the constituents of the ionic 
surfactants and steroids studied. 
Chemical Molecular formula Vm (Å
3) Mw (g mol
-1) ρ (x 10-6 Å-2) 
 Protiated Deuterated  Protiated Deuterated Protiated Deuterated 
4-CHOL C27H44O N/A 652.5 384.6 N/A 0.34 N/A 
ADRENO C19H24O3 N/A 422.6 300.4 N/A 1.27 N/A 
DTAB C15H34BrN C15D25H9BrN 477.7 308.4 333.5 -0.23 5.08 
TAB C3H9BrN N/A 124.0 139.0 N/A 0.18 N/A 
SDS NaC12H25SO4 NaC12D25SO4 414.0 288.4 313.0 0.39 6.66 
SS NaSO4 N/A 60.3 119.0 N/A 4.89 N/A 
ADS NH4C12H25SO4 NH4C12D25SO4 414.8 288.4 313.4 0.16 6.45 
AS NH4SO4 N/A 61.1 119.1 N/A 3.35 N/A 
LDS LiC12H25SO4 LiC12D25SO4 410 272.3 297.3 0.25 6.60 
LS LiSO4 N/A 56.3 103.0 N/A 4.4 N/A 




Aggregation behaviour of DTAB micelles 
SANS measurements for DTAB micelles were made at concentrations of 3 wt% and 
5 wt% in three contrasts as shown in Figure 4.4. From the SANS profiles, the 
scattering intensities increased with increasing surfactant concentration. For ionic 
surfactant micelles generally the electrostatic repulsion between the charged head 
groups could result in the existence of a peak in the SANS profile, located at Q = 2π/d, 
where d here is the mean distance between micelles. The peaks for DTAB micelles 
were observed at 0.06 – 0.07 Å in each contrast, and they shift to the right (higher Q 
value) at higher concentration indicating (as would be expected) that the inter-micelle 


















































Figure 4. 4 SANS profiles and model fits (solid line) for 3 wt % (black) and 5 wt % 
(red) d25DTAB in H2O (a), d25DTAB in D2O (b) and h25DTAB in D2O (c). 
The SANS data for DTAB micelles were modelled assuming that the micelle shell 
was composed of the trimethylammonium headgroups (TAB+) together with their 
associated counterions and solvent of hydration, while the core was taken to comprise 
just the C12 hydrocarbon chains. The SANS model fits consistently showed that the 
DTAB micelles were prolate ellipsoids as the core axial ratios (x) were greater 1 






volume increased from ~51k to ~55k Å3 while the thickness of the surfactant head 
group layer (the micelle shell thickness) remained unchanged (~5 Å). This results in 
more elongated ellipsoidal aggregates as x was seen to increase as the concentration 
was increased from 3 wt% to 5 wt%.  The larger micelles caused higher values for the 
aggregation number and micelle charge, while the area per molecule decreased 
slightly.  
Griffiths et al. [146] previously determined the structure of DTAB micelles using 
SANS. They also chose an elliptical core-shell model to fit the obtained SANS data 
using FISH [179]. In their model, the aggregation number was calculated from the 
volume of the hydrophobic core and the composition weight volume per tail, and the 
shell of the micelle was taken to consist of the surfactant head groups and water with 
the thickness of the shell taken as the size of the head group. Thus, it is valuable 
comparing the results from Griffiths et al. with the data obtained in this study because 
of the similar fitting procedure used.  
At a surfactant concentration of 1.5 wt%, Griffiths et al. found the core radius (R1) of 
DTAB micelles to be 16.7 ± 0.1 Å with the micelle axial ratio (x) of 1.1 ± 0.1, and the 
shell thickness was determined as 5.3 ± 0.2 Å, with the micelle charge, 11.7 e. It is 
encouraging that these results are in good agreement with the results presented here.  
Rodenas et al. [182, 183] also studied the geometry of DTAB micelles and reported 
an aggregation number at ~3 wt% in the range 66 to 73, which again is comparable 
with the results obtained here. In these studies, only one contrast was determined, as 
opposed to the three contrasts used in the present study and so small differences in the 






















Table 4. 2 Values of model fitted parameters for 3 wt% and 5 wt% DTAB micelles. 
 
 Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 



















5% Drop 15.9 1.62 25.7 4.8 52464 15 77 4528 59 6954 91 
5% Shell 16.1 1.58 25.4 4.8 57226 15 78 4554 59 7341 95 



















3% Drop 15.8 1.52 24.5 4.9 49731 14 73 4339 60 6678 92 
3% Shell 15.8 1.52 24.1 4.9 52013 14 71 4277 60 6867 96 




DTAB micelles in the presence of steroids 
Saturation of the DTAB micelles with either 4-CHOL or ADRENO did not alter the 
scattering intensities significantly in the ‘core’ and ‘drop’ contrasts (Figure 4.5/4.6, 
(a) and (c)). The greatest changes in I(Q) for DTAB micelles in the presence of the 
steroids presented in the ‘shell’ contrast (Figure 4.5/4.6, (b)). A slight shift in the peak 
to lower Q was observed in the 4-CHOL-saturated micelles, suggesting that the 
distance between the micelles became larger upon the addition of 4-CHOL. A much 
smaller shift of the interaction peak was found upon saturation of the DTAB micelles 
with ADRENO, indicating there was only a very slight change in the inter-micelle 
distance in this system. A comparable study was performed by Saaka [87] and showed 
that the presence of testosterone enanthate in the DTAB micelles exhibited significant 


















































Figure 4. 5 SANS profiles and model fits (solid line) for d25DTAB in H2O (a), d25DTAB 
in D2O (b) and h25DTAB (c) in D2O micelles alone (black), micelles in the presence of 
saturation amounts of 4-CHOL (red) and ADRENO (blue) at 3 wt % 
The model-fitted parameters for DTAB micelles in the presence of 4-CHOL and 
ADRENO are presented in Table 4.3.  The model used for fitting was the same as that 






















































Figure 4. 6 SANS profiles for d25DTAB in H2O (a), d25DTAB in D2O (b) and h25DTAB 
(c) in D2O micelles alone (black), micelles in the presence of saturation amounts of 4-
CHOL (red) and ADRENO (blue) at 5 wt %. 
As no significant changes were found in the shapes of the scattering curves, it is 
concluded that the 4-CHOL and ADRENO cause very little perturbation of the DTAB 
micelle structure. The core axial ratio of the micelles upon addition of 4-CHOL was 
increased by ~5% while the saturation amount of ADRENO in the micelle caused no 
significant change in x. 
There were also no significant changes seen in the aggregation numbers of the DTAB 
micelles formed in the presence of saturating levels of 4-CHOL and ADRENO. The 
same observation was also noted by Saaka who found that there was no change in the 
aggregation number of DTAB micelles in the presence of testosterone and testosterone 
propionate (both of these steroids having low solubilities in DTAB micelles) [87]. 
Assuming the micelle core as the locus of steroid solubilisation and exploiting the 
large difference in scattering length density between the steroids and the deuterated 
C12 chain (~ 0 x 10
-6 Å-2 vs 6.95 x 10-6 Å-2), the scattering length density of the micelle 
core determined through model-fitting the SANS profiles for the shell and core 






ADRENO incorporated within the micelles. In practice, however, the experimental 
uncertainty in the fitted scattering length densities, of ± 0.5 x 10-6 Å-2, means that it is 
not possible unequivocally to demonstrate the presence of 4-CHOL and ADRENO 
within the micelle core. The apparent molar ratios of 4-CHOL:DTAB and 
ADRENO:DTAB are determined as 1:15 and 1:30, respectively (see section 2.1) and 
so the expected scattering length density for the deuterated micelle core is greater than 
6.5 x 10-6 Å-2, and so is very close to the dC12 scattering length density of 6.95 x 10
-6 
Å-2. It is not surprising here, therefore, to find that the fitted micelle core scattering 
length density remained unchanged from that for the steroid-free DTAB micelles.  
Moreover, since the scattering length density of the protiated DTAB head groups (and 
indeed those of the protiated head groups of any of the surfactants studied here) are 
very similar to the scattering length densities of 4-CHOL and ADRENO, it is also 
difficult to use the fitted scattering length density of the micelle shell to provide a clear 

























Table 4. 3 Individual SANS fitting results for 3 wt% and 5 wt% DTAB micelles in the presence of steroids. 






















4-CHOL 3% Drop 15.8 1.61 25.4 4.5 51400 14 70 5 4462 63 6854 97 
3% Shell 15.3 1.61 23.7 4.8 48256 14 66 5 4065 62 6542 99 
3% Core 15.8 1.61 25.3 5.0 54875 14 75 5 4448 59 7148 95 
ADRENO 3% Drop 15.5 1.55 24.0 4.4 46843 14 67 2 4156 62 6419 96 
3% Shell 15.2 1.55 23.6 4.8 47932 14 68 2 4028 59 6512 95 


















































16.0 1.61 25.5 4.5 53843 16 74 5 4552 62 7071 96 
5% 
Shell 
15.8 1.61 25.5 4.8 53834 16 74 5 4477 61 7066 96 
5% Core 16.0 1.61 25.8 5.1 57420 16 78 5 4591 59 7374 94 
ADRENO 5% 
Drop 
15.7 1.60 25.1 4.5 50824 16 73 2 4433 61 6807 94 
5% 
Shell 
15.2 1.60 24.3 4.8 48565 16 69 2 4100 59 6589 95 
5% Core 15.5 1.60 24.8 4.9 51862 16 74 2 4281 58 6884 93 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), aggregation number of micelle and steroids(SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and 
whole micelle (Sm) and its corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 





Aggregation behaviour of SDS micelles 
The SANS profiles for all three contrasts of SANS data obtained for SDS micelles in 
the absence of steroids at 3 wt% and 5 wt% are presented in Figure 4.7. The data were 
modelled using the same model as used in analysis of the SANS data for DTAB 
micelles. As was seen for the DTAB micelles, there is an interaction peak in the SDS 
SANS profiles in the Q range 0.06 to 0.07 Å-1 which arises due to the electrostatic 
repulsion between the micelles, and the peak shifts to higher Q with increased SDS 
concentration. The increase in concentration of SDS, is also seen to cause an increase 






















































Figure 4. 7 SANS profiles and model fits (solid line) for 3 wt % (black) and 5 wt % 
(red) d25SDS in H2O (a), d25SDS in D2O (b) and h25SDS in D2O (c). 
The scattering in the SDS ‘shell’ contrast was much lower than that seen with DTAB 
micelles, and the scattering at high Q is much noisier with higher error bars.  
The SANS profile for the shell contrast for SDS micelles (Figure4.7 (b)) shows only 
very low scattering because the scattering length densities for the deuterated C12 chains 
and D2O are virtually the same (6.95 and 6.38 x 10






scattering length density for the SDS head group (DS-, 4.89 x 10-6 Å-2) is so close (and 
the surfactant head group layer of the micelle so thin) that there is very little contrast 
in this system. 
The model-fitted parameters of the SDS micelles are shown in Table 4.4. Consistent 
results are obtained for all three SANS contrasts. The micelles here are again prolate 
ellipsoids, with an axial ratio above 1. The micelles become more elongated as the 
surfactant concentration is increased, as evidenced by the increased core axial ratio 
and larger core radius. The shell thickness and micelle charge, however, do not show 
noticeable differences when the surfactant concentration is increased. The aggregation 
number for SDS micelles at 3 wt% and 5 wt% were 83 and 93 respectively, and the 
corresponding areas per molecule at these concentrations are much the same. 
The results presented here are reassuringly consistent with those presented by other 
workers and give confidence that the fitted models provide a reliable description of 
the SDS micelles. In the SANS studies reported by Caponetti et al. [184] and Hassan 
et al. [185] the SDS micelles were also found to be prolate ellipsoids, and the 
aggregation numbers and micelle charges found were close to the values obtained here 
(90 ± 5 and 79 ± 1, respectively, and 17 ± 5 and 33 ± 10, respectively). In the more 
comprehensive (three contrast) SANS study on 3 wt% and 5 wt% of SDS micelles 
conducted by Saaka [87], the micelle core axial ratios were determined as 1.5 at 3 







































3% Drop 16.7 1.51 25.2 3.0 46122 21 83 4743 57 6354 76 
3% Shell 16.7 1.51 25.2 3.1 46185 21 83 4743 57 6360 76 




















5% Drop 16.7 1.68 16.7 3.1 51368 21 93 5171 56 6909 75 
5% Shell 16.7 1.68 16.7 3.1 51368 21 93 5171 56 6909 75 
5% Core 16.7 1.68 16.7 3.1 51368 21 93 5171 56 6909 75 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and its 





SDS micelles in the presence of steroids 
The SANS profiles for SDS micelles formed in the presence of saturating amounts of 
4-cholesten-3-one (4-CHOL) were measured on LOQ and these data are shown in 
Figure 4.8. It may be noted here that the errors on the data at high Q are much higher 
than those of the data obtained on SANS 2D (see Figure 4.7) and also that the Q range 
is different for the different instruments. The model-fits to the SANS profiles 
measured on LOQ and SANS 2D were wholly consistent, however. 
The SANS profiles obtained for the SDS/4-CHOL micellar system show a shift of the 
interaction peaks to lower Q, indicating that the inter-micelle distance is increased. 
There is also an increase in the scattering intensities of the SDS micelles in the 
presence of 4-CHOL (Figure 4.8) and the shapes of the scattering curves also change, 
these observations clearly indicating that there are changes in both the size and shape 
of the micelles when the 4-CHOL is present – a finding that seems perfectly reasonable 
given that the solubilisation capacity of SDS for 4-CHOL is dramatically higher than 
that for any of the other C12 surfactants.  
Whereas the scattering intensity seen in the shell contrast for SDS micelles is very 
low, the intensity seen following the addition of 4-CHOL is very much higher, and it 
might thus be possible to make a reliable determination of the locus of solubilisation 
of 4-CHOL within the SDS micelles.  
The model-fitted parameters for the SDS/4-CHOL micelles are presented in Table 4.5. 
Surprisingly, the volume of the 4-CHOL-saturated SDS micelles is found to increase 
dramatically, with R1 increasing by more than 100%. The aggregation number of the 
SDS/4-CHOL micelles is found to be about twice that of the SDS micelles, and the 
volume of the micelles increases 3-fold. It should also be noted that the shape of the 
micelles changed from prolate ellipsoid to oblate ellipsoid in the presence of 4-CHOL. 
There are also increases seen in the shell thickness of the micelles upon the addition 
of 4-CHOL – 50% in the case of the 3 wt% system and 35 % in the case of the 5 wt% 
system.  
Despite the significant change in geometry of the SDS micelles in the presence of 4-
CHOL, however, there was no significant change seen in the surfactant area per 
molecule, and it is thus concluded that the 4-CHOL is solubilised in the core of the 




CHOL systems, the scattering length densities of the deuterated core were fitted as 4 
± 0.5 Å-2 and 3.5 ± 0.5 x 10-6 Å-2 for the 3 wt% and 5 wt% respectively, which would 
















































































































Figure 4. 8 SANS profiles and model fits (solid line) for 3 wt % (left column) and 5 wt 
% (right column) d25SDS in H2O (a), d25SDS in D2O (b) and h25SDS (c) in D2O in the 
presence (red) or absence (black) of 4-CHOL (SANS data obtained from LOQ). 
The SANS profiles obtained for SDS micelles in the presence of ADRENO are shown 
in Figure 4.9.  Unlike the 4-CHOL-saturated SDS micelles, the SANS profiles 
obtained for the SDS/ADRENO micelles showed no noticeable change in shape and 







for ADRENO is much lower than for 4-CHOL, it is unsurprising, therefore, that the 
SANS profiles obtained for the SDS micelles and the ADRENO-saturated SDS 
micelles are virtually superimposable. 
The model-fitted parameters for the SDS/ADRENO micelles are given in Table 4.5. 
The ADRENO-saturated SDS micelles are nearly spherical. The R1 of the micelle was 
increased by 13% in the presence of ADRENO, while the shell thickness remained 
unchanged. Best fits obtained for the core and shell SANS contrasts were obtained 
when the scattering length density of the micelle core was changed, indicating that the 
ADRENO is solubilised in the hydrophobic chain region of the micelle.  
The aggregation numbers of the SDS and steroids were calculated according to the 
molar ratio of surfactant to solubilised steroid (as reported in section 2.1).  For 
SDS/ADRENO micelles, the aggregation number was slightly smaller than that of the 
SDS micelles. For 4-CHOL-saturated SDS micelles, because of the much increased 
volume of the micelles, the aggregation number was higher than that of the pure SDS 
micelles, and increased with increased SDS concentration.  
The properties of SDS micelles in the presence of testosterone enanthate (TE), another 
steroid with high logP value, were determined by Saaka [87]. He determined the 
steroid-saturated SDS micelle aggregation numbers to be 147 at 3 wt% and 165 at 5 
wt %, and he found that the TE/SDS micelle remained as a prolate ellipsoid with a 
core axial ratio of 1.9 ± 0.1. Moreover, he also observed the aggregation numbers for 
SDS micelles in the presence of testosterone and testosterone propionate at 3 wt% 
were 80 and 76, respectively. However, in Saaka’s studies, the SDS micelles with 
saturation amounts of steroids were all prolate ellipsoidal. It should be noted here, 
however, that it is difficult to distinguish between oblate and prolate shapes by 
comparing the model fits to SANS profiles measured for low surfactant concentrations 
[186]. In the present study, the qualities of fits to the scattering curves for most of the 
pure surfactant micelles assuming prolate or oblate ellipsoid models were quite 
similar, but the fits to the SANS profiles for the 4-CHOL-saturated SDS micelles were 
appreciably better assuming oblate micelles. Moreover, it should be noted that for 
most prolate ellipsoid micelles observed in this study, model fits showed that 
increasing surfactant concentration resulted in a moderate increase in the core radius 




micelles, as seen here in the case of the 4-CHOL/SDS micelles in this study, increases 
































































































Figure 4. 9 SANS profiles model fits (solid line) for 3 wt % (left column) and 5 wt % 
(right column) d25SDS in H2O (a), d25SDS in D2O (b) and h25SDS (c) in D2O in the 


























Table 4. 5 Values of model fitted parameters for 3 wt% and 5 wt% SDS micelles in the presence of steroids. 






















4-CHOL 3% Drop 38.0 0.40 15.2 4.2 144001 34 188 61 11555 61 15185 81 
3% Shell 38.0 0.40 15.2 4.2 144001 34 188 61 11555 61 15185 81 
3% Core 38.0 0.40 15.2 4.2 144001 34 188 61 11555 61 15185 81 
ADRENO 3% Drop 18.9 1.05 19.8 3.1 46403 22 78 7 4489 57 6082 78 
3% Shell 18.9 1.05 19.8 3.1 46403 22 78 7 4489 57 6082 78 


















































4-CHOL 5% Drop 44.6 0.36 16.0 4.6 208770 35 273 88 15389 56 19997 73 
5% Shell 44.6 0.36 16.0 4.6 208770 35 273 88 15389 56 19997 73 
5% Core 44.6 0.36 16.0 4.6 208770 35 273 88 15389 56 19997 73 
ADRENO 5% Drop 18.9 1.11 21.0 3.2 49232 22 83 7 4821 58 6505 78 
5% Shell 18.9 1.11 21.0 3.2 49232 22 83 7 4821 58 6505 78 
5% Core 18.9 1.11 21.0 3.2 49232 22 83 7 4821 58 6505 78 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole 
micelle (Sm) and the corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 7, ± 







Aggregation behaviour of LDS micelles 
The SANS profiles measured for the core, shell and drop contrasts for LDS micelles 
at concentrations of 3 wt% and 5 wt% are presented in Figure 4.10. Given that LDS 
and SDS share the same dodecyl sulfate moiety but different counterions, we can 
predict that the aggregation behaviour of LDS and SDS micelles should be very 
similar. The interaction peak caused by electrostatic repulsion between the LDS 
micelles was observed (as for SDS micelles) in the Q range of 0.06 to 0.07 Å-1, and 
this agrees with the observations made by Liu et al [187]. At the higher LDS 
concentration there was a higher scattering intensity in the interaction peak observed 
for all three contrasts, indicating a greater repulsion between the aggregates at the 
higher concentration. The increased scattering seen at low Q with increased LDS 
concentration was assumed to arise because of large particles involving impurities in 
the samples and the fit to the data in this part of the SANS profiles was accordingly 
given lower weight in the model-fitting. This issue taken together with the generally 
low scattering intensity seen in the shell contrast (caused by the high scattering length 
density of the lithium sulfate head group, 4.4 x 10-6 Å-2) results in a less than 
satisfactory fitting of the SANS profiles for the shell contrast data but the values of 




















































Figure 4. 10 SANS profiles and model fits (solid line) for 3 wt % (black) and 5 wt % 






The values of the model-fitted parameters for the LDS micelles are tabulated in Table 
4.6. The core radius of the micelles was determined as 16.6 ± 0.3 Å, and the axial ratio, 
x, was seen to increase from 1.4 to 1.6 when the concentration of LDS was increased 
from 3 wt% to 5 wt%. In the SANS studies of LDS micelles reported by Bendedouch 
and Chen, the micelles were also fitted as prolate ellipsoids, with an axial ratio of about 
1.3 at 1 wt% [188], and the micelle aggregation number was determined to be 60 when 
the core of the micelle was constrained as 17 Å. The results obtained here are also 
consistent with those reported previously by Liu et al [187].  
The shell thickness of LDS micelles is found to be a little higher than that of the SDS 
micelles (4 ± 0.3 Å vs 3.1 ± 0.3 Å), as too are the volume and charge of the LDS 
micelles (48k Å3 vs 46k Å3 and 24 vs 21, respectively). As noted here earlier (section 
2.3) and also reported by Li et al. [189]  these differences between the SDS and LDS 
micelles can be attributed to the larger size of the hydrated Li+ SO4
- head group by 
comparison with that of the Na+ SO4







































3% Drop 16.6 1.42 23.6 4.0 48815 24 77 4465 58 6553 85 
3% Shell 16.6 1.42 23.6 4.0 48815 24 77 4465 58 6553 85 




















5% Drop 16.6 1.55 25.7 4.1 53332 24 84 4786 57 7006 83 
5% Shell 16.6 1.55 25.7 4.1 53332 24 84 4786 57 7006 83 
5% Core 16.6 1.55 25.7 4.1 53332 24 84 4786 57 7006 83 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 




LDS micelles in the presence of steroids 
The model-fits to the SANS profiles measured for the LDS micelles in the presence 
and absence of steroids are shown in Figure 4.11. The scattering intensity of the 
micelles in the presence of both 4-CHOL and ADRENO is found to be higher than 
that for the LDS micelles alone, while the changes in the scattering for the 4-CHOL-
saturated LDS micelles in the shell and drop contrasts are much more pronounced than 
those seen in the same contrasts for the ADRENO-saturated micelles. It is thus 
concluded that the steroids might be solubilised within the micelle core region. The 
interaction peak for the 4-CHOL/LDS micelles is shifted to lower Q, suggesting an 
increased inter-micelle distance. Again, in the shell contrast SANS profile there is a 
high scattering intensity in the low Q range which is attributed to large particles of 


















































Figure 4. 11 SANS profiles and model fit (solid line) for d25LDS in H2O (a), d25 LDS in 
D2O (b) and h25 LDS (c) in D2O micelles alone (black), micelles in the presence of 
saturation amounts of 4-CHOL (red) and ADRENO (blue) at 3 wt % 
The values of the model-fitted parameters for the LDS micelles in the presence of 






decision to be made as to whether the micelles were prolate or oblate (the quality of 
fit being similar for the two cases), but since the SDS micelles were determined to be 
oblate ellipsoid when saturated with 4-CHOL, it was assumed that the same shape 


















































Figure 4. 12 SANS profiles and model fits (solid line) for d25LDS in H2O (a), d25 LDS in 
D2O (b) and h25 LDS (c) in D2O micelles alone (black), micelles in the presence of 
saturation amounts of 4-CHOL (red) and ADRENO (blue) at 5 wt % 
The modelled parameters show that the 4-CHOL-saturated micelles grow with an 
increasing LDS concentration while R3 remained the same (at ca. 16 Å). The micelle 
shell thickness was found to increase slightly in the presence of steroid, whereas the 
charge on the micelles seemed unaffected by addition of the steroids.  
By comparison with the changes in the SANS profiles seen for SDS micelles in the 
presence of 4-CHOL and ADRENO, the corresponding changes seen for the LDS 
micelles were much smaller. These observations are consistent with the findings from 
the solubilisation experiments (presented in section 2.1) which showed that the molar 
ratios of surfactant:steroid for the LDS:steroid micelles were higher than those of the 
SDS:steroid micelles (viz., 4:1 vs. 3:1 for the 4-CHOL-containing LDS and SDS 






In the modelling of the SANS profiles for the shell and core contrasts for the LDS-
steroid systems, the fitted values of the micelle core scattering length densities were 
lower than those for pure SDS micelle cores, indicating the presence of the steroids in 
the hydrophobic core of the micelles. The area per molecule of the LDS micelles in 
the presence of steroids, however, only increased by 10% or less. It is concluded, 
therefore, that the major solubilisation locus for 4-CHOL and ADRENO lies within 

























Table 4. 7 Values of model fitted parameters for 3 wt% and 5 wt% LDS micelles in the presence of steroids. 






















4-CHOL 3% Drop 24.1 0.68 16.4 4.5 71568 24.7 91 21 5803 64 8638 95 
3% Shell 24.1 0.68 16.4 4.5 71568 24.7 91 21 5803 64 8638 95 
3% Core 24.1 0.68 16.4 4.5 71568 24.7 91 21 5803 64 8638 95 
ADRENO 3% Drop 16.7 1.42 23.7 4.0 49677 24.7 75 4 3505 46 6630 88 
3% Shell 16.7 1.42 23.7 4.0 49677 24.7 75 4 3505 46 6630 88 
















































4-CHOL 5% Drop 33.9 0.46 15.6 5.3 134488 25.1 171 40 9650 56 14017 82 
5% Shell 33.9 0.46 15.6 5.3 134488 25.0 171 40 9650 56 14017 82 
5% Core 33.9 0.46 15.6 5.3 134488 25.0 171 40 9650 56 14017 82 
ADRENO 5% Drop 16.7 1.52 25.4 4.1 53224 24.7 81 5 4768 59 6983 86 
5% Shell 16.7 1.52 25.4 4.1 53224 24.7 81 5 4768 59 6983 86 
5% Core 16.7 1.52 25.4 4.1 53224 24.7 81 5 4768 59 6983 86 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole 
micelle (Sm) and the corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 7, ± 




Aggregation behaviour of ADS micelles 
The SANS profiles measured for the core, shell and drop contrasts for ADS micelles 
at concentrations of 3 wt% and 5 wt% are presented in Figure 4.13. As was noted for 
the SDS and LDS micellar systems, the scattered intensities increase with increasing 
surfactant concentration, and the interaction peaks shift to higher Q at higher 
concentration indicating smaller mean inter-micelle distances, resulting from 
decreased repulsive interactions.  
As expected, given the low scattering length density of the hydrophilic head group of 
ADS (3.35 x 10-6 Å-2) the scattering intensity for the shell contrast is found to be low, 
and since the NH4
+ ion associated with the sulfate head group is expected to be less 
heavily hydrated by comparison with Na+ and Li+, the surfactant molecular surface 

















































Figure 4. 13 SANS profiles and model fits (solid line) for 3 wt % (black) and 5 wt % 
(red) d25ADS in H2O (a), d25ADS in D2O (b) and h25ADS in D2O (c). SANS data 
obtained from LOQ 
The values of the model-fitted parameters for the ADS micelles in the absence of 






best modelled as prolate ellipsoids, but they are much more elongated than the SDS 
and LDS micelles, with core axial ratios ranging from 2.5 at 3 wt% to 2.7 at 5 wt%.  
Kang and Lim investigated the size and structure of ADS micelles at various 
concentrations [190] and reported that the micelles were spherical at low surfactant 
concentrations and became progressively more ellipsoidal as the surfactant 
concentration was increased. While Kang and Lim modelled the ADS micelles formed 
at the higher concentrations as oblate ellipsoids, Vass et al. showed that the SANS data 
do not allow an unequivocal choice between oblate and prolate ellipsoids [191]. Vass 
et al., were clear, however, that the ADS aggregates become more elongated at higher 
surfactant concentration, with the micelle cross-section limited by the extended length 
of the surfactant hydrocarbon chain.  
In the present study, the best fits to the ADS micelle SANS data were likewise 
obtained with the thickness of the core constrained as the maximum extended length 
of the C12 hydrocarbon chains (16.7 Å). The shell thickness of the ADS micelles was 
determined as 2.8 Å, which, as expected, was smaller than the shell thickness of the 
micelles formed with lithium and sodium counterions.  
Using time-resolved fluorescence methods, Tcacenco et al. found an aggregation 
number of 103 ± 5 for ~4.6 wt % ADS micelles at 25 oC  [192], and this is 30% less 
than the value obtained on the basis of the SANS studies here. Saaka [87] reported the 
aggregation number of ADS micelle of 132 at 5 wt%, which is much closer to the 
value obtained in this study. 
With increasing concentration of ADS, the micelles are seen to grow, their aggregation 
number thus increasing, and the surface area per ADS molecule decreasing. In addition 
it is found that by comparison with the interaction peaks see in the SANS profiles for 
SDS and LDS micelles, the peak for ADS micelles becomes sharper and is moved to 
higher Q, indicating that the ADS micelles show a narrower distribution of inter-
micellar distances due to a stronger repulsive interaction between the aggregates [190]. 
The charge on the dodecyl sulfate micelles is found to increase as expected with ADS 










































3% Drop 16.7 2.49 41.6 2.9 71313 20 137 7267 53 9194 67 
3% Shell 16.7 2.49 41.6 2.9 71313 20 137 7267 53 9194 67 






















5% Drop 16.7 2.73 45.6 2.9 78126 20 151 7900 52 9960 66 
5% Shell 16.7 2.73 45.6 2.9 78126 20 151 7900 52 9960 66 
5% Core 16.7 2.73 45.6 2.9 78126 20 151 7900 52 9960 66 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 




ADS micelles in the presence of steroids 
The SANS profiles and model-fits for ADS micelles in the absence and presence of 4-
CHOL are shown in Figure 4.14. The data shown here were obtained from LOQ, and 
so the backgrounds and Q range are different from those of the SANS profiles 
measured on SANS 2D. Moreover, the scattering intensity in the low Q range appears 
anomalously high in the shell contrast for these systems and this is attributed to the 
presence of large particles of unknown composition. In model-fitting these SANS 
data, therefore, the quality of the fits to the data at low Q were regarded with caution. 
The addition of 4-CHOL to the ADS micelles caused a dramatic increase in the 
scattered intensities and the shape of the SANS profiles also changed significantly. 
The interaction peak for the 4-CHOL-saturated micelles was shifted to lower Q, 
indicating a significant effect of the 4-CHOL on the inter-micellar separation. It is 
interesting to note that in Figure 4.14 (b), there is a peak at Q ~ 0.12 Å-1 which could 
perhaps be attributed to formation of a lamellar phase. This peak, however, is not seen 
in Figures 4.14 (a) and (c), and so no attempts were made to fit the SANS data using 
a lamellar model. 
As noted earlier, when the SANS measurements are made for dilute solutions of ionic 
surfactants without added salt, it is generally not easy when modelling the data to 
distinguish between prolate and oblate ellipsoidal micelles. In the case of the 4-
CHOL/ADS micelles, however, the large amount of 4-CHOL solubilised allowed for 
an unequivocal assignment of oblate ellipsoid geometry and the fitted parameters 
values are shown in Table 4.9.  
By comparison with the ADS micelles, the 4-CHOL/ADS micelles are much more 
elongated and the micelle volume is found to increase by more than 400% in the 
presence of the steroid, which is consistent with the low mole ratio of 3.8:1 ADS:4-
CHOL.  
The shell thickness and charge on the ADS micelles were seen to increase slightly in 
the presence of 4-CHOL, and the change in the fitted values of the scattering length 
densities for the micelle cores in the shell and core contrasts were found to be similar 





The core axial ratio of the 4-CHOL-saturated ADS micelles is seen to decrease with 
increasing ADS concentration, with R1 increasing by 11% and R3 decreasing by 7% 
when the surfactant concentration is raised from 3 wt% to 5 wt%. The increase in ADS 
concentration also results in an increase in volume of the 4-CHOL/ADS micelles 
(from 37,000 to 42,000 Å3) and an increase too in the number of 4-CHOL molecules 
solubilised within the aggregates. The best model fits to the SANS data for these 












































































































Figure 4. 14 SANS profiles and model fits (solid line) for 3 wt % (left column) and 5 wt 
% (right column) d25ADS in H2O (a), d25ADS in D2O (b) and h25ADS in D2O (c) in the 




































































































Figure 4. 15 SANS profiles and model fits (solid line) for 3 wt % (left column) and 5 wt 
% (right column) d25ADS in H2O (a), d25ADS in D2O (b) and h25ADS in D2O (c) in the 
presence (red) or absence (black) of ADRENO. 
Figure 4.15 shows the model-fitted SANS profiles for ADS micelles in the presence 
of ADRENO. In contrast to the case for the 4-CHOL/ADS system, the addition of 
ADRENO to the ADS micelles caused no change in the shape of the scattering curve 
and the SANS profiles for the ADRENO/ADS micelle core and drop contrasts (Figure 
4.15 (a) and (c)) are superimposable on the corresponding profiles recorded for ADS 
micelles in the absence of steroids. It is concluded, therefore, that there is no change 







ADRENO. Model-fitting of the core and shell contrast data for the ADRENO/ADS 
system does show, however, that the presence of the steroid reduces the scattering 
length density of the alkyl chain region in the micelle, indicating that the ADRENO is 






















Table 4. 9 Values of model fitted parameters for 3 wt% and 5 wt% ADS micelles in the presence of steroids. 






















4-CHOL 3% Drop 62.0 0.25 15.5 4.4 366337 20.5 529 140 27370 52 32950 62 
3% Shell 62.0 0.25 15.5 4.4 366337 20.5 529 140 27370 52 32950 62 
3% Core 62.0 0.25 15.5 4.4 366337 20.5 529 140 27370 52 32950 62 
ADRENO 3% Drop 16.7 2.49 41.6 2.9 71313 19.9 132 6 7267 55 9194 69 
3% Shell 16.7 2.49 41.6 2.9 71313 19.9 132 6 7267 55 9194 69 

















































4-CHOL 5% Drop 69.0 0.21 14.3 4.3 417888 22.5 604 160 32872 54 38750 64 
5% Shell 69.0 0.21 14.3 4.3 417888 22.5 604 160 32872 54 38750 64 
5% Core 69.0 0.21 14.3 4.3 417888 22.5 604 160 32872 54 38750 64 
ADRENO 5% Drop 16.7 2.76 46.1 2.9 79029 20.5 147 7 7979 54 10060 69 
5% Shell 16.7 2.76 46.1 2.9 79029 20.5 147 7 7979 54 10060 69 
5% Core 16.7 2.76 46.1 2.9 79029 20.5 147 7 7979 54 10060 69 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole 
micelle (Sm) and the corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 7, ± 




4.4.2 SANS studies for zwitterionic surfactants  
Fitting parameters 
The SANS profiles for the zwitterionic surfactant micelles were model-fitted using a 
monodisperse two-shell ellipsoid model. With this model the micelles were considered 
to have an outer shell containing the surfactant head groups and associated water and 
an inner core containing only the C12 alkyl chains. The micelles were treated as 
electrically neutral and the model therefore differs from that used in modelling the 
SANS profiles for the ionic surfactants in that there is no account taken of electrostatic 
repulsion between the micelles. All fitted parameters other than micelle charge were 
thus the same as were considered for the ionic surfactant micelles, i.e., the micelle 
equatorial core radius (R1), axial core radius (R3), core axial ratio (x), and the micelle 
shell thickness (δ). The molecular volumes and scattering length densities used in the 
model-fitting are shown in Table 4.10. 
Note here that since the CMCs of zwitterionic surfactants are much lower than those 
of ionic surfactants, the micellar solutions of the DDAPS, DPC and DDAO were 










Table 4. 10 Molecular formulas, molecular volume (Vm), molecular weight (Mw) and scattering length density (ρ) of the constituents of the 
zwitterionic surfactants and steroids studied. 
Chemical Molecular formula Vm (Å
3) Mw (g mol
-1) ρ (x 10-6 Å-2) 
 Protiated Deuterated  Protiated Deuterated Protiated Deuterated 
4-CHOL C27H44O N/A 652.5 384.6 N/A 0.34 N/A 
ADRENO C19H24O3 N/A 422.6 300.4 N/A 1.27 N/A 
DDAPS C17H37O3SN C17D25H12O3SN 534.7 335.5 360.5 0.08 4.98 
DAPS C5H12O3SN N/A 181.0 166.2 N/A 1.01 N/A 
DDAO C14H31NO C14D25H6NO 422.6 229.4 254.4 -0.18 6.04 
DAO C2H6NO N/A 68.9 60.1 N/A 0.88 N/A 
DPC C17H38NO4P C17D25H13NO4P 536.7 351.5 389.7 0.16 5.20 
PC C5H13NO4P C5D13NO4P 183.0 182.1 N/A 1.22 8.62 





Aggregation behaviour of DDAPS micelles 
The SANS profiles and model-fitted curves obtained for the 2 wt% and 3.5 wt% 
DDAPS micelles are shown in Figure 4.16. Given that these micelles are electrically 
neutral, there is no interaction peak seen in the SANS profiles. The increase in DDAPS 
concentration gives rise to an increase in scattering intensity but there is no change in 

















































Figure 4. 16 SANS profiles and model fits (solid line) for 2 wt % (black) and 3.5 wt % 
(red) d25DDAPS in H2O (a), d25DDAPS in D2O (b) and h25DDAPS in D2O (c). 
Table 4.11 shows the values of the model-fitted parameters for the DDAPS micelles. 
As evidenced by the increase in core axial ratio and radius, the micelles are seen to be 
become more elongated at the higher surfactant concentration. The aggregates are best 
modelled as prolate ellipsoids with axial ratios of 2.5 and 3.3 at 2 wt% and 3.5 wt%, 
respectively, and the concomitant increase in the micelle volume results in a higher 
aggregation number.  
Ullah et al. [193] have also studied DDAPS micelles, but using light scattering 






concentrations of 2-3 wt%, and this is consistent with the values found in the studies 
reported here.  
The shell thickness of the DDAPS micelles was found to be around 50% larger than 
that of the ionic surfactant micelles and this is as expected given that the sulfopropyl 
group of DDAPS is significantly larger than the head groups of the dodecyl sulfate 
surfactants and DTAB. The best-fitted value of R1 (core equatorial radius) obtained in 
the studies here was 14 Å, which is ~85% of the fully extended C12 alkyl chain length. 
Any attempt to fit with an increased R1 resulted in a much poorer fit to the data. The 
fact that the DDAPS alkyl chains in the micelles are shorter than those in the SDS and 
DTAB micelles is in keeping with the larger area per molecule of DDAPS (62 ± 1 Å2 
vs. ca. 46 Å2) and indicates that the C12 chains in the DDAPS micelle have a different 
conformation to those in the ionic micelles. 
Masudo and Okada [194] used light scattering too to study DDAPS micelles and 
reported that the micelles were spherical with an aggregation number of 67 and a core 
radius of 17 Å. The concentration of DDAPS used in these studies was not given, 
however, and so no comparison can be made with the results presented here. 
Encouragingly, Hsieh also performed SANS studies for DDAPS micelles at 2 wt% 
and 3.5 wt% and determined R1 as 14.1 Å and 13.5 Å, respectively, with the 
corresponding core axial ratios, 2.5 and 3.6 [49].  
Qu et al. [86] studied the structure of DDAPS micelles using molecular dynamics and 
they too found that R1 was less than the C12 extended length, on average around 14.9 
Å.  
In the SANS studies performed by Saaka, the DDAPS micelles were modelled as 
prolate ellipsoids with the core axial ratios increasing from 2.8 to 3.4 when the 









































2% Drop 14.3 2.54 36.3 5.4 67824 88 5425 62 8760 100 
2% Shell 14.3 2.54 36.3 5.4 67824 88 5425 62 8760 100 




















3.5% Drop 14.1 3.30 46.6 5.6 84890 110 6742 61 10698 97 
3.5% Shell 14.2 3.27 46.3 5.6 84514 110 6707 61 10649 97 
3.5% Core 14.2 3.29 46.5 5.6 84968 110 6740 61 10698 97 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the corresponding areas per 




DDAPS micelles in the presence of steroids 
The scattering curves for DDAPS in the presence and absence of steroids in all three 
contrasts at surfactant concentration of 2 and 3.5 wt% are shown in Figures 4.17 and 
4.18. It can be seen here that the scattering intensities increase when saturating 
amounts of the steroids are added to the DDAPS micelles, with the increase for 4-
CHOL clearly larger than that for ADRENO, particularly in the case of the shell 
contrast (Figure 4.17/4.18, (b)). The addition of the steroids, however, does not cause 

















































Figure 4. 17 SANS profiles and model fits (solid line) for d25DDAPS in H2O (a), d25 
DDAPS in D2O (b) and h25 DDAPS (c) in D2O micelles alone (black), micelles in the 
presence of saturation amounts of 4-CHOL (red) and ADRENO (blue) at 2 wt %. 
The values of the model-fitted parameters for the DDAPS micelles in the presence of 
steroids are shown in Table 4.12. While the addition of ADRENO causes very little 
change in the structure of the DDAPS micelles, the addition of 4-CHOL leads to 
increases of about 6% in R1 and δ and an increase in the micelle volume of around 
25%. In order to improve the quality of the fitting, the scattering length density of the 























































Figure 4. 18 SANS profiles for d25DDAPS in H2O (a), d25 DDAPS in D2O (b) and h25 
DDAPS (c) in D2O micelles alone (black), micelles in the presence of saturation 
amounts of 4-CHOL (red) and ADRENO (blue) at 3.5 wt %. 
For the micelle containing 4-CHOL, the scattering length density of the deuterated 
surfactant core changed from 6.95 x 10-6 Å-2 to 6.0 ± 0.5 x 10-6 Å-2, giving clear 
evidence of the solubilisation of the steroid in the micelle core. There was no change 
in the deuterated core scattering length density, however, on addition of ADRENO to 
the DDAPS micelles. The model-fitting of the DDAPS/ADRENO data also showed 
no evidence of ADRENO within the hydrophilic shell of the micelles. The 
solubilisation locus of ADRENO thus remains undetermined but it would seem likely, 
however, that the ADRENO is solubilised in the micelle core but that there is so little 
solubilised that the change in core scattering length density cannot be detected.  
It is pertinent here to note that in the SANS studies performed by Saaka [87] it was 
the micelle core that was identified as the major locus of solubilisation of testosterone 
derivatives in DDAPS micelles. 
Although the volume of the DDAPS micelles is seen to be larger than those of the 






capacity for the steroids because their aggregation numbers in the DDAPS micelles 























Table 4. 12 Values of model fitted parameters for 2 wt% and 3.5 wt% DDAPS micelles in the presence of steroids. 


















4-CHOL 2% Drop 15.1 2.73 41.2 5.7 85036 106 5 6459 61 10323 97 
2% Shell 15.1 2.73 41.2 5.7 85436 107 5 6459 60 10353 97 
2% Core 15.1 2.72 41.1 6.0 87581 110 5 6437 59 10503 96 
ADRENO 2% Drop 14.2 2.65 37.6 5.4 69242 88 3 5559 63 8949 102 
2% Shell 14.2 2.65 37.6 5.4 69156 88 3 5559 63 8942 102 















































4-CHOL 3.5% Drop 14.9 3.56 53.0 6.0 107426 134 6 8049 60 12724 95 
3.5% Shell 14.9 3.56 53.0 6.0 107426 134 6 8049 60 12724 95 
3.5% Core 15.1 3.56 53.8 6.0 111438 139 6 8267 59 13042 94 
ADRENO 3.5% Drop 14.2 3.35 47.6 5.6 87314 111 4 6904 62 10939 99 
3.5% Shell 14.2 3.35 47.6 5.6 87314 111 4 6904 62 10939 99 
3.5% Core 14.2 3.35 47.6 5.6 87314 111 4 6904 62 10939 99 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and 





Aggregation behaviour of DDAO micelles 
The aggregation behaviour of the zwitterionic surfactant DDAO in the presence and 
absence of steroids was determined through SANS measurements made on SANS 2D. 
The SANS profiles and model-fitted curves are shown in Figure 4.19. In the profile 
for the core contrast it will be noted that there is a peak at Q = 0.06 Å-1, indicating that 
the DDAO micelles carry a small net charge. Barlow et al. [141] also reported a peak 
in the SANS data for DDAO micelles (at high concentration) and suggested that the 
hard sphere S(Q) model was not adequate to treat the repulsive forces between the 
micelles, and that a stronger and more repulsive potential should be included in the 
model. The data for the DDAO micelles were, therefore, re-fitted using the core-shell 



















































Figure 4. 19 SANS profiles and model fits (solid line) for 2 wt % (black) and 3.5 wt % 
(red) d25DDAO in H2O (a), d25DDAO in D2O (b) and h25DDAO in D2O (c). 
The values of the model-fitted parameters for the DDAO micelles in the absence of 
steroids are presented in Table 4.13. These micelles are found to be prolate ellipsoids 
with a core radius, R1 of 16.6 ± 0.3 Å. In contrast to the situation seen with the other 






with increased surfactant concentration, the results obtained for the DDAO micelles 
show that the aggregates have the same size and shape at both 2 wt% and 3.5 wt%. 
This was also found by Barlow et al. who determined the structure of DDAO micelles 
at various concentrations  [141]. These workers showed too that with 8 H2O per head 
group and an area per molecule of 82 Å, the micelle aggregation number remained the 
same (97 ± 2), regardless of concentration [141]. Saaka [87] also reported the DDAO 
micelles as prolate ellipsoidal, and quoted a similar aggregation number of ~ 90. He 
suggested too, however, that while R1 remained constant at 16.6 Å, there was a slight 
decrease in size of the micelles when the concentration was increased from 2 wt% to 
5 wt%, with a concomitant decrease in the core axial ratio from 1.7 to 1.6.  A similar 
small decrease in x is also found in the present study, but this is not regarded as 
significant since the difference falls within the experimental uncertainty (± 0.03). The 
shell thickness of the DDAO micelles in this study was determined as 4.1 Å, regardless 












































2% Drop 16.6 1.71 28.4 4.1 58308 4 93 5185 56 7516 81 
2% Shell 16.6 1.71 28.4 4.1 58308 4 93 5185 56 7516 81 






















3.5% Drop 16.6 1.67 27.7 4.1 56897 3 90 5085 56 7374 82 
3.5% Shell 16.6 1.67 27.7 4.1 56897 3 90 5085 56 7374 82 
3.5% Core 16.6 1.68 27.9 4.1 57194 3 91 5110 56 7405 81 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 






DDAO micelles in the presence of steroids 
The SANS profiles and model-fitted curves for DDAO micelles in the presence of 4-
CHOL and ADRENO in all three contrasts at 2 wt% and 3.5 wt% are presented in 
Figures 4.21 and 4.22.  For the contrast provided by d25DDAO in D2O, the addition of 
the steroids is seen to cause an increase in the scattering intensity, with 4-CHOL giving 
rise to greater increase than ADRENO. For the other two contrasts, there is no 
observable increase in I(Q) for the DDAO micelles upon addition of ADRENO, while 
the presence of 4-CHOL in the micelles gives rise to a slight increase in I(Q).  
The values of the model-fitted parameters for the DDAO micelles in the presence of 
steroids are shown in Table 4.14.  
Model-fitting of the SANS data for the ADRENO/DDAO micelles shows that this 
steroid causes no change in the micelle structure, suggesting that there is very little 
ADRENO solubilised within the aggregates, and this is wholly consistent with the 
findings from the solubilisation experiments (section 2.1).  
The model-fitting of the SANS data does show, however, that there are changes in the 
DDAO micelle structure caused by addition of 4-CHOL. For the micelles containing 
4-CHOL, the scattering length density of the deuterated surfactant core is seen to 
change from 6.95 x 10-6 Å-2 to 6.0 ± 0.5 x 10-6 Å-2, giving clear evidence of the 
solubilisation of 4-CHOL in the DDAO micelle core.  In addition it is found that R1 
increases by ~15% in the presence of 4-CHOL, with the core axial ratio also 
decreasing slightly. It is interesting to note too, however, that the thickness of the shell 
of the DDAO micelles is also found to increase upon the addition of 4-CHOL, with 
increases of 15% and 10% at the surfactant concentrations of 2 wt% and 3.5 wt%, 
respectively. Notwithstanding this change in shell thickness, it is concluded that the 






















































Figure 4. 20 SANS profiles and model fits (solid line) for d25DDAO in H2O (a), d25 
DDAO in D2O (b) and h25 DDAO in D2O(c) micelles alone (black), micelles in the 
presence of saturation amounts of 4-CHOL (red) and ADRENO (blue) at 2 wt %.  
As noted earlier, the model-fitting of the SANS data for the DDAO micelles showed 
that they tended to become more spherical with increasing concentration, and the same 
trend is also observed here for DDAO micelles in the presence of 4-CHOL or 
ADRENO. This trend was reported too by Saaka for the case of DDAO micelles in 
the presence of testosterone derivatives [87].  
Although the model-fitted values of the parameters R1, x, δ and Nagg for the DDAO 
micelles were very similar to those of the parameters for the ionic surfactant micelles, 
there are large differences between the DDAO and ionic surfactant micelle 
solubilisation capacities and this would suggest that the level of steroid solubilisation 
is influenced by the differing nature of the hydrophilic head groups of the surfactants 

























































Figure 4. 21 SANS profiles and model fits (solid line) for d25DDAO in H2O (a), d25 
DDAO in D2O (b) and h25 DDAO in D2O (c) micelles alone (black), micelles in the 


























Table 4. 14 Values of model fitted parameters for 2 wt% and 3.5 wt% DDAO micelles in the presence of steroids. 






















4-CHOL 2% Drop 19.6 1.57 30.7 4.7 87807 5 130 9 6727 52 9782 75 
2% Shell 19.6 1.57 30.8 4.7 88029 5 131 9 6741 52 9799 75 
2% Core 19.6 1.57 30.78 4.7 88029 5 131 9 6741 52 9799 75 
ADRENO 2% Drop 16.6 1.76 29.2 4.1 59994 4 94 2 5310 56 7688 82 
2% Shell 16.6 1.76 29.2 4.1 59994 4 94 2 5310 56 7688 82 


















































4-CHOL 3.5% Drop 18.6 1.54 28.6 4.5 73910 4 110 7 5977 54 8704 79 
3.5% Shell 18.6 1.54 28.6 4.5 73910 4 110 7 5977 54 8704 79 
3.5% Core 18.6 1.54 28.6 4.5 73910 4 110 7 5977 54 8704 79 
ADRENO 3.5% Drop 16.6 1.66 27.6 4.1 56818 3 89 2 5060 57 7362 83 
3.5% Shell 16.6 1.66 27.6 4.1 56818 3 89 2 5060 57 7362 83 
3.5% Core 16.6 1.66 27.6 4.1 56818 3 89 2 5060 57 7362 83 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole 
micelle (Sm) and the corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 7, ± 




Aggregation behaviour of DPC micelles 
For DPC micelles, the SANS profiles and model-fitted curves for all three contrasts at 
2 wt% and 3.5 wt% are shown in Figure 4.22. It can be seen that the scattering 
intensities increase with increasing surfactant concentration while there is no 
significant change in the shape of the curves. As expected, there is no evidence of any 
interaction peak in the scattering curves, suggesting no significant electrostatic 



















































Figure 4. 22 SANS profiles and model fits (solid line) for 2 wt % (black) and 3.5 wt % 
(red) d25DPC in H2O (a), d25DPC in D2O (b) and h25DPC in D2O (c). 
The values of the model-fitted parameters found for the DPC micelles in the absence 
of steroids at surfactant concentrations of 2 wt% and 3.5 wt% are given in Table 4.15. 
At both concentrations, the micelles are found to be best modelled as prolate ellipsoids 
with a core axial ratio of 1.5, and a core radius consistent with the fully extended C12 
chain length. Just as with DDAO micelles, there is no evidence that the DPC micelles 
become more asymmetric with increasing surfactant concentration, the change in x (of 






The thickness of the shell of the DPC micelles was determined as 5.6 ± 0.3 Å, which 
is higher than that of the DDAO micelles, and is just as expected given the difference 
in size of the surfactants’ head groups.  
In the scattering studies conducted by Pambou et al. the shapes and structures of DPC 
micelles were determined for four different concentrations of surfactant using a 
spherical core-shell model [195]. These researchers report a decrease in the micelle 
shell thickness from 10 ± 2 Å to 5.5 ± 2 Å when the DPC concentration is increased 
from 0.35 wt% to 7 wt%. This thinning of the shell they suggested was due to a 
dehydration of the DPC head groups at the higher concentrations due to a closer 
packing of the surfactant molecules.  
Molecular dynamics simulations of DPC micelles in water have been reported by 
Wymore et al. [196] and Tieleman et al. [197] and these workers report that the 
micelles are slightly asymmetric  at low concentration, and that they become more 
spherical as the surfactant concentration is increased. More recently, Oliver et al. used 
small-angle X-ray scattering to study DPC micelles and determined the core equatorial 
radius (R1) to be 16.1 - 16.4 Å with the micelle aggregation number estimated as ~80 
at 2.7 wt% [35]. In addition, they suggested that the micelles form prolate ellipsoids 










































2% Drop 16.6 1.55 25.7 5.6 64836 84 4786 57 7961 95 
2% Shell 16.6 1.55 25.7 5.6 64836 84 4786 57 7961 95 


















3.5% Drop 16.6 1.53 25.4 5.6 63992 83 4736 57 7882 95 
3.5% Shell 16.6 1.53 25.4 5.7 63992 83 4736 57 7882 95 
3.5% Core 16.6 1.53 25.4 5.7 63992 83 4736 57 7882 95 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle 
volume (Vm), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 





DPC micelles in the presence of steroids 
Figures 4.23 and 4.24 show the SANS profiles and model-fitted curves for DPC 
micelles in the presence and absence of 4-CHOL and ADRENO. The addition of the 
steroids to the DPC micelles leads to an increase in scattering intensity for the shell 
SANS contrast. The increase seen for ADRENO at 2 wt% surfactant is higher than 
that for 4-CHOL but the increases for the two steroids are much the same at a 
surfactant concentration of 3.5 wt%.  
The model-fitted parameters for these systems (Table 4.16), show that the micelle 
volume increases by 10% upon the addition of ADRENO, and the best fit to the SANS 
profile is found when the scattering length density of the micelle core is lowered to 
6.4 ± 0.5 x 10-6 Å-2. According to the solubilisation experiment (section 2.1), the 
solubilisation capacity of DPC for ADRENO is slightly higher than for 4-CHOL, so it 
is reasonable to find that the scattering length density of the deuterated core of DPC 


















































Figure 4. 23 SANS profiles and model fits (solid line) for d25DPC in H2O (a), d25 DPC in 
D2O (b) and h25 DPC in D2O (c) micelles alone (black), micelles in the presence of 






























































Figure 4. 24 SANS profiles and model fits (solid line) for d25DPC in H2O (a), d25 DPC in 
D2O (b) and h25 DPC in D2O (c) micelles alone (black), micelles in the presence of 
saturation amounts of 4-CHOL (red) and ADRENO (blue) at 3.5 wt %. 
In contrast to what was seen for the other surfactant micelle systems investigated in 
this study, the addition of 4-CHOL in the DPC micelles did not lead to any noticeable 
change in scattering intensity.  The micelle volume increased by only 3% in the 
presence of 4-CHOL and no changes were seen in the scattering length density of 
either the core region or the shell of the micelle.  
Given the relatively large head group of DPC, one might expect an interaction between 
the steroids and its hydrophilic head group. Wymore et al. studied the interaction 
between the DPC head group and water via molecular dynamics simulation [196]. 
They suggested that the water molecules formed strong hydrogen bonds with the 
phosphate oxygen atoms, while the charged choline group interacted with the water 
oxygen. It is not unreasonable to assume, therefore, that the ADRENO molecules are 
solubilised within the shell of the DPC micelles because the head group has three 
carbonyl groups.  
Saaka [87] determined the structure of DPC micelles in the presence of testosterone 






solubilisation of testosterone enanthate, with testosterone and testosterone propionate 






















Table 4. 16 Values of model fitted parameters for 2 wt% and 3.5 wt% DPC micelles in the presence of steroids. 


















4-CHOL 2% Drop 16.6 1.59 26.4 5.7 66450 85 2 4885 58 8111 96 
2% Shell 16.6 1.59 26.4 5.7 66450 85 2 4885 58 8111 96 
2% Core 16.6 1.59 26.4 5.7 66450 85 2 4885 58 8111 96 
ADRENO 2% Drop 16.6 1.70 28.2 5.8 71079 91 2 5160 57 8540 94 
2% Shell 16.6 1.70 28.2 5.8 71079 91 2 5160 57 8540 94 














































4-CHOL 3.5% Drop 16.6 1.55 25.7 5.6 64757 82 2 4786 58 7954 97 
3.5% Shell 16.6 1.55 25.7 5.6 64678 82 2 4786 58 7948 97 
3.5% Core 16.6 1.55 25.7 5.6 64757 82 2 4786 58 7954 97 
ADRENO 3.5% Drop 16.6 1.65 27.4 5.7 68928 88 2 5035 57 8341 95 
3.5% Shell 16.6 1.65 27.4 5.7 68928 88 2 5035 57 8341 95 
3.5% Core 16.6 1.65 27.4 5.7 68928 88 2 5035 57 8341 95 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and 





4.4.3 SANS studies for non-ionic surfactants  
Fitting models and parameters 
The SANS profiles for the non-ionic surfactant micelles were model-fitted using the 
same monodisperse two-shell ellipsoid model incorporating a hard sphere structure 
factor that was used in modelling the data for the zwitterionic surfactant micelles. The 
details of the model were described earlier (section 4.4.2) and the fitted parameters are 
summarised in Table 4.17. Given that the CMCs of the non-ionic surfactants are much 
lower than those of ionic surfactants, the micellar solutions of Brij 35 and Tween 20 























Table 4. 17 Molecular formulas, molecular volume (Vm), molecular weight (Mw) and scattering length density (ρ) of the constituents of the 
zwitterionic surfactants and steroids studied. 
Chemical Molecular formula Vm (Å
3) Mw (g mol
-1) ρ (x 10-6 Å-2) 
 Protiated Deuterated  Protiated Deuterated Protiated Deuterated 
4-CHOL C27H44O N/A 652.5 384.6 N/A 0.34 N/A 
ADRENO C19H24O3 N/A 422.6 300.4 N/A 1.27 N/A 
Tween 20 C58H114O26 C12H25D89O26 1782.3 1227.5 1316.5 0.62 4.10 
Tween20 20 C46H89O26 C46D89O26 1438.6 1058.2 1147.2 0.87 7.35 
Brij35 C58H118O24 C58D25H93O24 1778.6 1428.6 N/A 1.12 N/A 
Brij35 23 C46H93O24 N/A 1424.9 1030.2 N/A 1.20 N/A 
Alkyl chain C12H25 C12D25 353.7 169.3 194.5 -0.39 6.95 






Aggregation behaviour of Tween 20 micelles 
Tween 20 is a non-ionic surfactant with 20 ethylene oxide groups in its head group. 
SANS measurements were made for Tween 20 with both protiated and deuterated 
ethylene oxide groups either in D2O or H2O, at surfactant concentrations of 2 wt% and 
3.5 wt%. For this surfactant, the shell SANS contrast sample involved d-Tween 20 
dispersed in H2O (d-/h- here used to refer to the presence of deuterated/protiated 
ethylene oxide groups), and the sample having d-Tween 20 dispersed in D2O is 
referred to as the core contrast. The drop SANS contrast for this system remains the 
same as described previously (viz., h-Tween 20 dispersed in D2O).  
As expected, the SANS profiles for the Tween 20 micelles show an increase in 
scattering intensity with increasing concentration, while the shape of the profiles 

















































Figure 4. 25 SANS profiles and model fits (solid line) for 2 wt % (black) and 3.5 wt % 
(red) d-Tween 20 in H2O (a), d-Tween 20 in D2O (b) and h-Tween 20 (c) in D2O. 
The values of the model-fitted parameters for the Tween 20 micelles are summarized 
in Table 4.18. The micelles are found to be prolate ellipsoidal with a core axial ratio 






and structure of the prolate micelles is not seen to change significantly, and the shell 
thickness too remains the same (19.6 Å).  
The aggregation number of 55 determined here for the Tween 20 micelles is in good 
agreement with the value obtained by Ullah et al. [198] who used dynamic light 
scattering (Nagg = 52) in their study. However, in the SANS studies performed by 
Penfold et al. [199], an aggregation number of 90 ± 10 was reported for Tween 20 
concentrations in the range 0.5 wt% to 2 wt% and these workers also reported prolate 
ellipsoids with a larger core axial ratio of 1.6.  
The results from Saaka’s studies of Tween 20 micelles are reassuringly closer to those 
reported here, with an aggregation number of ~50 quoted for surfactant concentrations 
in the range 2 wt% to 5 wt%. While the model-fitting conducted in the present studies 
showed the micelles as prolate ellipsoids, however, Saaka proposed that they were 
oblate ellipsoidal and tended to become more oblate with increasing concentration 
[87].  As noted earlier, however, there is generally very little difference between the 
quality of the fits obtained assuming prolate and oblate ellipsoids and so it is often not 







































2% Drop 16.0 1.14 18.2 19.6 200881 55 3521 64 16598 300 
2% Shell 16.0 1.14 18.2 19.6 201213 55 3521 64 16616 300 




















3.5% Drop 16.0 1.11 17.8 19.4 195061 54 3455 64 16272 302 
3.5% Shell 16.0 1.11 17.8 19.4 195061 54 3455 64 16272 302 
3.5% Core 16.0 1.11 17.8 19.5 195061 54 3455 64 16272 302 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the corresponding areas per 





Tween 20 micelles in the presence of steroids 
The SANS profiles and the model-fitted curves for the Tween 20 micelles in the 
presence and absence of steroids are displayed in Figure 4.26. The addition of the 
steroids to the micelles causes an increase in the scattering intensity as expected. In 
this case, these changes are much more noticeable for the d-Tween 20/H2O (shell) 
contrast because of the deuterated head group of the Tween 20. 
Since the head group of Tween 20 is very much larger than the head groups of all the 
other surfactants studied here, it might be expected that the solubilisation of the steroid 

















































Figure 4. 26 SANS profiles and model fits (solid line) for d-Tween 20 in H2O (a), d-
Tween in D2O (b) and h-Tween in D2O (c) micelles alone (black), micelles in the 
presence of saturation amounts of 4-CHOL (red) and ADRENO (blue) at 2.0 wt %. 
The values of the model-fitted parameters are listed in Table 4.19. Though the amounts 
of steroids solubilised in the micelles are not enough to cause a change in the shape of 
the micelles there is evidence of their increasing sphericity in the presence of 4-CHOL 






the shell thickness decreases slightly when ADRENO is solubilised in the micelle 
present at a Tween 20 concentration of 3.5 wt%.  
From the solubilisation studies (section 2.1), it was found that the molar ratios for 4-
CHOL and ADRENO were 1 per 5 and 50 molecules of Tween 20, respectively, and 
these findings are consistent with the calculated aggregation numbers given in Table 
4.19. These differences in solubilisation capacity, however, do not lead to any 
significant change in the shape of the Tween 20 micelles.  
Since the chain deuterated Tween 20 was not available for these studies, the scattering 
length density value of the hydrocarbon chain region was not adjusted. However, the 
fitted scattering length densities of the deuterated micelle shell region did not change 
upon addition of saturating amounts of the steroids. It is reasonable to predict, 
therefore, that the locus of solubilisation of 4-CHOL in Tween 20 micelles was in the 


















































Figure 4. 27 SANS profiles for d-Tween 20 in H2O (a), d-Tween 20 in D2O (b) and h- 
Tween 20 (c) in D2O micelles alone (black), micelles in the presence of saturation 
























Table 4. 19 Values of model fitted parameters for 2 wt% and 3.5 wt% Tween 20 micelles in the presence of steroids. 


















4-CHOL 2% Drop 16.0 1.12 17.9 19.5 197537 53 10 3477 66 16411 312 
2% Shell 16.0 1.12 17.9 19.5 30345 53 10 3477 66 16411 312 
2% Core 16.0 1.12 17.9 19.5 197537 53 10 3477 66 16411 312 
ADRENO 2% Drop 16.0 1.12 17.1 19.5 197537 54 1 3477 64 16411 302 
2% Shell 16.0 1.12 17.1 19.5 32613 54 1 3477 64 16411 302 














































4-CHOL 3.5% Drop 16.0 1.07 17.9 19.2 188503 50 10 3368 67 15902 317 
3.5% Shell 16.0 1.07 17.9 19.2 30377 50 10 3368 67 15902 317 




3.5% Drop 16.0 1.02 16.3 18.9 179365 49 1 3251 66 15381 312 
3.5% Shell 16.0 1.02 16.3 18.9 30371 49 1 3251 66 15381 312 
3.5% Core 16.0 1.02 16.3 18.9 179365 49 1 3251 66 15381 312 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and 







Aggregates behaviour of Brij 35 micelles 
SANS profiles are shown in Figure 4.28 for Brij 35 micelles only in the drop SANS 
contrast as deuterated Brij 35 was not available.  As expected, the scattering intensity 
is seen to increase with increasing surfactant concentration but very surprisingly there 
is an interaction peak seen at Q = 0.06 Å-1 and this becomes more pronounced as the 
surfactant concentration is increased. In model-fitting these SANS data, however, the 
hard sphere structure factor (HS S(Q)) was still used because physically sensible 


















Figure 4. 28 SANS profiles and model fits (solid line) for 2 wt % (black), 3.5 wt % (red) 
and 5 wt% (blue) h25Brij 35 in D2O  
The Brij 35 micelles were found to be prolate ellipsoidal with a core radius at 16.7 Å 
(Table 4.20). With increasing concentration, the micelles were found to become more 
spherical, with x decreasing from 1.2 to 1. The increase in surfactant concentration 
also led to a decrease in micelle volume by 5% and 19% at concentrations of 2 wt% 
and 5 wt%, respectively. 
Tummino and Gafni [200] studied the aggregation number of Brij 35 micelles using 
steady-state fluorescence quenching. They found that for 1.2 wt% Brij 35 at 30 oC, the 
micelles had an aggregation number of 53 ± 3. In later SANS studies carried out by 
Borbély, the aggregate structure of Brij 35 micelles was determined at different 
temperatures for concentrations ranging from 0.5 wt% to 20 wt% [201]. Borbély 
proposed that at low concentrations, the micelles could be modelled as a polydisperse 
spherical core with tethered polymer chains on the surface. Studied at 20 oC, the 
micelles were shown to have a core radius of 18 ± 0.5 Å, with aggregation numbers 




explained that the core radius of the micelles was longer than the fully extended length 
of a C12 chain because of the intrusion of hydrated poly (ethylene oxide) moieties into 
the micelle alkyl chain region.  At temperatures above 20 oC, the micelles are found 
to be larger, while the core radius increases only slightly. In the studies presented here 
the model used in describing the Brij 35 micelles is simpler than the one used by 
Borbély, but it is still considered satisfactory.  
Preu et al. have also reported studies of Brij 35 micelles using SANS and they too 
employ an ellipsoidal core/shell model to describe their geometry as a function of 
concentration [202]. These workers found aggregation numbers of 42, 42 and 44 for 
surfactant concentrations of 1 wt%, 4 wt% and 6 wt%, respectively, and the micelles 
formed were shown in all cases to be prolate ellipsoidal. The surfactant head groups 
were modelled as having 7 water molecules per ethylene oxide unit and the micelle 
shell thickness was quoted at 33 Å. In the present study, there were determined to be 
only 2 H2O per ethylene oxide unit and the shell thickness of the micelle was found to 









































2 wt%  16.7 1.24 20.7 19.0 211984 68 4077 60 17227 252 
3.5 wt%  16.7 1.15 19.2 18.6 196508 63 3860 61 16359 258 
5 wt%  16.7 1.01 16.9 18.0 175858 56 3528 63 15180 272 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle 
volume (Vm), micelle aggregation number (SAA Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and the 









Brij 35 micelles in the presence of steroids 
Figure 4.29 presents the SANS profiles and the model-fitted curves for Brij 35 
micelles in the absence and presence of 4-CHOL and ADRENO. In each contrast, 
there is no obvious change in the scattering intensities nor in the shapes of the curves. 
This suggests that the presence of the solubilised steroids does not perturb the structure 
of the Brij 35 micelles.  
 Q (Å-1)













































Figure 4. 29 SANS profiles and model fits (solid line) for 2 wt% (a), 3.5 wt% (b) and 5 
wt% (c) of h25Brij in D2O in the absence (black) and in the presence of 4-CHOL (red) 
and ADRENO (blue). 
This inference was confirmed by the values obtained for the model-fitted parameters 
(Table 4.21). The volumes of the micelles were increased by less than 5% upon the 
addition of 4-CHOL and ADRENO, and x increased by ~10% in the presence of the 
steroids.  
It was not possible from the SANS model-fitting to determine with any confidence 
whether there were changes in the micelle shell and core regions of the Brij 35 micelles 
caused by the addition of the 4-CHOL and ADRENO because of the similarity in the 






surfactant. Given also that there is also only 1 molecule of steroid solubilised per 























Table 4. 21 Values of model fitted parameters for 2 wt%, 3.5 wt% and 5 wt% Brij 35 micelles in the presence of steroids. 




















4-CHOL 2 wt% 16.7 1.33 22.2 19.4 227149 73 1 4297 59 18067 248 
3.5 wt% 16.7 1.33 22.2 19.4 227149 73 1 4297 59 18067 248 
5 wt% 16.7 1.30 21.7 19.3 222630 72 1 4224 59 17816 249 
ADRENO 2 wt% 16.7 1.31 21.9 19.3 223536 72 1 4248 59 17868 248 
3.5 wt% 16.7 1.23 20.5 19.0 211092 68 1 4053 60 17176 253 
5 wt% 16.7 1.20 20.0 18.8 205033 66 1 3980 60 16839 255 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole micelle (Sm) and 






4.4.4 The structure of dodecyl sulfate surfactant micelles in the 
presence of steroids as a function of time 
The neutron reflectivity studies of the surfactant monolayers showed that the time 
taken for the dodecyl sulfate surfactant monolayers to reach equilibrium when in the 
presence of 4-cholesten-3-one (4-CHOL) was very much longer than for the 
monolayers formed in the presence of saturation amounts of adrenosterone 
(ADRENO). It was hypothesised, therefore, that the time required for the dodecyl 
sulfate micelles to reach equilibrium in the presence of 4-CHOL would be longer than 
that required in the presence of ADRENO. In order to test this hypothesis, further 
SANS studies were performed to determine the effect of time on the dodecyl sulfate 
surfactant micelle dispersions in the presence and absence of the two steroids.  
SANS data were obtained using LOQ and only the drop (h25SAA in D2O) contrast was 
measured for each sample. As expected, there were no differences apparent in the 
SANS profiles recorded for the fresh surfactant micelle solutions in the absence of 
steroids and those recorded for the samples stored for 14 days, and this was the case 
regardless of the surfactant concentration and counterion (Appendix C). It is thus 
concluded that the dodecyl sulfate micelles are stable in solution even over a period 
of two weeks.  
The same observation was made for dodecyl sulfate micelles in the presence of 
ADRENO (Appendix C). There was no difference seen in any of the SANS profiles 
recorded beyond 6 hours and through to 14 days, suggesting that the amount of 
ADRENO solubilised within the micelles reaches a maximum at ≤ 6 hours.  
In order to monitor the kinetics of formation of the 4-CHOL/SAA micelles, the SANS 
measurements for each system were recorded at 6 hours, 12 hours, 1 day, 2 days, 3 
days, 5 days, 7 days, 9 days, 11 days, 14 days and 16 days. As shown in Figure 4.30, 
it can be confirmed that, unlike ADRENO, the time for the 4-CHOL/SAA systems to 
reach equilibrium is much longer than 6 hours. When comparing the SANS profiles 
of the micellar solutions in the presence of 4-CHOL collected after 6 hours, 1 day and 
7 days, the interaction peak is seen to shift to the left and the scattering intensity is 
seen to increase, while the shape of profile shows no significant change. It can be 




solubilised within the micelles increases over time. The SANS data were fitted by 
using the same method for anionic surfactant micelles and the values of the model-







































































































Figure 4. 30 SANS profiles and model fits (solid line) of dodecyl sulfate micelles in the 
presence of 4-CHOL at surfactant concentration 3 wt% (left column) and 5 wt%(right 
column) ○: 6 hours, ∆:1 day, ◊: 5 days, □: 7 days 
 
For the ADS and SDS micelles in the presence of 4-CHOL, the fitted parameters show 







equilibrium time is found to be ca. 5 days. There is no evidence to suggest a relation 














































6 hours 61.1 0.25 15.3 4.2 347850 15 454 120 30244 67 37826 83 
1 day 61.9 0.25 15.5 4.2 361255 18 472 125 31062 66 38826 82 
7 days 62.0 0.25 15.5 4.2 362807 21 474 126 31165 66 38942 82 
16 days 62.0 0.25 15.5 4.2 362807 21 474 126 31165 66 38942 82 
ADS 
5 wt% 
6 hours 68.6 0.21 14.2 4.3 410825 19 532 141 35587 67 43487 82 
1 day 68.8 0.21 14.2 4.3 414347 21 536 142 35759 67 43736 82 
7 days 69.0 0.21 14.3 4.3 418023 23 541 143 35971 66 44000 81 

















































6 hours 33.5 0.41 13.7 3.7 101064 25 114 37 11879 104 16474 144 
1 day 38.4 0.39 15.0 4.2 145336 32 164 53 15184 93 21061 129 
7 days 42.0 0.39 16.4 4.5 189114 35 214 69 18318 85 25341 118 




6 hours 35.8 0.42 15.0 4.0 126308 24 143 46 13938 98 19386 136 
1 day 43.7 0.36 15.7 4.5 196889 30 223 72 18714 84 25704 115 
7 days 44.56 0.36 16.0 4.6 208956 35 236 77 19489 82 26796 113 



















































6 hours 35.8 0.42 15.0 4.0 60746 22 67 16 13938 208 19386 289 
1 day 43.7 0.36 15.7 4.5 72906 24 80 19 18714 233 25704 320 
5 days 44.6 0.36 16.0 4.6 77421 26 85 20 19489 228 26796 314 




6 hours 27.0 0.49 13.1 4.4 71929 20 79 18 8751 110 13570 171 
1 day 29.2 0.46 13.4 4.6 86171 22 95 22 9781 103 15176 160 
5 days 31.6 0.46 14.5 5.0 109149 24 120 28 11577 96 17941 149 
16 days 31.8 0.46 14.6 5.0 111426 25 123 29 11748 96 18206 148 
Fitting parameters include the core equatorial radius (R1), core axial radius (R3), core axial ratio (x), shell thickness (δ), micelle volume (Vm), 
micelle charge (Z), micelle and steroids aggregation number (SAA Nagg and steroids Nagg), surface area for hydrocarbon chain (Score) and whole 
micelle (Sm) and the corresponding the area per molecule (Acore and Am). Uncertainty for R1, x, δ, Nagg, S and A = ± 0.3, ± 0.03, ± 0.3, ± 7, ± 




According to Table 4.22, the micelle core equatorial radius gets larger with time. The 
core axial radii in all cases are less than one, indicating that the micelles are oblate in 
shape and become flatter with time. The change in x with time is more pronounced for 
the 4-CHOL/SDS and 4-CHOL/LDS systems than for the 4-CHOL/ADS system. As 
expected, the size of the micelles in the presence of 4-CHOL also increases with time, 
as too do the aggregation numbers of the surfactant and steroids.  
It is interesting to note too that when comparing the extent of the increased size of 
micelles among SDS, LDS and ADS systems, the size of the ADS micelles in the 
presence of 4-CHOL only increases by less than 5% between 6 hours after saturating 
and reaching the equilibrium, while the growth rate of 4-CHOL/SDS micelles is the 
highest.   
To further study the properties of the dodecyl sulfate micelles in the presence of 
steroids at different times following their preparation, the concentrations of 4-CHOL 
and ADRENO in each micellar solution were determined using UV/VIS spectroscopy. 
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Figure 4. 31 Concentration of 4-cholesten-3-one in micellar solutions (at surfactant 
concentration □:  3 wt%, ○: 5 wt%) 






From Figure 4.31, it is clear that the concentration of 4-CHOL in the micellar solutions 
increases until equilibrium is reached. The time taken to reach equilibrium follows the 
order: ADS < SDS ≈ LDS.  
It should be noted that the solubilisation capacity of LDS for 4-CHOL is much lower 
than that of SDS and ADS, and so the increase in 4-CHOL in the LDS micelles may 
not be detected because of the limited sensitivity of the SANS measurements 







The micelles formed by nine different C12 chain surfactants (SAA), each with a 
different type of polar head group, were investigated using small angle neutron 
scattering (SANS), to probe the composition of the micelles in the presence and 
absence of the steroids, 4-cholesten-3-one (4-CHOL) and adrenosterone (ADRENO). 
The SANS studies were performed using the three different isotopic contrasts of 
d25SAA in H2O (the core contrast), d25SAA in D2O (the shell contrast) and h25SAA in 
H2O (the drop contrast). The three SANS profiles measured for each system were 
modelled individually until a consistent set of parameters describing the detailed 
structure of the micelles was obtained. The micelles were modelled as core-shell 
ellipsoids for which the core equatorial radius (R1), core axial ratio (x) and aggregation 
number (Nagg) were determined. 
The structures of the micelles formed by the anionic surfactants SDS, ADS and LDS 
were different from one another, testifying to the influence of the counterions on the 
surfactant aggregation behaviour. In all cases, however, the micelles formed were 
prolate ellipsoidal and became more elongated with increased surfactant 
concentration. The ADS micelles were much larger micelles than those formed by 
SDS and LDS but they were found to have a much thinner shell. The charge on these 
anionic micelles (modelled with a Hayter-Penfold structure factor) followed the order 
ADS < SDS < LDS.  
The addition of 4-CHOL caused a change in shape of the anionic surfactant micelles 
from prolate ellipsoidal to oblate and, as found for the steroid-free micelles, these 
tended to become flatter with increased surfactant concentration. In contrast, the 
addition of ADRENO caused no significant change in structure of the anionic 
surfactant micelles, and the ADRENO-saturated SDS micelles were found to be 
spherical rather than ellipsoidal. The locus of solubilisation of the steroids in the 
anionic surfactant micelles was confirmed as the micelle core region as evidenced by 
the fitted scattering length density for the micelle core obtained in model-fitting the 
SANS profiles for the core and shell contrasts.  
By comparison with the ionic surfactant micelles, the changes in micelle structure 




were very much smaller. This can be explained by the much lower solubilisation 
capacities of these surfactants for the steroids (as determined through the solubilisation 
studies; section 2.1). It is interesting to note here though that in some of these systems, 
increasing surfactant concentration led to the micelles becoming more spherical while 
in other cases the micelles tended to be more elongated with increased surfactant 
concentration.  
The SANS studies detailed here clearly show that the charge and hydration of a 
surfactant’s polar head group can significantly affect the level of steroid solubilisation. 
Electrostatic interactions between charged head groups modulate the packing of 
surfactant molecules within a micelle and so change the volumes of the core and shell. 
Hydrogen bond interactions between the solubilised steroid and the surfactant head 
groups will influence the orientation of the steroid within the micelle and thereby 
affect how the steroid inserts into the aggregate.  
SANS studies of the dodecyl sulfate/steroid micelles performed as a function of time 
showed that the ADRENO/SAA system reached equilibrium after 6 hours, while the 
4-CHOL/dodecyl sulfate micellar systems required 5 – 7 days to reach equilibrium. It 
was also found that although the shape and size of the 4-CHOL/SAA micelles showed 
little change over time, the amount of 4-CHOL that was solubilised within the micelles 




Chapter 5  
 
Conclusions and future prospects 
5.1 Conclusions 
The solubilisation of drugs within surfactant micelles has long been considered as a 
means by which to facilitate the formulation and delivery of drugs that have poor 
aqueous solubility. Unfortunately, however, for any given drug and any given micellar 
surfactant, it is not yet possible to predict with any certainty either the amount of drug 
that can be solubilised inside the micelle or its locus of solubilisation. 
In the work reported here the aim was to clarify the link between the structures of 
surfactant molecules and the micelles they form in aqueous solution, and then to 
determine how these influence the level and manner of solubilisation of two poorly 
water-soluble drug-like compounds, 4-cholesten-3-one (4-CHOL) and adrenosterone 
(ADRENO). A range of C12-chain surfactants with varying head group were used to 
solubilise the two steroids, and the physical-chemical properties of the surfactant 
micelles were determined in their presence and absence. 
On the basis of the collected findings from these various studies, the following general 
conclusions are drawn: 
• A priori, the solubilisation of solutes within surfactant micelles will be affected 
by the shape of the micelles, and this in turn will be influenced by the surfactant 
molecular interfacial surface area. 
From the SANS studies performed here, it is seen that the ionic surfactants occupy 
relatively lower interfacial molecular surface areas in their micelles compared with the 
zwitterionic and non-ionic surfactants (viz., 60 – 80 Å2 vs. ~90 Å2 and 250 – 300 Å2, 
respectively), and (from the solubilisation studies performed) it is found that the 




CHOL and ADRENO, and the non-ionic surfactants, Brij-35 and Tween 20, solubilise 
the least. 
• A priori, the solubilisation of solutes within a given type of surfactant micelles 
will be affected by the size of the micelles, with the expectation that larger 
volume micelles are likely to incorporate higher levels of solute. 
The SANS studies of the anionic surfactant micelles provide some support for this 
assertion, in that at low surfactant concentrations (3 wt% and 5 wt%) the SDS micelles 
solubilise less than the ADS micelles, the latter having a larger volume than the former. 
The opposite trend is seen, however, at the higher surfactant concentrations (> 10 wt%), 
and it is also noted from the SANS studies, that the solubilisation of 4-CHOL and 
ADRENO leads to changes in the sizes and shapes of the surfactant micelles.  
• Solutes that have extensive apolar molecular surface areas are most likely to 
insert into the hydrocarbon chains layer of a surfactant monolayer, and are 
most likely to be solubilised in the hydrophobic core of a surfactant micelle. 
The locus of solubilisation of 4-CHOL and ADRENO in the C12-chain surfactants was 
made by determining the structures of the surfactant monolayers at the air-water 
interface using neutron reflectivity (NR), and in the surfactant micelles in bulk solution 
using small angle neutron scattering (SANS). It was shown that 4-CHOL and 
ADRENO inserted into the hydrocarbon layer of the C12-chain surfactants monolayers 
and into the micelle cores – and this was regardless of the nature of the surfactant head 
group. Such findings accord with the generally non-polar nature of the two steroids 
(Figure 5.1) and given that these two molecules have quite different shapes, polar 
surface areas, and amphiphilicities (Figure 5.1), it is easy to see why 4-CHOL is 
solubilised within the surfactant C12-chains to a greater extent than ADRENO. 
• The findings from neutron reflectivity studies of a solute’s interactions with a 
surfactant monolayer formed at the air-water interface might reasonably be 
assumed to give clues as to the solubilisation of the solute within the surfactant 
micelles. 
For the ionic surfactants (SDS, ADS, LDS and DTAB), the level of 4-CHOL and 
ADRENO solubilised within the surfactant monolayers (determined through the 




solubilisation of the steroids seen in the corresponding micelles (determined through 
the SANS studies), but this appears not to be true for the zwitterionic surfactants (DPC 
and DDAO) (Figure 5.2). It would seem, therefore, that caution should be exercised 
when using the findings from studies of a drug’s interactions with surfactant 
monolayers to extrapolate its interactions with aggregates in the bulk. 
 
  
Figure 5. 1 Space-filling models of adrenosterone (left) and 4-cholesten-3-one (right), 
generated using Accelrys Discovery Studio 4.0. The molecular surface associated 
with oxygen atoms is coloured red; all other surface is shown in grey. 
Molar ratio from NR






























 Figure 5. 2 The molar ratio obtained from solubilisation (y axis) and NR (x axis) 




• Non-polar solutes that are solubilised in the core of a surfactant micelle are 
unlikely to be well-solubilised if the surfactant carries a polar head group that 
is heavily hydrated (since this will hinder its insertion into the micelle core). 
This assertion is supported by the findings from the SANS studies reported here, 
wherein it is seen that the heavily hydrated non-ionic surfactants, Brij 35 and Tween 
20, have extremely low solubilisation capacities for the non-polar solutes, 4-CHOL 
and ADRENO, while the ionic and zwitterionic surfactants – that have head groups 
that are much less heavily hydrated – have higher solubilisation capacities for these 
steroids.  
• Electrostatic interactions between the head groups of surfactants will 
modulate the packing of the molecules within the micelle and as a consequence 
will change the volumes of the micelle core and shell, and these changes in 
turn will affect the level of solubilisation of solutes. 
The solubilisation measurements and SANS studies performed here show clearly that 
there are marked differences in the levels of steroid solubilisation between ionic, 
zwitterionic and non-ionic surfactants, and these differences can in part be attributed 
to ion-dipole interactions between the charged and zwitterionic surfactant headgroups 
and the surrounding water molecules. 
• Hydrogen bond interactions between a solute and the head group of the 
solubilising surfactant are likely to influence the orientation of the solute 
within the micelle and will thus affect how the solute inserts into the aggregate. 
None of the experiments performed and reported here provide information to allow 
this hypothesis to be tested because the analytical modelling of the reflectivity and 
SANS data cannot furnish details of the orientation of solutes within a surfactant 
monolayer or micelle. 
• The solubilisation capacity of non-ionic surfactant is much lower than that of 
ionic surfactants. 
Micelle-forming surfactants will generally disrupt the structure and integrity of 
biological membranes and because of this they can be irritant when applied to the skin 
and can be toxic when ingested. The usefulness of a surfactant as an aid to the 




solubilisation capacity but also on its relative toxicity. While non-ionic surfactants are 
not electrically charged and show minimal toxicity, their solubilisation capacities – as 
shown here in the solubilisation and SANS studies – are much lower than found for 
ionic and zwitterionic surfactants. The solubilisation capacities of the ionic surfactants 
are shown to be significantly greater than the non-ionic surfactants, but their toxic 
effects make them less ideal in drug solubilisation.  
• The time needed for solutes to reach equilibrium when inserting into surfactant 
monolayers or when solubilised in micellar solutions will depend on the 
nature/structure of the solute. 
For the solubilisation of ADRENO, the NR studies performed here show that the time 
needed to reach equilibrium is of the order of minutes when the surfactant is organised 
as a monolayer at the air-water interface, and from the SANS studies performed here 
the equilibration time is shown to be of the order of 6 hours when the steroid inserts 
into the surfactant micelles. The solubilisation of 4-CHOL in the dodecyl sulfate 
surfactant monolayers and micelles takes much longer to reach equilibrium than does 
ADRENO – the equilibration time for the monolayers being around 12 hours and for 
the micelles, 5 – 7 days. For the various other surfactants studied here, the equilibration 
times for solubilisation of the 4-CHOL and ADRENO are much shorter and more 
similar. 
The studies here thus show that the equilibration times not vary according to the nature 
of the solute but also according to the nature of the surfactant. Moreover, while there 
have been some studies reported previously in which it has been noted that the transfer 
rate of drugs into surfactant micelles depends on the nature of the micelle [203-205], 
there are no reports of systems that exhibit equilibrium times as long as those observed 
here. 
5.2 Future prospects 
• In all of the different C12-chain surfactant micelles studied here, 4-cholesten-
3-one was solubilised to a far greater extent than adrenosterone. These two 
steroids have a similar molecular weight but different topography and 




studies for other poorly water-soluble steroids which show other, perhaps more 
significant, variations in structure. Such studies might include, for example, 
cholesterol – which has a hydroxyl at C3, or campesterol which has a hydroxyl 
at C3 and a dimethylheptyl chain at C17.  
It should also be noted here, however, that the modelling of both the neutron 
reflectivity data obtained for surfactant monolayers and the SANS data 
obtained for surfactant micelles would benefit greatly from having an 
additional isotopic contrast provided through the use of a perdeuterated or 
selectively deuterated steroid. With the additional isotopic contrasts so 
provided, it would then be possible more clearly to define the locus of steroid 
solubilisation. 
• The locus of surfactant solubilisation of 4-CHOL and ADRENO were made 
here using the neutron contrast variation afforded through the use of D2O/H2O 
mixtures and protiated and chain deuterated surfactants. The contrasts used, 
however, did not allow the interaction of the two steroids with the hydrophilic 
head groups of the surfactant micelles to be explored. With the additional 
isotopic contrast(s) which would be afforded with the availability and use of 
head group deuterated surfactants, it would be much easier to determine the 
extent to which the steroid molecules inserted into the surfactant monolayers 
and micelles. 
• The details of solute orientation and solute-surfactant interatomic interactions 
in surfactant micelles – which are difficult to determine unambiguously simply 
by analytic modelling of SANS data – could be explored using full atom 
molecular dynamics simulations. 
• The long equilibration times seen for the insertion of 4-CHOL into SDS, LDS 
and ADS monolayers and for the solubilisation of this steroid in the micelles 
formed by these surfactants is speculated to be due to the water inserted 
between the surfactant head groups hindering the entry of the 4-CHOL 
molecules. In truth, however, none of the various experiments performed here 
allow the structural basis of these long equilibration times to be determined, 
and there are no other studies reported where similarly long equilibrium times 
have been seen. Further studies are thus needed to explain this phenomenon 




surfactant (such as sulfonates and gluconates), and make use of head group 
deuterated surfactants and/or deuterated steroids to probe the mechanism of 
the solubilisation process in detail. 
A systematic and comprehensive study of a wide range of surfactants with two 
different solutes was performed here. With an improved understanding of the 
relationship between surfactant and solute molecular structure and its influence on the 
locus of a drug’s solubilisation within a surfactant micelle, it might be hoped that we 
would then be better able to make a quantitative prediction of the level of drug 
solubilised in a specific micelle system and so be better able to select/design 
surfactants to speed up the drug formulation process. The studies performed here go 
only part of the way towards achieving these ends and much more work is needed 
before the process of formulating poorly water soluble drugs using surfactant micelles 












Appendix A Supplementary solubilisation, viscometry and densitometry results 
Table A. 1 Amount of 4-cholesten-3-one (wt%) solubilised in aqueous solutions of surfactant micelles at ambient temperature 
Surfactant. 
concentration wt% 
SDS ADS LDS DTAB DPC DDAPS DDAO Tween 20 Brij 35 
2.5 0.52 ± 0.04 1.02 ± 0.01 0.27 ± 0.06 0.11 ± 0.01 0.09 ± 0.00 0.10 ± 0.00 0.19 ± 0.01 0.16 ± 0.00 0.01 ± 0.00 
5 1.62 ± 0.25 2.36 ± 0.07 1.23 ± 0.03 0.19 ± 0.00 0.11 ± 0.01 0.22 ± 0.00 0.37 ± 0.01 0.30 ± 0.00 0.03 ± 0.00 
7.5 2.76 ± 0.15 3.10 ± 0.13 1.72 ± 0.21 0.33 ± 0.03 0.17 ± 0.02 0.35 ± 0.01 0.61 ± 0.02 0.45 ± 0.02 0.05 ± 0.00 
10 3.94 ± 0.10 4.03 ± 0.22 2.87 ± 0.20 0.51 ± 0.06 0.19 ± 0.01 0.48 ± 0.03 0.78 ± 0.02 0.60 ± 0.01 0.07 ± 0.00 
12.5 4.85 ± 0.25 4.89 ± 0.33 3.88 ± 0.87 0.74 ± 0.03 0.27 ± 0.01 0.63 ± 0.04 0.94 ± 0.01 0.74 ± 0.02 0.08 ± 0.00 













Table A. 2 Amount of adrenosterone (wt%) solubilised in aqueous solutions of surfactant micelles at ambient temperature 
Surfactant 
concentration wt% 
SDS ADS LDS DTAB DPC DDAPS DDAO TWEEN BRIJ SACR 
2.5 0.43 ± 0.01 0.28 ± 0.01 0.33 ± 0.01 0.16 ± 0.00 0.07 ± 0.00 0.12 ± 0.00 0.13 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.10 ± 0.00 
5 0.73 ± 0.07 0.47 ± 0.03 0.62 ± 0.01 0.29 ± 0.01 0.13 ± 0.00 0.22 ± 0.00 0.19 ± 0.02 0.04 ± 0.00 0.03 ± 0.00 0.15 ± 0.00 
7.5 0.99 ± 0.02 0.61 ± 0.04 0.86 ± 0.02 0.36 ± 0.03 0.18 ± 0.01 0.31 ± 0.01 0.25 ± 0.02 0.05 ± 0.00 0.04 ± 0.00 0.20 ± 0.00 
10 1.18 ± 0.05 0.72 ± 0.04 1.04 ± 0.01 0.47 ± 0.02 0.23 ± 0.00 0.41 ± 0.02 0.30 ± 0.02 0.06 ± 0.00 0.05 ± 0.00 0.23 ± 0.01 
12.5 1.40 ± 0.11 0.80 ± 0.01 1.25 ± 0.04 0.55 ± 0.03 0.28 ± 0.00 0.50 ± 0.02 0.36 ± 0.02 0.07 ± 0.00 0.06 ± 0.00 0.25 ± 0.01 







Table A. 3 The reduced and inherent viscosity of SDS micellar solution at 25 ± 0.1 oC 
SDS Concentration wt% Reduced viscosity Inherent viscosity 
5.0 4.44 ± 0.02 4.02 ± 0.01 
4.5 4.34 ± 0.00 3.97 ± 0.00 
4.0 4.26 ± 0.04 3.95 ± 0.03 
3.5 4.17 ± 0.05 3.92 ± 0.05 
3.0 4.09 ± 0.02 3.87 ± 0.02 
 
Table A. 4 The reduced and inherent viscosity of DTAB micellar solution at 25 ± 0.1 oC 
DTAB Concentration wt% Reduced viscosity Inherent viscosity 
5.0 3.64 ± 0.00 3.35 ± 0.00 
4.5 3.58 ± 0.00 3.32 ± 0.00 
4.0 3.52 ± 0.00 3.29 ± 0.00 
3.5 3.47 ± 0.00 3.28 ± 0.00 
3.0 3.42 ± 0.00 3.25 ± 0.00 
 
Table A. 5 The reduced and inherent viscosity of DDAO micellar solution at 25 ± 0.1 oC 
DDAO Concentration wt% Reduced viscosity Inherent viscosity 
5.0 5.31 ± 0.00 4.71 ± 0.00 
4.5 5.18 ± 0.00 4.66 ± 0.00 
4.0 5.06 ± 0.00 4.60 ± 0.00 
3.5 4.92 ± 0.00 4.54 ± 0.00 
3.0 4.78 ± 0.00 4.47 ± 0.00 
 
Table A. 6 The reduced and inherent viscosity of DDAPS micellar solution at 25 ± 0.1 
oC 
DDAPS Concentration wt% Reduced viscosity Inherent viscosity 
5.0 4.24 ± 0.00 3.85 ± 0.00 
3.8 3.96 ± 0.00 3.70 ± 0.00 
3.0 3.79 ± 0.00 3.59 ± 0.00 
2.5 3.66 ± 0.00 3.50 ± 0.00 









Table A. 7 The reduced and inherent viscosity of Brij 35 micellar solution at 25 ± 0.1 oC 
Brij 35 Concentration wt% Reduced viscosity Inherent viscosity 
10.0 22.30 ± 0.00 11.72 ± 0.00 
6.7 14.27 ± 0.22 10.03 ± 0.11 
5.0 12.74 ± 0.05 9.85 ± 0.03 
4.0 11.58 ± 0.20 9.52 ± 0.13 
3.3 10.98 ± 0.02 9.36 ± 0.01 
 
Table A. 8 The reduced and inherent viscosity of SDS micellar solution in the presence 
of 4-cholesten-4-one at 25 ± 0.1 oC 
SDS Concentration wt% Reduced viscosity Inherent viscosity 
5.0 7.26 ± 0.02 6.20 ± 0.02 
4.5 6.97 ± 0.00 6.06 ± 0.00 
4.0 6.70 ± 0.00 5.93 ± 0.00 
3.5 6.45 ± 0.00 5.81 ± 0.00 
3.0 6.20 ± 0.00 5.68 ± 0.00 
 
Table A. 9 The reduced and inherent viscosity of SDS micellar solution in the presence 
of adrenosterone at 25 ± 0.1 oC 
SDS concentration wt% Reduced viscosity Inherent viscosity 
5.0 4.93 ± 0.01 4.41 ± 0.01 
4.5 4.79 ± 0.02 4.34 ± 0.01 
4.0 4.68 ± 0.02 4.29 ± 0.02 
3.5 4.58 ± 0.00 4.24 ± 0.00 
3.0 4.47 ± 0.00 4.19 ± 0.00 
 
Table A. 10 The reduced and inherent viscosity of DTAB micellar solution in the 
presence of 4-cholesten-4-one at 25 ± 0.1 oC 
DTAB concentration wt% Reduced viscosity Inherent viscosity 
5.0 3.75 ± 0.02 3.44 ± 0.01 
4.5 3.69 ± 0.00 3.42 ± 0.00 
4.0 3.66 ± 0.05 3.42 ± 0.04 
3.5 3.60 ± 0.01 3.39 ± 0.01 








Table A. 11 The reduced and inherent viscosity of DTAB micellar solution in the 
presence of adrenosterone at 25 ± 0.1 oC 
DTAB concentration wt% Reduced viscosity Inherent viscosity 
5.0 3.92 ± 0.04 3.58 ± 0.03 
4.5 3.87 ± 0.00 3.57 ± 0.00 
4.0 3.81 ± 0.01 3.55 ± 0.00 
3.5 3.80 ± 0.04 3.57 ± 0.04 
3.0 3.71 ± 0.01 3.51 ± 0.01 
 
Table A. 12 The reduced and inherent viscosity of DDAPS micellar solution in the 
presence of 4-cholesten-4-one at 25 ± 0.1 oC 
DDAPS concentration wt% Reduced viscosity Inherent viscosity 
5.0 4.47 ± 0.01 4.04 ± 0.01 
3.8 4.29 ± 0.06 3.98 ± 0.06 
3.0 4.10 ± 0.06 3.87 ± 0.06 
2.5 4.00 ± 0.07 3.81 ± 0.07 
2.2 3.96 ± 0.09 3.79 ± 0.08 
 
Table A. 13 The reduced and inherent viscosity of DDAPS micellar solution in the 
presence of adrenosterone at 25 ± 0.1 oC 
DDAPS concentration wt% Reduced viscosity Inherent viscosity 
5.0 4.41 ± 0.01 4.00 ± 0.00 
3.8 4.21 ± 0.04 3.91 ± 0.03 
3.0 4.07 ± 0.00 3.84 ± 0.00 
2.5 3.95 ± 0.10 3.77 ± 0.09 
2.2 3.97 ± 0.00 3.81 ± 0.00 
 
Table A. 14 The intrinsic viscosity [η], density of solvent ρ0, partial specific volume ?̅?𝟏 




3/g) ρ1 (g/mL) 
SDS 3.64 0.9999 0.867 1.1533 
SDS + 4-cholesten-3-one 4.76 0.9999 0.863 1.1589 
DTAB 3.10 0.9979 0.927 1.0790 


























Figure B. 1 NR profile for monolayer of d25-SDS in ACMW (blue) and D2O (red) in 























Figure B. 2 NR profile for monolayer of d25-SDS in ACMW (blue) and D2O (red) in 

























Figure B. 3 NR profile for monolayer of d25-SDS in ACMW (blue) and D2O (red) in the 




















































Figure B. 4 NR profile for monolayer of d25-SDS in ACMW (red) and D2O (blue) in the 


















































Figure B. 5 NR profile for monolayer of d25-DTAB in ACMW (red) and D2O (blue) in 























































Figure B. 6 NR profile for monolayer of d25-DDAO in ACMW (red) and D2O (blue) in 





















































Figure B. 7 NR profile for monolayer of d25-DDAPS in ACMW (red) and D2O (blue) in 




















































Figure B. 8 NR profile for monolayer of d25-DPC in ACMW (red) and D2O (blue) in the 






Table B. 1 χ2 values obtained for modelling of the NR profile of surfactant at the air-
water interface in the presence of 4-CHOL at 2 x CMC using model 1, 2 and 3. 
Fitting model SDS DTAB DDAO DDAPS DPC 
1 91.2 10.7 15.7 14.5 12.4 
2 40.6 12.5 16.8 8.7 19.6 
3 10.4 12.6 24.4 14.0 31 
 
Table B. 2  χ2 values obtained for modelling of the NR profile of surfactant at the air-
water interface in the presence of ADRENO at 2 x CMC using model 1, 2 and 3. 
Fitting model SDS DTAB DDAO DDAPS DPC 
1 6.5 12.7 18.2 14.4 9.5 
2 7.1 11.7 22.5 14.4 17.5 








































































































Figure C. 1 SANS profiles of 3 wt% (black) and 5 wt% (red) for d25 SDS in D2O 
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